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Summary 
The major goal of this work was to investigate whether human eccrine sweat gland 
cells, in analogy to cells of the hair-follicle bulge, exhibit the capacity to develop into a 
functional epidermis. Conclusive results towards this question were not reported so 
far. 
To address this issue, I generated dermo-epidermal skin substitutes in vitro. All skin 
substitutes were based on collagen hydrogels, containing human primary dermal 
fibroblasts within the gel, and eccrine sweat gland cells on the gel (or epidermal 
keratinocytes as controls). Skin substitutes generated in vitro were transplanted onto 
the backs of immuno-incompetent rats and the expression of epidermal markers, 
indicative of the grade of homeostasis and differentiation, was determined. In 
addition, potential stem cell markers were tested. I was able to demonstrate both, in 
vitro and in vivo, the capability of human eccrine sweat gland cells to form a stratified 
interfollicular epidermal substitute on collagen hydrogels (Biedermann, 2010). This 
was substantiated by the following findings: (1) A stratified epidermis consisting of 
10-12 cell layers is formed by sweat gland cells. (2) A distinct stratum corneum 
develops and is maintained after transplantation onto immuno-incompetent rats. (3) 
Indicative proteins, such as filaggrin, loricrin, involucrin, envoplakin, periplakin, and 
transglutaminases I and III, are matching the characteristic expression pattern of 
normal human skin. (4) Junctional complexes and hemidesmosomes are readily and 
regularly established. (5) Cell proliferation in the basal layer reaches homeostatic 
levels. (6) The sweat gland derived epidermis is anchored by hemidesmosomes 
within a well developed basal lamina. (7) Palmoplantar or mucosal markers are not 
expressed in the sweat gland derived epidermis. These data suggest that human 
eccrine sweat glands are an additional source of keratinocytes that can generate a 
stratified epidermis. Based on these findings a novel question arises, namely as to 
which extent human skin is repaired and/or permanently renewed by eccrine sweat 
gland cells. 
I am presently determining if sweat gland cells forming an epidermis are capable to 
take up melanin, produced by melanocytes (Biedermann, in preparation). If so, this 
would prove that sweat gland cells are indeed fully differentiated epidermal 
keratinocytes, because this characteristic was never observed before to be a 
property of eccrine sweat gland cells. 
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Zusammenfassung 
Das Hauptziel dieser Arbeit war es, nachzuweisen, ob humane ekkrine 
Schweissdrüsenzellen, in Analogie zum Haarfollikel-Bulge, die Fähigkeit besitzen, 
eine Epidermis zu bilden. Eindeutige Resultate hinsichtlich dieser Fragestellung 
wurden bisher nicht gezeigt. 
Ich habe dazu dermo-epidermale Hautsubstitute hergestellt. Diese Hautsubstitute 
basieren auf Kollagenhydrogelen, die humane primäre dermale Fibroblasten im Gel 
enthalten und auf deren Oberfläche ekkrine Schweissdrüsenzellen (oder aber 
normale epidermal Keratinozyten – als Kontrollzellen) aufgebracht wurden. 
Die auf Vollhautwunden immun-inkompetenter Nacktratten transplantierten 
Substitute wurden auf epidermale Marker der Gewebshomeostase und der 
Hautdifferenzierung,  aber auch bezüglich potentieller Stammzellmarker getestet. 
Ich konnte nachweisen, dass humane ekkrine Schweissdrüsenzellen sowohl in vitro 
als auch in vivo fähig sind, eine stratifizierte interfollikuläre Epidermis auf Kollagen- 
Hydrogelen zu bilden (Biedermann, 2010). Dies wird durch folgenden Befunde 
untermauert: (1) Eine stratifizierte Epidermis, bestehend aus 10-12 Zellschichten, 
wird durch Schweissdrüsenzellen gebildet. (2) Es entwickelt sich ein ausgeprägtes 
Stratum Corneum, das auch nach Transplantation auf immuninkompetente Ratten 
vorhanden ist. (3) Proteine wie Filaggrin, Loricrin, Involucrin, Envoplakin, Periplakin, 
Transglutaminase I und III zeigen das gleiche charakteristische Expressionsmuster 
wie in normaler humaner Haut. (4) Junctionale Komplexe und Hemidesmosomen 
werden etabliert. (5) Die Zellproliferation in der basalen Schicht erreicht ein 
homoestatisches Niveau. (6) Die aus Schweissdrüsenzellen resultierende Epidermis 
ist durch Hemidesmosomen auf einer gut entwickelten Basallamina verankert. (7) In 
der aus Schweissdrüsenzellen gebildeten Epidermis sind keine palmo-plantaren oder 
mukosalen Marker vorhanden. Diese Resultate sind ein starker Beleg dafür, dass 
Schweissdrüsen eine zusätzliche Quelle für epidermale Keratinocyten sind, die eine 
stratifizierte Epidermis bilden können. Die gewonnenen Erkenntnisse erlauben 
nunmehr die weiterführende Frage, in welchem Ausmaß ekkrine 
Schweissdrüsenzellen fähig sind, die humane Haut zu reparieren und/oder sie 
ständig zu erneuern. 
Gegenwärtig versuche ich nachzuweisen, ob Schweissdrüsenzellen, die eine 
Epidermis bilden, Melanin aufnehmen können, welches Melanocyten produziert 
haben (Biedermann, in preparation). Dies würde zusätzlich unterstreichen, dass 
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Schweissdrüsenzellen voll funktionsfähige epidermale Keratinocyten sind, da dies 
eine Eigenschaft ist, die nicht bei Schweissdrüsenzellen, die als solche in der 
Schweissdrüse funktionieren, beobachtet werden kann. 
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1   Introduction 
 
1.1 Structure and function of human skin 
As the largest organ of the body and the interface between the body and the 
environment, the skin plays a fundamental role in protecting and maintaining the 
internal milieu of humans. Moreover, the skin is responsible for mediating immune 
reactions and sensory input. The skin consists of the superficial ectodermally derived 
epidermis, the dermis originated from the mesoderm and the subcutaneous fat 
tissue, the hypodermis (Fig. 1). The total surface of the skin of a human adult is 
about 1.5 - 2 m2 and the skin weights about 1/6 of the total body weight. Depending 
on the site of the body its thickness varies between 1.5 – 4 mm, not including the 
hypodermis. Keratinocytes are the main cell type in the epidermis; other less frequent 
cells are melanocytes, Langerhans and Merkel cells. The basement membrane 
separates the epidermis from the underlying dermis. Fibroblasts are the dominating 
cell type in the dermis, producing extracellular matrix components such as elastic 
fibres, collagenous fibres and reticular fibres. Furthermore, the dermis contains blood 
vessels in the papillary and reticular compartments for nourishment. Importantly, the 
epidermis is supported via diffusion from the dermal connective tissue.  
In addition, skin appendages and adnexal structures, like hair follicles, sebaceous 
glands, sweat glands and nails are situated in the human skin.  
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Figure 1: Epidermis and skin appendages. The epidermis, the dermis and hypodermis (fat 
tissue) compose the skin. Skin appendages such as hair follicles, sebaceaous and sweat 
glands reside in the dermis. (BL: basal layer, SL: spinous layer, GL: granular layer, SC: 
stratum corneum) (Fuchs, 2002).  
 
 
 
 
 
 
 
Fat tissue  
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1.2  The Epidermis 
1.2.1 Structure and function of human epidermis 
The outermost surface of the body is the stratified squamous epidermis. This part of 
the skin is the first barrier against environmental influences. It protects against 
physical and chemical environmental influences, such as UV-light or against 
microbial assaults like bacteria or fungi (Proksch, 2008). Moreover the epidermis is 
important to prevent dehydration, protein and electrolyte loss. The epidermis consists 
mainly of keratinocytes (Fig. 2) and among them reside pigment producing 
melanocytes, Langerhans cells as cells of the immune system (Merad, 2008) and 
touch sensing Merkel cells (Halata, 2003, Moll, 2005, Lucarz, 2007). The innermost 
layer of the epidermis, the basal layer (stratum basale), rests on the basement 
membrane (Freinkel, 2001). Keratinocytes in this layer proliferate, giving rise to more 
differentiated cells of the stratum spinosum, granulosum and corneum. The 
outermost layer, the stratum corneum, consists of terminally differentiated (dead) 
cells.  
 
 
 
 
Figure 2: Structure of human interfollicullar epidermis. The epidermis consists of 
keratinocytes, melanocytes, Langerhans and Merkel cells. (http://www.med-
ed.virginia.edu/courses/cell/handouts/images/Skin2.jpg). 
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1.2.2 Keratinocytes 
As keratinocytes (Fig. 3) are the main cell type of the epidermis they are responsible 
of replenishing the epidermis throughout life. There is a dynamic state between 
keratinocyte stem cells, progeny cells, more differentiated cells and terminally 
differentiated cells (Blanpain, 2009). One epidermal keratinocyte stem cell has the 
capacity to give rise to enough cells to cover the body surface (Rochat, 1994, Watt, 
2000).  
The progeny cells of the stem cells, residing in the basal layer, are referred to as 
transit amplifying cells (Jones, 1993, Jones, 1995). Transit amplifying cells are 
rapidly dividing cells that proliferate until they withdraw from the cell cycle starting 
their terminal differentiation. For differentiation, keratinocytes detach from the 
basement membrane by losing their anchorage by hemidesmosomes (Barrandon, 
1987, Watt, 1998). They enter the spinous layer and modify their cytoskelatal 
composition and intercellular connections. Important intercellular adhering junctions 
are desmosomes. They serve to attach neighbouring cells to each other. 
Desmosomes are found predominantly in the epidermis and the heart (Green, 2000). 
Functionally, they consist of three families of proteins. To these belong cadherins 
(desmocollins and desmogleins), plakins (desmoplakin) and armadillo proteins 
(plakoglobin and plakophilins). The localization of desmogleins and plakophilins 
varies in the epidermis, whereas proteins like plakoglobin and desmoplakin are 
expressed throughout the epidermis. As example, desmoglein 1 (Dsg1) is found in 
the upper epidermal layers. High expression levels of desmoglein 3 (Dsg3) are 
detected in lower layers (Kottke, 2006). The differential expression pattern in the 
epidermis could play a role in tissue morphogenesis. Desmoglein 1 normally 
promotes terminal differentiation of keratinocytes in upper epidermal layers, whereas 
Desmoglein 3 might function in proliferation of keratinocytes. This was confirmed by 
the observation that overexpression of desmoglein 3 caused hyperproliferation in 
upper epidermal layers of transgenic mice (Merritt, 2002). 
Desmosomes are anchored to the intermediate filament cytoskeleton (Green, 2007). 
Hence, desmosomes provide rigidity and strength to keratinocytes. This function was 
confirmed by studies showing that an autoantibody against desmoglein 3 destroyed 
the desmosomes causing the skin disease pemphigous vulgaris (Jones, 1986, 
Amagai, 1991, Payne, 2004).  
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As keratinocytes enter the granular layer they produce proteins necessary to 
establish the epidermal barrier. Tight junctions are most important for the constitution 
of the epidermal water barrier. They also regulate the paracellular flux of water-
soluble molecules between adjacent cells (Turksen, 2002). The main structural 
proteins of tight junctions are claudins and occuldins. There exist approximately 24 
subtypes of claudins. Each of the claudins displays a unique tissue expression 
pattern. In the epidermis the main claudins are claudin 1 and 4 (Furuse, 2006). 
Claudins also bind to other membrane macromolecules, including the zona 
occludens (ZO) proteins ZO-1, ZO-2, ZO-3, and multi-PDZ domain protein-1 
(Anderson, 2004, Niessen, 2007). The ZOs provide a direct link to the actin 
cytoskeleton of keratinocytes. 
In the stratum corneum the cells have turned into dead flattened squames 
constituting the outer protective cell layer. 
 
 
Figure 3: Human primary keratinocytes in culture. These keratinocytes were isolated from a 
human skin biopsy and cultured on cell culture plastic. (bar, 100 µm). 
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1.2.2.1 Cytokeratins 
 
Eucaryotic cells contain three major types of cytoskeletal proteins: microtubles, actin 
filaments (microfilaments) and intermediate filaments (Fig. 4). 
Keratins belonging to the group of intermediate filaments are structural proteins in 
epithelial cells (Fuchs, 1995). They are classified according to their biochemical 
properties (Moll, 1982, Moll, 1992). There are type I or acidic and type II or basic 
epithelial keratins. Type I keratins are the (cyto-) keratins K9-20 and type II keratins 
are the (cyto-) keratins K1-8. Furthermore, there are also type I (K31-40) and type II 
(K81-86) hair keratins (Schweizer, 2006). Other intermediate filaments are vimentin, 
glial fibrillary acidic protein (GFAP), desmin (which are all Type III intermediate 
filaments), nestin a type IV, and lamin A a member of type V intermediate filaments. 
 
 
 
 
Figure 4: Cytoskeleton of eukaryotic cells. The cytoskeleton supports structure, stress 
resistance, shape change and movement.  (Metzler, 2001). 
A) The three different components of the cytoskeleton illustrated in a neuronal cell: 
microtublues (green), intermediate filaments (purple), actin filament (red).  
B) The diameter of the different components is shown in electron-micrographs. (Fletcher, 
2010). 
 
microtubule intermediate  
filament 
actin  
filament 
A B 
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The simplest subunit of cytokeratins is a dimer composed of a central α-helical rod 
domain which is flanked by non-helical amino-terminal head and carboxy-terminal tail 
domains (Fig. 5 A). This dimer is built from a type I and type II keratin. Type I and II 
keratins are orientated in parallel in the heterodimer and display a central coiled-coil 
rod domain (Fuchs, 1998, Coulombe, 2002, Gu, 2007, Arin, 2007). Two of the linear 
filaments interact in an antiparallel manner, forming the protofilament. In addition, two 
of the protofilaments form the protofibril. Four protofibrils give rise to the mature 
intermediate filament, 8-10 nm in diameter (Fig. 5 B). The head and tail domains of 
the heterodimers are highly conserved ends, so mutations can cause severe 
consequences in the formation of the intermediate filaments (Letai, 1992).  
 
 
 
Figure 5: Basic structure and organization of keratin intermediate filaments (IF).  
A) The keratin IF dimer structure. The coiled-coil dimer consists of a type I and type II 
keratin. Hydrophobic interaction of these two α-helical domains results in a central rod 
domain.  
B) Model of the 8-10 nm keratin intermediate filaments. Two dimers are arranged antiparallel 
forming a protofilament (2-3 nm). The protofibril (4-5 nm) is composed of two protofilaments. 
Four protofibrils arrange into the intermediate filament which is 8-10 nm in diameter. (Rao, 
1996).  
 
 
A 
B 
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Mutations in keratin genes can cause several genetic diseases. Examples for such 
diseases are the ichtyosis bullosa of Siemens caused by K2 gene mutations 
(Rothnagel, 1994, Fuchs, 1994, Fuchs, 1997) and K9 gene mutations that result in 
palmo-plantar keratodermas (Moll, 1982, Vassar, 1991, Reis, 1994, Kuster, 1995, 
Kuster, 2002). It was shown that epidermolysis bullosa simplex is caused in almost 
all cases by mutations in the K5 and/or K14 genes (Coulombe, 1991, Bonifas, 1991, 
Rosenberg, 1991, Lane, 1992). 
 
In the epidermis keratins are indicators of the state of keratinocyte differentiation. In 
very young skin K15 is expressed in all keratinocytes of the stratum basale, whereas 
in the skin of older individuals it is expressed in cells of the lower parts of the rete 
ridges only (Pontiggia, 2009). Suprabasal keratinocytes show no K15 expression 
(Waseem, 1999; Ghali, 2004; Porter, 2000; Webb, 2004) which implies that in human 
interfollicular epidermis K15 is not necessarily a stem cell marker (as stated by some 
authors) but rather a marker for basal keratinocytes anchored to a functional 
basement membrane (Fig. 6).  
K19-positive keratinocytes are highly abundant in the epidermis of fetuses and 
neonates (Van Muijen, 1987; Kwaspen, 1997). It is still detectable in keratinocytes of 
the stratum basale of 1.5-year-old children (Pontiggia, 2009). The epidermis of these 
individuals is characterized by rapid lateral growth. Therefore, it is suggested that 
K19-positive cells represent a population that is adapted to this rapid lateral 
expansion of the epidermis and represents a keratinocyte population that is 
uncommitted to terminal squamous differentiation (Pontiggia, 2009). 
Furthermore, cytokeratins K5 and K14 are described to be also expressed in the 
basal layer of the epidermis (Fuchs, 1980). They are downregulated suprabasally, 
whereas K1 and K10 are expressed in all epidermal layers except the stratum basale 
(Moll, 1982, Ishida-Yamamoto, 1998). The expression pattern of keratins is also 
dependent on the body site. Keratin 9 is only expressed in palmo-plantar skin, K2e is 
found in spinous and granular layers of interfollicular epidermis (Moll, 1982, Corden, 
1996). 
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Figure 6: Keratins in human epidermis. Keratins are expressed in different layers of the 
human epidermis, e.g K15 and K19 in the basal layer, whereas K2e is expressed 
suprabasally. (Alonso, 2003). 
 
Keratins are important to maintain cell and tissue integrity (Fig. 7 A). They mediate 
the mechanical support in surface epithelia such as the epidermis, oral mucosa and 
cornea. Keratins are organized in dense filament networks, linked to cell-cell 
adhesions like desmosomes and cell-matrix adhesions like hemidesmosomes 
providing stiffness and strength (Yamada, 2002, Kirfel, 2003, Beil, 2005). Skin 
blistering can be seen frequently when keratin intermediate filaments get arranged 
perinuclearly which leads to a softening of the cytoplasm and the detachment of the 
epidermis from the basement membrane (Beil, 2003).  
It was shown that there are also interactions (Fig. 7 B) between intermediate 
filaments, microfilaments and microtubules (Wiche, 1989, Wiche, 1993, Yang, 1996, 
Svitkina, 1996, Fuchs, 2001). Such interactions can be mediated through cytolinker 
proteins like desmoplakin, plectin and bullous pemphigoid antigen (BPAG) resulting 
in reversibly cross-linked cytoskeletal structures (Leung, 2002). 
 
After injury there is the need for cell migration (Fig. 7 C). Keratinocytes migrate from 
the wound margins if the epidermis is lost. It was observed that the organization of 
K1, K2e, K10    
K15, K19, (K5, K14) 
 
K9 (palmo-plantar) 
K1, K2e, K9, 10    
K1, K2e, K10    
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intermediate filaments rapidly changes prior to cell migration (Martin, 1997, Pekny, 
1999, Omary, 2002, Wong, 2003, Lariviere, 2004). Keratin filaments are rearranged 
in the perinuclear area to facilitate the migration process (Odland, 1968, Paladini, 
1996). Furthermore, a change in keratin expression occurs. Non-wound keratins 
such as K1/10 are downregulated and wound keratins like K16 are upregulated 
(Mansbridge, 1987).  
Novel functions of intermediate filaments were discovered as it was noticed that they 
interact with kinases, receptors and adaptors (Fig. 7 D) regulating the cell cycle and 
programmed cell death (Coulombe, 2000, Omary, 2002, Oshima, 2002, Paramio, 
2002, Owens, 2003, Giancotti, 2003, Omary, 2004, Lariviere, 2004). Keratins can 
modulate the response to pro-apoptotic signalling (Caulin, 2000, Gilbert, 2001, Ku, 
2003) through interacting with receptors like Fas receptor or TNFR2 (tumor necrosis 
factor receptor 2) and regulate cell apoptosis via interaction with TRADD (tumor 
necrosis factor receptor 1 associated death domain protein) a protein involved in the 
regulation of apoptosis (Inada, 2001).  
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Figure 7: Functions of intermediate filaments. 
A) Mechanical support. Keratin intermediate filaments (IF, green in basal layer, blue and pink 
in suprabasal layers, different colours for different IFs) are abundant in epidermal 
keratinocytes, in which they are spread throughout the cytoplasm. They are attached to the 
desmosomes (red dots) and to hemidesmosomes (yellow dots). Therefore, mechanical 
support in sheets of keratinocytes is maximized.   
B) Cytoarchitecture. The architecture of a cell depends also on the interactions of the 
cytoplasmatic intermediate filaments like keratins (light blue), actin filaments (dark green) 
and microtubules (dark blue). These interactions are mediated by linker proteins like plectin 
and bullous pemphigoid antigen BPAG (yellow). 
C) Cell migration. Extravasation of a lymphocyte is shown here as an example. Vimentin 
intermediate filaments are rearranged after activation. Thereby the viscoelastic properties 
needed for extravasation are changed.  
D) Signal modulation. Intermediate filaments can interact with cell surface receptors like Fas 
(left) modulating their density and function or interaction with adaptor proteins like TRADD 
(pink on the right) causing limitations of this adaptor to ligand–bound receptor for 
transmission of a signal. Possibly these mechanisms are involved in the response of 
epithelial cells to pro-apoptotic or other signals. BPAG: Bullous Pemphigoid Antigen, IF: 
intermediate filaments, TRADD: TNFRSF1A-associated via death domain. (Coulombe, 
2004).   
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Moreover, keratins are implicated in the control of protein synthesis and cell 
proliferation. Recently, it was shown that K17 binds 14-3-3σ, an adaptor protein 
regulating mTOR (mammalian target of rapamycin) activity. The K17/14-3-3σ 
interaction influences protein synthesis and cell proliferation (Bertram, 1998, Kim, 
2000, Bridges, 2005). Keratin 10 is suggested to interact with the kinase Akt to 
influence proliferation in vivo. Overexpression of K10 in cell lines and mouse models 
reduces cell proliferation (Paramio, 1999, Santos, 2002) supporting the thesis that 
K10 expressed in suprabasal layers in normal epidermal keratinocytes triggers 
differentiation (Paramio, 2002).  
Keratins also play a role in the pigmentation of skin. The mechanisms still remain 
vague. It is known that several disorders, e.g. the Naegeli-Franschetti-Jadassohn 
syndrome, caused by a K14 mutation, displays (as one of several symptoms) a 
reticulate or mottled hyperpigmentation (Lugassy, 2006). Hyperpigmentation and 
dark hyperkeratotic papules are seen in the Dowling-Degos-disease, a disorder 
linked to keratin 5 haploinsufficiency (Betz, 2006). 
Several authors suggest that keratins are also markers for epithelial stem cells. 
Keratin 15 and 19 are postulated candidates as stem cell markers (Lane, 1991, 
Jones, 1995, Michel, 1996, Lyle, 1998). Some hints point toward this suggestion but 
the final proof for this hypothesis is still missing. 
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1.2.2.2  Cornification of human epidermis 
Cornification of the epidermis provides a barrier against water and physical 
resistance to mechanical forces (Michel, 1988, Kalinin, 2002, Presland, 2002, Segre, 
2003). Cornification actually starts in the granular layer. There, the keratinocytes 
synthesize immature structural proteins that are stored beneath the plasma 
membrane. Later a rigid structure is formed by covalent attachment of linker proteins, 
such as involucrin and loricrin (Fig. 8). The differentiated keratinocytes also acquire 
so-called keratohyalin granules containing profilaggrin. Keratin filaments are 
aggregated via mature filaggrin into tight bundles which are closely aligned in regular 
arrangements (Steinert, 1981). After this aggregation the intermediate filaments 
“collapse”, leading to a flattening of the former ellipsoid cells (transforming into flat 
squames) which is characteristic for cells in the cornified layer.  
Structural proteins, such as glutamine and lysine-rich proteins involucrin and loricrin, 
and small proline-rich proteins (SPRs), are cross-linked to tight keratin bundles 
beneath the plasma membrane through transglutaminases (Fig. 8). This process 
reinforces the formation of tight bundles forming the cornified envelope. Involucrin 
and loricrin are the main components of the cornified envelope, constituting 70-80 % 
of the protein mass in the cornified layer (Steinert, 1995, Steinert, 1998, Kalinin, 
2001, Candi, 2005). Desmosomes are also modified during keratinocyte 
differentiation. In the stratum spinosum they are mediating the tight attachment of 
keratinocytes, whereas in the upper strata they are proteolytically degraded to allow 
desquamation (Serre, 1991).  
Not only proteins but also lipids are involved to establish the cornified layer. Lipids 
are attached to the proteins of the cornified envelope, or they arrange into 
intercellular lamellae to support the water barrier function.  
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Figure 8: Cornification in human epidermis.  
Starting in suprabasal layers, several proteins are expressed in particular regions in the 
epidermis during epidermal differentiation. The cornified envelope is established by 
crosslinking of keratin with proteins like loricrin or involucrin by transglutaminases (inset on 
the right). (BPAG, bullosus pemphigoid antigen; SPR, small proline-rich proteins; TG, 
transglutaminase). (Candi, 2005). 
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1.2.3  Human melanocytes 
 
Neural crest derived melanocytes migrate during embryogenesis via the 
mesenchmye into the epidermis and hair follicles. Interestingly, melanocytes also 
migrate to the cochlea in the inner ear, to the leptomengines and to the uveal tract of 
the eye. In the hair follicle melanocytes are situated in the outer root sheath and in 
the hair matrix above the dermal papilla where they are responsible for hair color 
(Bolognia, 2003, van Neste, 2004, Slominski, 2005). It is hypothesized that the hair 
follicle melanocyte stem cells are found in the hair follicle bulge, whereas the 
interfollicular epidermis contains its own melanocyte stem cells in the basal layer 
(Tobin, 1996, Passeron, 2007, Tobin, 2008, Blanpain, 2010). In the basal layer of the 
epidermis (Fig. 9) the ratio of melanocytes to keratinocytes is about 1:5 (Haass, 
2005).  
 
 
 
 
Figure 9: The human epidermis contains melanocytes.  
A) The basal layer of human epidermis contains melanocytes. With its dendrites one 
melanocyte is in contatct with about 36 keratinocytes located in different layers of the 
epidermis. Melanosomes containing the pigment melanin are transferred along the dendrites 
to keratinocytes. (Bolognia, 2003).  
B) Human melanocytes (here displaying their dendritic processes on cell culture plastic) were 
isolated in our laboratory from human skin biopsies. They were expanded as a 
homogeneous and pure cell population in a specific melanocyte medium. (bar, 50 µm). 
 
The so-called epidermal melanin unit describes the number of keratinocytes being 
provided with melanin by one melanocyte. One melanocyte is associated with about 
A B 
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36 keratinocytes in the epidermis (Fitzpatrick, 1963, Jimbow, 1976). Melanin is 
important to protect the skin against ultraviolet (UV) radiation via its optical and 
chemical filtering properties (Ahene, 1995). Melanosomes containing the pigment 
melanin are translocated via a microtubule and actin filament driven process to the 
tips of the dendritic protrusions of the melanocytes (Jimbow, 1998, Lambert, 1999, 
Wu, 2000, Wasmeier, 2008).  
The transfer process of melanosomes from melanocytes to keratinocytes is not 
entirely understood. Several hypotheses are suggested for this process such as 
release of melanosomes from melanocytes into the intercellular space subsequently 
followed by endocytosis by keratinocytes or keratinocyte-membrane fusion and 
uptake of melanosomes by keratinocytes through the “fusion channel” (Yamamoto, 
1994, Jimbow, 1998, Boissy, 2003). Apparently, the PAR-2 (protease activated 
receptor 2) receptor plays a crucial role in the uptake of melanosomes (Sharlow, 
2000, Seiberg, 2000, Scott, 2001, Cardinali, 2005). Once taken up into the 
keratinocytes, melanosomes are situated in supranuclear caps (Fig. 10).  
 
 
 
Figure 10: Human dermo-epidermal skin substitutes containing melanocytes. 
A) Human melanocytes (green) reside in our dermo-epidermal skin constructs in the basal 
layer of the epidermis which always is in contact with the basement membrane (Laminin-5, 
red). The antibody HMB-45 (green) detects melanosomes in the melanocytes. Therefore, the 
dentritic protrutions towards the upper layers of keratinocytes in the epidermis are also 
stained.  
B) Fontana-Masson staining reveals melanin (brownish-black dots) in the epidermis in our 
substitutes. White arrows denote melanin, located in supranuclear caps (black grains) in the 
keratinocytes. (Biedermann, manuscript in preparation). This is in accordance with the 
normal in vivo situation of human skin. (bars, 10 µm). 
 
HMB-45 
Laminin-5 
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Melanin can be divided into two main types, pheomelanin (red/yellow) and eumelanin 
(black/brown). The pigments, pheomelanin and eumelanin, are both synthesized and 
stored in melanosomes. Several morphologically distinguishable stages (I-IV) are 
observed in the complex process of melanosome biogenesis (Fig. 11).  
 
 
 
Figure 11: Maturation of melanosomes.  
A) Schematic representation of dendritic process of a melanocyte. There are different stages 
of maturation from I to IV. The intensity of black color indicates the degree of melanization.  
B) Transmission electron microscopy pictures displaying stage II to IV melanosomes in 
human melanocytes. (Marks, 2001). 
 
 
Both pigments accumulate in the organelles by enzymatic oxidation of tyrosine, later 
the pathways for pheomelanin and eumelanin separate (Raposo, 2002, Kushimoto, 
2003, Setaluri, 2003). Eumelanin undergoes further hydroxylation, oxidation and 
carboxylation processes. Pheomelanin needs at least one reduction reaction which is 
cysteine dependent (Hearing, 1999). Genetic disorders affecting the melanosomes 
display defects in skin and hair pigmentation e.g. oculo-cutaneous albinism in 
humans (Oetting, 2003).  
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1.3 Skin appendages 
 
1.3.1 Hair follicles 
 
Hair follicles are multilayered cylindrical skin appendages (Fig. 12) formed mainly by 
cells of epidermal origin.  
A crosstalk between keratinocytes and dermal cells is required in fetal skin to 
establish the hair anlagen. These signaling cues include Wnt/β-catenin, sonic 
hedgehog (Shh), fibroblast growth factors (FGFs), and bone morphogenetic proteins 
(BMPs) (Fuchs, 2008). Several lines of evidence suggest that activation of Wnt/β-
catenin signaling in epithelial cells is a key initial step in placode formation (Holbrook, 
1991, Hardy, 1992, Botchkarev, 1999, Milliar, 2002, Botchkarev, 2002, Ito, 2007). 
The epidermal cells differentiate, followed by the induction of dermal cells to form a 
condensed defined area of mesenchymal cells. In turn, the dermal cells express 
proteases cleaving the extracellular matrix to pave the way for the ingrowth of the 
originating hair follicles into the dermis (Karelina, 1993, Karelina, 1994, Karelina, 
2000). 
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Figure 12: The hair follicle in a schematic overview and an isolated human hair follicle.  
A) The pilosebaceous unit containing the hair follicle and the sebaceous gland are 
embedded in the dermis. The outer root sheath forms the external sheath of the follicle. The 
inner root sheath forms the channel for the hair itself. The bulge, a specialized compartment 
in the outer root sheath below the sebaceous gland, contains multipotent stem cells. These 
cells can give rise to cells of the hair follicle, the sebaceous gland and in a wound situation to 
cells of the epidermis. Mesenchymal cells in the dermal papilla interact with hair matrix cells 
necessary to regulate the hair cycle. (Alonso, 2003). 
B) Complete human hair follicle isolated in our laboratory from human scalp donor tissue.  
 
Hair growth is a tightly regulated regeneration cycle classified into three phases:  
1. anagen (phase of active hair growth),  
2. catagen (follicle regression) 
3. telogen (follicle rest) (Hardy, 1992, Stenn, 2001).  
 
Dermal papilla cells secrete growth factors and other signaling molecules that 
regulate proliferation and differentiation of keratinocytes during the hair cycle 
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(Messenger, 1991a, Messenger, 1991b, Shimaoka, 1994, Rudman, 1997, Paus, 
1999, Kulessa, 2000, Botchkarev, 2003). 
In the anagen phase the lower portion of the follicle is generated. Keratinocytes in the 
so-called bulb, which is located above the dermal papilla, proliferate and give rise to 
inner root sheath cells and hair shaft cells. The catagen period is typified by apoptotic 
cell death of the lower two-thirds of the hair follicle (Weedon, 1981). As the hair 
follicle regresses, the dermal papilla cells maintain their contact with the basement 
membrane. This draws the dermal papilla up to the base of the permanent epithelial 
portion of the follicle.  
At this point, the follicle enters a resting phase known as telogen. The telogen phase 
can last for months in humans. The old non-anchored hair shaft becomes fragile and 
can be liberated from its site when physically stressed (Fuchs, 2001). 
After this resting period, a new hair cycle is initiated by a hair germ-like structure.  
The outer root sheath harbours a specialized region, the bulge. This part of the hair 
follicle is located below the sebaceous gland at the insertion site of the arrector pili 
muscle (Stohr, 1903, Pinkus, 1958, Cotsarelis, 1990). In contrast to rodents, the 
bulge of human adults is less distinctive (Rochat, 1994, Cotsarelis, 2006). The 
microenvironment of the bulge enables hair follicle stem cells to be maintained in this 
specialized niche region (Cotsarelis, 1990). The self-renewing bulge stem cells exit 
the niche in the anagen phase, proliferate and differentiate into several cell lineages 
of the hair follicle (Morris, 1994, Morris, 1999, Oshima, 2001, Braun, 2003, Morris, 
2004, Ohyama, 2006). In addition, these stem cells are also recruited in wound 
healing, giving rise to keratinocytes to repair the epidermal defect (Wilson, 1994, 
Ghazizadeh, 2001, Oshima, 2001, Tumbar, 2004, Blanpain, 2004, Levy, 2007, 
Langton, 2008). Keratinocyte stem cells located in the bulge are not involved in 
homeostatic maintenance of the epidermis (that is in non-wound situations) as it was 
postulated (Taylor, 2000). It was convincingly shown in several studies that the 
epidermis contains unipotent progenitor cells able to maintain tissue homeostasis 
(Potten, 1988, Lavker, 2000, Morris, 2004, Ito, 2005, Levy, 2005). Furthermore, 
palmo-plantar skin lacks hair follicles, but normal epidermal homeostasis and wound 
healing are observed (Montagna, 1954), indicating that hair follicles are not an 
indispensable source of keratinocyte stem cells.  
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1.3.2  Eccrine and apocrine sweat glands 
About 2 to 4 million sweat glands are dispersed over the human body (Saga, 2002, 
Groscurth, 2002). Sweat glands are classified according to morphology and function 
as eccrine and apocrine sweat glands.  
The highest density of eccrine sweat glands can be found on palms and soles, the 
axillae or the forehead. Sweat glands are absent in lips, nail beds, the inner preputial 
surface or the glans penis (Szabo, 1967, Sato, 1977).  
 
Eccrine sweat glands are important in the thermoregulation of humans and primates. 
The body temperature is lowered by evaporation of sweat. Sweat glands can 
produce up to 10 liters of sweat per day. The excreted sweat is an odorless, clear 
and hypotonic fluid. It contains sodium, potassium, chloride, calcium, amino acids, 
lactate, urea and immunoglobulins (Shibasaki, 2010). Patients lacking sweat glands 
suffer from increased body temperature in hot environments or during physical 
activities. Such patients are burn victims with deep large-area burns or patients with 
congenital anhidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome), the 
latter characterized by abnormal or absent sweat glands, teeth, nails and hairs 
(Blecher 1986, Loth, 1998, Priolo, 2000, Gaide, 2003, Drögemüller, 2003, Itin, 2004).  
 
The development of eccrine sweat glands is detectable during the third month of 
embryogenesis (Hashimoto, 1965, Sato, 1989 Moll, 1992, Ersch, 1999). Epithelial 
downgrowth from epidermal ridges can be seen and solid cords elongate into the 
dermis. The secretory domain of the gland is formed by the lower end of the ductal 
cord in the dermis. The fusion of intracytoplasmatic vacuoles and the detachment of 
desmosomes lead to the formation of a lumen between the fourth and eighth month 
of pregnancy. Although they display no function before birth, mature sweat glands 
are noticeable at about week 32.  
 
Apocrine sweat glands are located in areas such as the axilla, the perianal region, 
the scrotum and the prepuce. These glands produce a thick, milky, odorless fluid rich 
in proteins, ammonia, lipids and carbohydrates. A characteristic smell is produced 
when bacteria residing on the skin decompose the produced fluid (Groscurth, 2002). 
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Eccrine sweat gland consists of two main segments, a duct and a secretory domain 
(Fig. 13). The excretory duct extends through the dermis and opens to the epidermis 
(Hashimoto, 1966, Ellis, 1967, Montagna, 1974, Hurley, 2001, Langbein, 2008). It is 
composed of two cell layers, a peripheral cell layer and an inner cell layer. The duct 
is segemented in a proximal coiled intraglandular duct, a straight intradermal duct 
and an intraepidermal spiral duct, known as the acrosyringium (Langbein, 2005).   
 
 
 
 
Figure 13: The human sweat gland.  
A) The eccrine sweat gland and its main segments are shown in a schematic presentation 
(Langbein, 2005). The numbers on the left indicate the segments:  
 (1) upper spiral intraepidermal duct of the acrosyringium 
 (2) lower sweat duct ridge of the acrosyringium 
 (3) intradermal duct  
 (4) intraglandular duct portion  
 (5) secretory duct portion.  
B) This complete gland was isolated in our laboratory for subsequent cell isolation. The 
parentheses denote the different segments according to the schematic presentation. 
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A basal (outer) and a luminal (inner) cell layer form the duct. Luminal cells, exhibiting 
a Na-K-ATPase activity, reabsorb solutes like sodium chloride and lactate from the 
isotonic fluid produced by the secretory domain (Bijman, 1987, Reddy, 1989, Reddy, 
1991, Reddy, 1994, Reddy, 1999, Granger, 2003).  
The coiled single layer secretory domain is composed of myoepithelial cells, dark and 
clear secretory cells. Clear cells have a high transepithelial activity in fluid and 
electrolyte transport. The majority of the sweat, water and electrolytes, is secreted by 
these cells. The function of dark cells is not known, although it was observed that 
they secrete PAS-positive glycoproteins into the sweat (Sato, 1993).  
The spindle shaped myoepithelial cells express cytokeratins and also α-smooth-
muscle actin. By their contraction the sweat is “pumped” through the duct. In addition, 
myoepithelial cells provide mechanical strength and serve as a protection against 
overexpansion in large volume sweat secretion phases (Sato, 1979, Sato, 1980). 
    
Eccrine sweat gland cells serving as a stem cell resource  
In contrast to hair follicles, sweat glands are not in focus of research in respect to 
molecular signalling, development or maintenance throughout life. Of course, this 
lack of knowledge can be explained by the absence of an appropriate animal model, 
to study the biology of sweat glands.   
In analogy to the stem cell containing bulge in hair follicles, it is proposed that sweat 
glands harbour (keratinocyte) stem cells (Barrandon 2003, Gambardella 2003, 
Nakamura, 2009). Although data are rare, it is known that the acrosyringium is a non-
self-renewing segment (Lobitz, 1954, Christophers, 1973, Kanitakis, 1987). Hence, 
the intraepidermal duct cells are renewed by upward migration of intradermal duct 
cells. It was hypothesized that under homeostatic conditions luminal cells at the base 
of the intraglandular duct are able to maintain the integrity of the luminal duct layer 
(Langbein, 2005). Other authors described transitional cells, ranging in phenotype 
between myoepithelial cells and dark and clear cells, suggesting a pool of stem cells 
in the secretory portion (Sato, 1993). 
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1.4 The Dermis 
 
1.4.1 Structure and function of human dermis 
 
The dermis is a connective tissue underlying the epidermis. It harbours the epithelial 
appendages, provides mechanical support and is important for epithelio-
mesenchymal interactions. The dermis is rich in extracellular matrix, such as 
collagens, elastin and glycosaminoglycans. The papillary dermis displays a higher 
number of fibroblasts and has a different tissue organisation compared to the 
reticular dermis (Fig. 14). Beside this, a lot of microvascular structures pass through 
the papillary dermis, especially the dermal papillae, to assure blood supply for 
nourishment of the epidermis (Cormack, 1987). The rete subpapillare denotes the 
border between papillary and reticular dermis. The reticular dermis extends to the 
rete cutaneum, the boundary to the adipocyte rich hypodermis. Skin appendages 
often reach through the reticular dermis to terminate in the hypodermis (Sorrell, 2004, 
Mine, 2008). 
 
 
Figure 14: Histological section of human skin and isolated human dermal fibroblasts.  
A) The papillary dermis, with dermal papillae extending the contact surface of epidermal-
mesenchymal ridge, is the dermal part underlying the epidermis. This part of the dermis 
contains a higher cell density compared to the reticular dermis. The reticular dermis is 
separated by the rete subpapillare from the papillary dermis (bar, 45 µm). (Sorrel, 2004).  
B) Human dermal fibroblasts isolated from a skin biopsy in cell culture (bar, 100 µm). 
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1.4.2 Basement membrane deposition and scar formation –  two functions of 
dermal fibroblasts 
 
Fibroblasts are important for the biosynthesis of extracellular matrix components, 
cytokines, growth factors and basement membrane components (Smith, 1997, 
Postlethwaite, 1999). Moreover, they remodel the connective tissue by expression of 
matrix metalloproteinases (MMPs) (Page-McCaw, 2007).  
Both, fibroblasts and keratinocytes, are involved in the production of basement 
membrane components. The basement membrane is a multi-molecular structure 
(Fig. 15) on which the basal epithelial cells reside. It separates the epidermis 
physically from the underlying dermis, whereas it connects them functionally 
(Burgeson, 1997, Aumailley, 1999, LeBleu, 2007).  
Dermal fibroblasts express laminin-1, nidogen, collagen type IV and VII. Epidermal 
keratinocytes produce laminin-5, perlecan and collagen IV and VII (Contard, 1993, 
Marinkovich, 1993, Fleischmajer, 1995, Moulin, 1995, Smola, 1998). A cooperative 
effort of both epidermal keratinocytes and dermal fibroblasts is necessary to form a 
basement membrane (Fleischmajer, 1993, Moulin, 2000, Sorrell, 2004). One 
example of this interaction is the fact that transforming growth factor-β1 (TGF-β1) 
secreted by dermal fibroblasts activates the expression of collagen VII by epidermal 
keratinocytes (König, 1991, König, 1994, Monical, 1994, Fusenig, 1994). 
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Figure 15: Schematic diagram depicting the relative positions of selected epidermal 
basement membrane components. 
The diagram demonstrates the series of structural proteins that form a continuous link from 
keratin intermediate filaments to dermal collagens via the hemidesmosome complex. Keratin 
intermediate filaments (red) within the keratinocyte cytoplasm are capable of binding both 
plectin (light green rods) and bullous pemphigoid antigen 1 (dark green rods, BPAG1e). 
These two plakin family protein members form a series of interactions (via erbin, in blue) with 
the two major hemidesmosome transmembrane molecules, integrin α6β4 (red and blue) and 
collagen XVII (yellow). Integrin α6β4 is the receptor for the extracellular ligand laminin-5 (red, 
yellow and green). Laminin-5 in turn binds to the collagen VII NC-1 domain (dark blue 
circles), to nidogen (small green dumbbells), fibronectin (brown oval) and fibulin 2 (pink oval). 
The majority of collagen VII molecules form semicircular loop structures (dark blue loops) 
called anchoring fibrils (collagen VII) immediately beneath the lamina densa. In the dermis 
there are dermal collagen fibres comprising collagens type I and III (parallel black lines) 
(Scale bar: 100 nm). (McMillan, 2003). 
 
Dermal fibroblasts organize and maintain the connective tissue in homeostasis. 
Moreover, fibroblasts play a crucial role in response to injury (Shaw, 2009).  
Skin wound healing involves two main phenomena (Tomasek, 2002). On the one 
hand, it means re-epithelialization, which involves proliferation and migration of 
keratinocytes to reconstitute the epidermis.  
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On the other hand, de novo formation and contraction of dermal granulation tissue 
appears. The granulation tissue is essentially composed of small vessels, fibroblasts, 
myofibroblasts and inflammatory cells (Martin, 1997). Contraction of the wound is 
caused, at least in part, by the presence of myofibroblasts which develop 
characteristics of smooth muscle cells (expression of α-smooth-muscle actin and 
non-muscle myosin) under the influence of TGFβs (Kreis, 1980, Singer, 1984, Skalli, 
1986, Darby, 1990, Burridge, 1996, Chicurel, 1998, Dugina, 2001, Geiger, 2001). In 
contrast to embryonic wound healing (Adzick, 1994, Gurtner, 2008), which still occurs 
without scarring, wound contraction is the general mode of wound healing in humans 
after birth (Liechty, 2000, Harrison, 2008). 
Fibroblasts produce at fist a provisional wound matrix containing hyaluronan and 
fibronectin. Secondly, they remodel the granulation tissue by formation of a 
collagenous matrix (Clark, 1990, Gailit, 1994, Juhlin, 1997, Singer, 1999, Wong, 
2007). However, the new (scar) tissue will have a distinct collagen pattern and a 
different skin texture (and quality) than the initial (and surrounding) normal skin. 
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1.5 Tissue Engineering 
 
1.5.1  Tissue engineering – defininition, achievements, state of the art 
 
In 1987 the Washington National Science Foundation bioengineering panel adopted 
the term “tissue engineering” (Nerem, 1992). This term stands for the “application of 
the principle methods of engineering toward the development of biological 
substitutes” (Atala, 2007). There is the need for organ transplantation in patients 
suffering from life-threatening diseases. It is possible to transplant organs like hearts, 
livers, kidneys or lungs from organ donors, but of course the need exceeds the 
supply. Organ transplantation from other species (especially from pigs), so-called 
xenotransplantations (Hecht, 2009), remain speculative not only because of the 
immunological barrier or ethical problems but also because of microbiological 
hazards (like pig endogenous retro-virus). Tissue engineering overcomes such 
problems like immunological rejections, as autologous cells from the patient are 
used. 
Today, there is a broad spectrum of possibilities in the field of tissue engineering. 
Worldwide there is research and engineering for almost every organ or tissue, the 
outcome of which remains sometimes suspect. Nevertheless, successfully applied 
approaches in clinical use display that there is progress in tissue engineering. Some 
examples of progress in tissue engineering are shown in Fig. 16. Other fields of 
tissue engineering not shown in Fig. 16 include the liver (Kaufmann, 1999, Kim, 
1999), the lung and the trachea (Kojima, 2003, Kanzaki, 2006, Macchiarini, 2008), 
the kidney (Steer, 2004, Atala, 2007), the salivary gland (Baum, 1999, Aframian, 
2007, David, 2008) and esophageal cell sheet transplantation (Ohki, 2006, 
Murakami, 2006). 
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Figure 16: Current state of human tissue engineering.  
Examples of research areas in the field of tissue engineering include bladder (Oberpenning, 
1998), epidermal/corneal cell sheet (Ronfard, 2000, Nishida, 2004, Hata, 2007), heart valve 
(Shinoka, 1995, Stock, 2000, Schmidt, 2007), blood vessels (Levenberg, 2005; L’Heureux, 
2007), cartilage (Chung, 2008), intervertebral disc (Mizuno, 2005), ear (Cao, 1997) and bone 
(Yoshikawa, 2000). Note that in several areas of research different achievements were 
obtained. In some fields clinical trials are undertaken.  
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1.5.2  Tissue Engineering of skin 
 
There is a great need for tissue engineered skin because the loss of skin can occur 
by many diseases and accidents. The western world faces increasing life 
expectancy, hence one of the most common skin defects are chronic, non-healing 
ulcers in elderly people (Fig. 17 A) (Falanga, 1993, Paquette, 2002, Falanga, 2005, 
Dalla Paola, 2006, Gary Sibbald, 2008). There is also a need for skin to treat 
congenital disorders such as giant melanocytic (melanocyte) naevi (Fig. 17 B) or 
epidermolysis bullosa, where large areas need to be replaced by healthy skin (Zaal, 
2004, Bauer, 2005, Earle, 2005, Tannous, 2005, Aumailley, 2006, Mavilio, 2006, 
Arneja, 2007, Fine, 2008). Furthermore, in reconstructive surgery treating burn 
accidents followed by scar management (Fig. 17 C), tissue engineered skin could be 
favourably used (Swope, 2002, Atiyeh, 2005, Harrsion, 2008). In addition, studying 
wound repair and cancer biology have a need for laboratory grown skin (Garlick, 
2007, Andreadis, 2007, Carlson, 2008).     
 
 
 
Figure 17: Different examples demonstrating the need for tissue engineerd skin. 
A) An adult patient suffering from venous stasis leg ulcer, a common chronic wound. 
(Fonder, 2008).  
B) Congenital giant nevus of the leg of an infant. (Kryger, 2008).  
C) Scar contracture on the wrist after a burn injury. (Tomasek, 2002). 
 
The today’s gold standard to cover large wounds is the transplantation of autologous 
split-thickness skin (Pereira, 2007). Split-thickness skin contains all of the epidermis 
but only partially dermis (Fig. 18 B), and if transplanted without good dermal support, 
frequently leads to scarring (Arabi, 2007, Barbour, 2008, Berman, 2008).  
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In contrast, full-thickness skin transplantation (Fig. 18 C) is not usually associated 
with scarring, however autologous full-thickness skin transfer can only be performed 
for injured areas <2% total body surface area (TBSA) (Rivera, 2005). 
Concerning the application of laboratory grown skin, a major breakthrough was made 
in 1975, when Rheinwald and Green managed to grow human primary epidermal 
cells in serial culture on a layer of lethally irradiated 3T3 murine fibroblasts 
(Rheinwald, 1975). These researchers showed that limitations observed previously in 
the cultivation of epidermal cells in surface cultures were not intrinsic, but due to the 
complex relationship between keratinocytes and fibroblasts. Taking advantage of the 
3T3 cell feeder layer technique, an epidermal graft could be expanded to more than 
500 times its size within 3–4 weeks (Rheinwald, 1977). After the first clinical 
application (O´Connor, 1981), so-called cultured epidermal autografts (CEAs) were 
tested in almost all leading burn centers world wide (Fig. 18 A) (Gallico, 1984, 
Odessey, 1992, Atiyeh, 2007, Guerra, 2009). However, there were disadvantages 
that included a widely variable CEA take, depending on the wound site and status, 
age of the patient, and knowledge and experience of the operator (Munster, 1996, 
Wood, 2006). 
Often, an acellular dermal template, such as Integra Artificial Skin, was applied in a 
first surgical intervention to yield a well-vascularized dermal wound bed onto which 
split-thickness skin was transplanted in a second surgical step (Ruszczak, 2003, 
Horch, 2005, Hata, 2007, MacNeil, 2007, van der Veen, 2010). 
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Figure 18: Examples for skin grafts.  
A) A black, 11-year old burn patient was treated with cultured epidermal autografts (CEAs) 
on the abdomen and anterior thighs. Nine months after grafting hypopigmentation was 
observed (black arrows) in the grafted areas, whereas there was normal pigmentation in 
areas in which full-thickness meshed autografts were transplanted (white arrows). 
Contamination with autologous melanocytes caused hyperpigmented spots in the 
transplanted keratinocyte cell sheets (open arrowheads). (Swope, 2002).  
B) Example of an autologous split-thickness skin mesh. The meshed skin was transplanted 
onto an Integra-based neodermis. (Loss, 2000).  
C) Example of application of a tissue expander for full-thickness skin transplantation. A 3 
year old boy displaying a pigmented naevus retroauricular. A self-filling tissue expander was 
implanted just underneath the naevus, expanding the skin area. Subsequently the naevus 
was excised and the wound was closed with the overlapping expanded full-thickness skin. 
(Ronert, 2003). 
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1.5.2.1 Engineering a dermo-epidermal substitute  
 
A central goal of the Tissue Biology Research Unit is the development of a full 
thickness skin substitute that allows the reconstitution of all spatial, functional and 
cosmetic properties of normal skin. In addition, scarring should be minimized. 
The aim is the development of dermo-epidermal skin substitutes. These substitutes 
consist of human dermal fibroblasts seeded in collagen type I hydrogels as the 
dermal part, and of human keratinocytes seeded on top of the hydrogels as the 
epidermal compartment (Fig. 19 A).  
 
 
 
Figure 19: Three-dimensional culture of dermo-epidermal skin substitutes. 
A)  Schematic representation of a dermo-epidermal substitute grown at air-liquid interface in 
a cell culture insert. The main disadvantage of this method is the limited diameter in which 
the substitutes can be grown.  
B) For future use in large burns or for reconstructive surgery, larger sizes of substitutes are 
necessary. A biodegradable scaffold (fibre mesh) can ensure a greater stability, an important 
concern for clinical application of skin substitutes. (Pampaloni, 2007).  
 
Indeed, we succeeded in developing such dermo-epidermal substitutes. They were 
grown in cell culture inserts before being transplanted onto the backs of athymic 
immuno-incompetent rats. 
 
Using this technique, we also aimed at searching for tools suited to evaluate the 
quality and self-renewing potential of the transplanted engineered human dermo-
epidermal skin grafts (Pontiggia, 2009). We found a distinct population of K19 
(cytokeratin 19) positive keratinocytes in the basal layer of engineered, stratified skin 
substitutes. The clustered pattern of these keratinocytes corresponds to the 
distribution one would expect for self-renewing keratinocytes in the stratum basale. 
B A 
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Concomitantly, there are several reports stating that K19-expressing keratinocytes 
represent self-renewing keratinocytes (Lane, 1991, Michel, 1996). 
Furthermore, transplanted grafts exhibited a continuous layer of basal cells 
expressing K15 (cytokeratin 15), with K19-positive cells representing a subpopulation 
of these. 
In very young human skin (from neonate to 1.5-year old) K15 was expressed in all 
keratinocytes of the stratum basale, whereas in the skin of older patients it was 
expressed in cells of the lower parts of the rete ridges (Pontiggia, 2009). Suprabasal 
keratinocytes did not show K15 expression. These data are in accord with previous 
studies (Waseem, 1999, Ghali, 2004, Porter, 2000, Webb, 2004) and imply that in 
human interfollicular epidermis, K15 is not necessarily a stem cell marker but rather a 
marker for basal keratinocytes anchored to a functional basement membrane. 
In summary it can be said that K19/K15-double-positive keratinocytes represent a 
distinct basal-cell population in growing skin. For engineered skin substitutes, K19 
and K15 in combination are valuable tools to monitor tissue homeostasis and the 
potential to self-renew (Pontiggia, 2009). 
 
1.5.2.2  Eccrine sweat gland cells can reconstitute a stratified human epidermis 
 
Keratinocyte stem cells are supposed to assure the homeostatic renewal of the 
epidermis and to be responsible for re-epithelialization of the epidermis after skin 
injuries. Keratinocyte stem cells reside not only in the epidermis but also in 
appendageal structures protruding into the dermis. Outer root sheath cells of hair 
follicles were shown to be able to regenerate a fully differentiated epidermis in vitro 
and were used for the production of epidermal equivalents for the treatment of skin 
damage or disease (Lenoir, 1988, Limat, 2003). 
We reasoned that human eccrine sweat glands may be an additional source of 
epidermal stem cells, which may contribute to the in vitro maintenance and long-term 
survival and function of engineered epidermal grafts. There are some indications that 
sweat gland cells may have a certain capacity to form an epithelium in culture and in 
vivo (Lobitz, 1954, Miller, 1998). This fact prompted us to ask whether sweat gland 
derived epithelial cells can differentiate into keratinocytes and form an epidermis.  
To address this issue, we raised organotypic cultures consisting of a dermal 
component and a stratified epidermal substitute formed by sweat gland cells. These 
Introduction                                                                                     
 35 
sweat gland derived substitutes were transplanted onto the backs of immuno-
incompetent rats.  
The expression of protein markers indicative of the grade of differentiation and 
homeostasis was determined (Biedermann, 2010). They exhibit almost all the 
properties of an epidermis derived from a priori epidermal keratinocytes. This is 
substantiated by the following findings: (1) a stratified epidermis consisting of 10–12 
cell layers is formed by sweat gland cells; (2) a distinct, anuclear stratum corneum 
develops and is maintained after transplantation of sweat gland derived epidermal 
substitutes in vivo; (3) proteins centrally involved in the process of cornification, such 
as filaggrin, loricrin, involucrin, envoplakin, periplakin, and the transglutaminases I 
and III, are expressed in a pattern that matches that of normal human skin; (4) 
junctional complexes and hemidesmosomes are readily and regularly established; (5) 
K15 and K19-expressing keratinocytes become expressed in a distinct stratum 
basale 3 weeks after transplantation (K19-expressing cells disappear 7 weeks after 
transplantation.); (6) cell proliferation in the basal layer reaches homeostatic levels; 
(7) the sweat gland derived epidermis is anchored within a well-developed basal 
lamina; (8) palmo-plantar or mucosal markers are not expressed in the sweat gland-
derived epidermis; (9) similar to keratinocyte derived epidermal substitutes, 
engineered sweat gland cell derived epidermal substitutes undergo maturation after 
their transplantation onto a living organism. Although with a delay in comparison with 
epidermal keratinocytes, sweat gland derived cells developed ‘‘de novo’’ into a 
functional stratified, interfollicular epidermis (Biedermann, 2010). 
 
 
A crucial point for a future application of our dermo-epidermal skin substitutes is the 
size of the grafts. We can now increase the dermo-epidermal constructs in size for 
clinical application (Braziulis, manuscript in preparation). A biodegradable mesh (Fig. 
19 B) can be integrated into a collagen I or fibrin hydrogel to stabilize this for easier 
handling and suturing by the surgeon. We already started to transplant these 
substitutes using autologous porcine cells onto pigs in a clinical applicabable size 
(Fig. 20). Hence, after successful termination of these preclinical studies, our novel 
dermo-epidermal skin substitutes are going to be transplanted onto patients. 
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Figure 20: Preclinical study of large scale dermal skin substitutes.  
A) As example the application of an artifical dermal substitute (Integra) onto the back of a pig 
is shown.  A 7 x 7 cm full-thickness wound was prepared. Integra was applied and sutured.  
B) Wound control three weeks after application. Note the excellent quality of the neodermis.      
 
 
 
1.5.2.3  The application of skin tissue engineering for melanoma research 
 
Importantly, our dermo-epidermal skin grafts can also be employed to study the 
biology of skin tumors (Hendrixs 2003, Burdett, 2010). In this respect, primary human 
melanoma cells were used to produce skin grafts followed by the transplantation onto 
immuno-incompetent rats (Fig. 21). This in vivo tumor model facilitates the study of 
melanoma cell biology e.g. the process of penetrating the basement membrane and 
migrating into the dermis (Biedermann, manuscript in preparation). The still unsolved 
question, if there exist proliferative or migratory melanoma stem cells, can be asked. 
Possibly, our skin system would also allow preclinical evalution of anticancer drugs. 
The superiority of this tumor model compared to in vitro spheroid cultures or in vivo 
subcutaneous xenografts, is the fact that real melanomas can develop in human skin, 
and here very specifically in the stratum basale, and that melanoma cell proliferation 
and invasion can be studied in an authentic environment. 
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Figure 21: In vivo 3-dimensional tumor model. 
A) Hematoxylin and eosin staining of a human dermo-epidermal skin graft. Primary human 
melanoma cells were seeded together with human keratinocytes on top of a collagen 
hydrogel that was previously populated by human dermal fibroblasts. The engineered 
tumorigenic skin was transplanted onto immuno-incompetent rats. The black arrow denotes 
the epidermis. Human melanoma cells are located at the dermo-epidermal junction (black 
star) and in the dermis (black stars).   
B) Hematoxylin and eosin staining of a primary human melanoma as compared to the skin 
graft melanoma model in A).  
 
* 
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Abstract 
 
Eccrine sweat glands are generally considered to be a possible epidermal stem cell 
source. Here we compared the multilayered epithelia formed by epidermal 
keratinocytes and those formed by eccrine sweat gland cells. 
We demonstrated both in vitro and in vivo the capability of human eccrine sweat 
gland cells to form a stratified interfollicular epidermis substitute on collagen 
hydrogels. This is substantiated by the following findings: (1) a stratified epidermis 
consisting of 10–12 cell layers is formed by sweat gland cells; (2) a distinct stratum 
corneum develops and is maintained after transplantation onto immuno-incompetent 
rats; (3) proteins such as filaggrin, loricrin, involucrin, envoplakin, periplakin, and 
transglutaminases I and III match with the pattern of the normal human skin; (4) 
junctional complexes and hemidesmosomes are readily and regularly established; (5) 
cell proliferation in the basal layer reaches homeostatic levels; (6) the sweat gland-
derived epidermis is anchored by hemidesmosomes within a well-developed basal 
lamina; (7) palmo-plantar or mucosal markers are not expressed in the sweat gland-
derived epidermis. These data suggest that human eccrine sweat glands are an 
additional source of keratinocytes that can generate a stratified epidermis. Our 
findings raise the question, to what extent the human skin is repaired and/or 
permanently renewed by eccrine sweat gland cells. 
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Introduction 
Keratinocyte stem cells are supposed to assure the homeostatic renewal of the 
epidermis and to be responsible for reepithelialization of the epidermis after skin 
injuries. Keratinocyte stem cells reside not only in the epidermis but also in 
appendageal structures protruding into the dermis. Outer root sheath cells of hair 
follicles were shown to be able to regenerate a fully differentiated epidermis in vitro 
and were used for the production of epidermal equivalents for the treatment of skin 
damage or disease (Lenoir et al., 1988; Limat et al., 1996, 2003).  
The bulge region of both mouse and human hair follicles has been shown to contain 
a multipotent stem cell population (reviewed in Alonso and Fuchs, 2003; Cotsarelis, 
2006). In the mouse, these stem cells do not appear to contribute to epidermal 
regeneration under homeostatic conditions (Ito et al., 2005; Levy et al., 2005). It 
remains to be investigated whether this is also true for the human skin. Interestingly, 
human glabrous skin, which is completely free of hair follicles but contains a high 
number of sweat glands (Frinkel and Woodley, 2001), also exhibits regenerative 
potential. This fact prompted us to ask whether sweat gland-derived epithelial cells 
can differentiate into keratinocytes and form an epidermis.  
Human eccrine sweat ducts develop at around gestational week 15–20 by budding 
from the basal cell layer. The resulting anlagen protrude into the dermis, forming the 
globular secretory domain (Moll and Moll, 1992; Ersch and Stallmach, 1999). As very 
little is known about the differentiation of sweat glands, any effort to regenerate them 
in vitro remains extremely ambitious (Shikiji et al., 2003). There are some indications 
that sweat gland cells may have a certain capacity to form an epithelium in culture 
and in vivo (Lobitz et al., 1954; Jones et al., 1988; Miller et al., 1998). Yet, these few 
studies did not address the issue of the type and quality of the epithelium produced. 
The presence of a sufficient number of viable epidermal stem cells in cultured 
epidermal autografts is of major clinical importance (O’Connor, 1981; Auger et al., 
2004; De Luca et al., 2006; MacNeil, 2007). We reasoned that human eccrine sweat 
glands may be an additional source of epidermal stem cells, which may contribute to 
the in vitro maintenance and long-term survival and function of engineered epidermal 
grafts.  
To address this issue, we raised organotypic cultures consisting of a dermal 
component and a stratified epidermal substitute (ES) formed by epidermal 
keratinocytes and sweat gland cells, respectively. These substitutes, designated 
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KdES (keratinocyte-derived ES) and SdES (sweat gland derived ES), respectively, 
were transplanted onto the backsof immuno-incompetent rats and the expression of 
protein markers indicative of the grade of differentiation and homeostasis was 
determined. Although with a delay in comparison with epidermal keratinocytes, sweat 
gland-derived cells developed ‘‘de novo’’ into a functional stratified, interfollicular 
epidermis. 
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Results 
Sweat gland derived epithelial cells acquire properties of epidermal 
keratinocytes in engineered dermo-epidermal substitutes 
Human eccrine sweat glands were isolated from the scalp, abdomen, and the retro-
auricular area of young patients ranging in age from 1 to 18 years. As depicted in 
Figure 1a, preparations of glandular structures consisted of the secretory domain 
(white arrowheads), the intraglandular duct, and stretches of the intradermal duct of 
varying length (black arrows). Isolated intradermal ducts always lacked the 
intraepidermal acrosyringium and a significant stretch of the upper duct (Figure 1a). 
Consequently, epidermal cells were avoided in sweat gland-derived cell preparations. 
Keratinocytes were isolated mainly from foreskins. Both cell types were expanded 
during passage 1. In Figure 1b, the outgrowth of the above-mentioned three domains 
of an eccrine sweat gland is depicted. Myoepithelial cells were associated with 
secretory sweat gland cells and were co-isolated. They were detected by smooth 
muscle actin expression and shown to disappear from the culture within 5–7 days 
(data not shown).  
In the subsequent experiments, sweat gland-derived (three-dimensional) cell cultures 
were compared with the corresponding cultures of keratinocytes. The cells were 
initially seeded within a ring of 0.7cm2, and were grown on collagen type I hydrogels 
that had been previously populated with 1x105 primary human dermal fibroblasts. 
Keratinocytes finally covered the entire gel, thereby showing a surface expansion of 
about 4 times (Figure 1c). Sweat gland cells expanded somewhat slower, increasing 
the surface of the initial cell layer by approximately 2.5 times (Figure 1d).  
After the in vitro culture phase, the composite substitutes consisting of a dermal and 
a multilayered epidermal equivalent were transplanted onto the backs of 
immunoincompetent Nu/Nu rats. All the subsequent comparative analyses were 
performed on histological sections of dermo-epidermal grafts after their 
transplantation onto immuno-incompetent rats. To prevent the ingrowth of rat-derived 
skin cells, a transplantation chamber was used as previously described (Pontiggia et 
al., 2009; Figure 1e and f). Histological analyses 21 days after transplantation 
revealed that both epidermal keratinocytes and sweat gland cells formed a stratified 
epidermis, which consisted of a basal layer, 10–12 suprabasal layers, and a well-
differentiated anuclear stratum corneum (Figure 1g and h). 
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Characteristics of a stratified epidermis formed by sweat gland cells 
Owing to the use of the microdissection technique, it is unlikely that our sweat gland 
cell preparations were contaminated by epidermal keratinocytes. Nevertheless, we 
performed control experiments to discriminate between keratinocytes and sweat 
gland cells in the initial cell preparations (Figure 2c and d) and in SdES and KdES 
(Figure 3a–f). As shown in Table 1, only a very limited selection of antibodies, such 
as antibodies to K2e and K8, could be used for these analyses. K2e is expressed in 
all suprabasal keratinocytes of the human epidermis (Smith et al., 1999), whereas it 
cannot be recognized in the sweat gland, not even in the intraepidermal 
acrosyringium (Figure 2a and b). As shown in Figure 2b, K8 expression is confined to 
the secretory domain of the sweat gland.  
Cytospins of newly prepared primary sweat gland cells and keratinocytes were 
analyzed for the expression of K2e and K8. Importantly, none of the sweat gland cell 
preparations (n=3) contained K2e-expressing cells, whereas about 50% were 
positive for K8 (Figure 2d). These findings indicate that the sweat gland cell 
preparations were not contaminated by (suprabasal) epidermal keratinocytes. In 
contrast, the majority of epidermal keratinocytes expressed K2e, whereas these cells 
did not stain for K8 (Figure 2c). Although epidermal keratinocytes completely 
downregulated K2e expression on cell culture plastic (data not shown), a significant 
number of them re-expressed K2e when integrated into differentiated ESs, whereas 
K8 was not expressed by epidermal keratinocytes (Figure 2e). 
One significant difference between human eccrine sweat gland cells and epidermal 
keratinocytes was that only a relatively low number of sweat gland cells expressed 
K2e within 5–7 weeks in differentiating epidermal equivalents (Figure 2f). Notably, 
the number of K2e-expressing cells in SdES did not significantly increase 7–10 
weeks after their transplantation (data not shown). Thus, the K2e-expressing cells in 
SdES may represent sweat gland-derived cells that underwent additional epidermal 
differentiation steps. It remains to be investigated, however, whether the number of 
K2e-positive sweat gland cells would still increase during an extended in vivo 
differentiation period of ≥3 months. Notably, K8-positive cells were completely absent 
in SdES, indicating that this (secretory domain-specific) sweat gland marker was no 
longer expressed in the engineered epidermis (Figure 2f).  
In the next experimental series we set out to explore whether the SdES exhibited 
mucosal or palmo-plantar characteristics. This was done by screening the two types 
Human Eccrine Sweat Gland Cells Can Reconstitute a Stratified Epidermis                                                  
 43 
of ESs for the expression of K4, a mucosal marker, and K9, a marker of palmo-
plantar epidermis. In none of these experiments (n=4) did we find expression of K4, 
indicating that there was no mucosal differentiation. Furthermore, K9-positive cells 
were detected neither in KdES nor in SdES (n=4), showing that palmo-plantar 
properties were absent (Figure 2g and h).  
To monitor the contribution of rat keratinocytes to the formation of the ES, we 
intended to confirm the human origin of the substitutes. Paraffin sections of 
engineered transplants were subjected to in situ hybridization using DNA probes 
specifically hybridizing to primate-specific Alu repeats. Figure 2i shows the well-
defined transition zone (black dotted line) between the graft of human origin and the 
underlying, unstained rat tissue. Immunostaining for the human-specific nuclear 
antigen and for the human fibroblast specific CD90/Thy-1 antigen also confirmed the 
human origin of the analyzed tissue sections (data not shown).  
As there was no reliable antibody allowing to discriminate between basal epidermal 
keratinocytes and sweat gland cells (see also Table 1), we used an indirect assay to 
determine whether cells of the epidermal stratum basale were ‘‘contaminating’’ the 
sweat gland cell fraction. This was achieved by screening the two different types of 
ESs (KdES and SdES) for the presence of epidermal melanocytes. Melanocytes 
arelocated in the epidermal stratum basale, and are always present in epidermal 
keratinocyte preparations, whereas they are absent in eccrine sweat glands. We 
were able to show that melanocytes were present in all KdESs investigated (Figure 
3a), whereas no melanocytes could be detected in SdESs (Figure 3b). Accordingly, 
we showed that the transfer of melanin from melanocytes to keratinocytes takes 
place in KdES (Figure 3c and e), whereas this was not possible in SdES (Figure 3d 
and f). 
Homeostasis of transplanted epidermal substitutes. 
To determine the proliferative capacity of the epithelial cells in the ESs, frozen 
sections were stained for Ki-67, a nuclear cell proliferation-associated antigen, which 
is expressed in all active stages of the cell cycle (Gerdes et al., 1991). In unwounded, 
homeostatic human skin, Ki-67 was expressed in single keratinocytes in the basal 
and first suprabasal layers in the interfollicular epidermis (Supplementary Figure 
S1a). We observed Ki-67-positive cells in the basal layer of both types of ESs (Figure 
4a and b) 3 weeks after transplantation, indicating that the stratification process was 
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ongoing and that, as in normal skin, only a small subpopulation of keratinocytes 
maintained epidermal renewal. An identical pattern of proliferative cells was observed 
in 7-week-old grafts (Figure 4c).  
Normal, homeostatic interfollicular epidermis lacks the expression of K16 and K17 
(Moll et al., 1983; Troyanovsky et al., 1989; see also Supplementary Figure S1a 
online). These keratins are induced in suprabasal, post-mitotic keratinocytes when 
tissue homeostasis is perturbed in wound-repair situations, such as the re-
epithelialization after transplantation of dermo-epidermal substitutes or in cultures of 
dissociated keratinocytes grown on cell culture plastic (Leigh et al., 1995; Paladini et 
al., 1996; Coulombe, 1997). In both KdESs and SdESs, the expression of K16 was 
clearly detected in suprabasal cell layers soon after transplantation (Figure 4a and b), 
indicating a persistent wound-healing activity. At about 7–10 weeks after 
transplantation K16 was somewhat downregulated in both types of substitutes 
(Figure 4c; data not shown). 
Stratification of engineered epidermal equivalents 
Involucrin, envoplakin, and periplakin are markers of the cornification process and 
are associated with the formation of desmosomes and intermediate filaments 
(DiColandrea et al., 2000). In normal human skin involucrin and loricrin are 
expressed in the upper granular and cornified layers (Supplementary Figure S1c 
online).  
We found that the ‘‘early’’ pattern of involucrin expression differed from that of 
homeostatic skin in both types of substitutes. In fact, a strong expression was visible 
in the spinous layer 3 weeks after transplantation (Figure 4d and e). At 7 weeks after 
transplantation, as stratification and tissue homeostasis had further progressed, the 
lower suprabasal layers had downregulated involucrin expression (Figure 4f). The 
expression pattern of loricrin was similar to that of normal skin, both in the KdESs 
and in the SdESs, 3 weeks (Figure 4d and e) and 7 weeks (Figure 4f) after 
transplantation. Expression of envoplakin, filaggrin, and the transglutaminases I and 
III essentially confirmed the findings obtained with loricrin and involucrin (data not 
shown). Once again, the differences between KdESs and SdESs were moderate. 
The distribution of K1/10, as late differentiation markers (Patel et al., 2006), is 
indicative of the degree of tissue homeostasis in normal human skin. In fact, during 
the stratification process K10 appeared sooner in all suprabasal layers, whereas K1 
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expression was delayed and started in the more upper layers (Stark et al., 1999). 
KdES (Figure 4g) eventually showed a staining pattern comparable to that of normal 
skin (see also Supplementary Figure S1d online). In general, the stratification 
process of the SdES was delayed in comparison with the KdES, with K1 being 
expressed after 3 weeks only in the upper stratum spinosum and granulosum (Figure 
4h). In SdES the expression pattern of normal human skin was reached at about 7 
weeks after transplantation (Figure 4i).  
During stratification the epidermis establishes an intricate network of different 
intercellular junctional complexes to establish its functions as a barrier against 
external agents, as a water-balance regulator, and as a nutrient circulator (Morita and 
Miyachi, 2003; Perez-Moreno et al., 2003; Dusek et al., 2007). We analyzed the 
presence of tight junctions, as, together with the lamellar bodies of the cornified 
envelope, these establish the epidermal diffusion barrier (Malminen et al., 2003; 
Schluter et al., 2004). One of the major constituents of tight junctions, occludin, is 
expressed in the upper granular layer of the human skin (Supplementary Figure 
S1e). Its typical expression pattern was obtained in both types of ES, 3 weeks after 
transplantation (Figure 4k and l). However, in the SdES we observed stronger and 
more homogeneous occludin expression only at 7 weeks after transplantation (Figure 
4m).  
E-cadherin is expressed as a component of adherens junctions in the living 
keratinocyte layers of the human epidermis (Moles and Watt, 1997; see also 
Supplementary Figure S1e online). Both types of ESs showed the expression pattern 
of a normal epidermis (Figure 4k, l, and m). 
Desmosomes and the dermo-epidermal junction in engineered SdES  
The desmosomal proteins desmoglein (Dsg) 1 and 3 are expressed in a graded 
manner in the human epidermis. Dsg 3 is expressed in the stratum basale, whereas 
Dsg 1 can be detected in the upper layers (Supplementary Figure S1f online). Dsg 1 
and 3 and their partners desmocollin 1 and 3, respectively, are involved in the 
regulation of epidermal differentiation (Elias et al., 2001; Dusek et al., 2007). Dsg 3 is 
expressed exclusively in the ductal portion of the sweat gland (data not shown). 
During the first 3 weeks after transplantation both types of substitutes showed a 
somewhat unbalanced (mixed) expression pattern of Dsg 1 and Dsg 3. The 
suprabasal layers co-expressed both proteins in comparable quantities (Figure 5a 
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and b). For the establishment of the physiological protein gradients, longer time 
periods (7 weeks and more) were necessary (Figure 5c).  
Periplakin was detected in all suprabasal layers, but was more prominent in the 
upper spinous and granular layers (Figure 5d and f, and Supplementary Figure S1b 
online). Once again, this pattern was not yet completely established in SdES after 3 
weeks (Figure 5 e).  
Integrin α6β4 has a central role in the binding of hemidesmosomes to laminin 332 
(laminin 5), which is an important constituent of the basement membrane on which 
basal epidermal keratinocytes reside (Aumailley and Rousselle, 1999).  
Integrin α6 (Figure 5d, e, and f) and laminin 332 (laminin 5, Figure 5g, h, and i), as 
well as laminin 511 (laminin 10, data not shown), were found to be expressed in the 
basement membranes of KdES and SdES. For both proteins the expression pattern 
did not differ from that of normal skin (for comparison, see Supplementary Figure 
S1b and g online). However, in SdES, homogeneous expression was delayed.  
K5 is expressed in the basal layer and the first suprabasal layers in normal human 
homeostatic epidermis (Supplementary Figure S1g online). However, expression of 
K5 can be induced in migrating (activated) keratinocytes at wound edges (Patel et 
al., 2006). Our analyses revealed that in KdES almost the normal staining pattern 
was found after 3 weeks (Figure 5g), whereas in SdES, K5 was strongly expressed 
suprabasally (Figure 5h). At 7 weeks after transplantation both types of ESs showed 
a K5 distribution that was similar to that of normal human epidermis (Figure 5i).  
K15 is a useful indicator of epidermal homeostasis, as it is almost exclusively 
expressed in basal keratinocytes in a homeostatic epidermis (Pontiggia et al., 2009). 
Indeed, it is absent during wound healing (Waseem et al., 1999; Porter et al., 2000). 
Consistently, K15 was neither expressed in keratinocytes and sweat gland cells 
grown on culture plastic, nor in KdES/SdES before transplantation. After 
transplantation K15 became upregulated in the stratum basale, which then exhibited 
the K15 expression pattern of normal human skin (Figure 5k, l, and m; compare with 
Supplementary Figure S1h online).  
K19 is considered to be a marker of very ‘‘young’’, proliferative human skin (found in 
children from less than 2 years) (Pontiggia et al., 2009). In normal interfollicular 
epidermis, K19-positive keratinocytes are clustered in the stratum basale as a 
subpopulation of K15-positive basal keratinocytes in young skin and disappear with 
age (Pontiggia et al., 2009; Supplementary Figure S1h online). Figure 5k and l shows 
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K19 expression in both KdESs and SdES 3 weeks after transplantation. Note that in 
Figure 5l some K19-positive keratinocytes are still distributed suprabasally, indicating 
that tissue homeostasis was not yet completely established. In 7-week-old 
transplants, K19 expression was already undetectable in both types of substitutes 
(Figure 5m). The expression patterns of all markers used in this study are 
summarized in Table 2. 
Ultrastructural analysis of the epidermal substitutes 
Using transmission electron microscopy, we set out to study the two types of ESs on 
an ultrastructural level. Figure 6a shows an overview of an SdES, whereas the same 
structures in KdES are not shown. Quite frequently, blood vessels containing 
erythrocytes were evident (data not shown). The transplants were generally readily 
tolerated by the rats. Accordingly, macrophages and leukocytes in the dermal 
extracellular matrix were rare. Relatively large epidermal intercellular spaces, 
indicative of active fluid transport and occasional autophagosomes in the epithelial 
cells (asterisk in Figure 6b), denote a high metabolic turnover in the ESs.  
Figure 6b illustrates a sweat gland-derived cell with clearly visible intermediate 
filament bundles (white arrow). This basal cell formed hemidesmosomes (large black 
arrows) connecting to the basement membrane (group of small black arrows). The 
complex organization of hemidesmosomes is illustrated in Figure 6c. In the spinous 
layer, sweat gland cells interconnected to one another via desmosomes (Figure 6d). 
All structures indicative of a normal cornified envelope can be detected (Figure 6e): 
In the upper spinous layer, cells flattened during keratinization and became 
considerably smaller. Keratohyalin granules (Figure 6e, arrows) were detected in the 
cells of the granular layer. They increased in number and size toward the stratum 
granulosum, whereas the nuclei disappeared. Finally, an electron-dense stratum 
corneum, consisting of flattened cells devoid of organelles, as well as detaching 
squames were evident. Figure 6f shows the magnification of a lamellar body in 
contact with the plasma membrane.  
Taken together, transmission electron microscopy analyses of SdES revealed that 
human eccrine sweat gland cells can form a stratified ES, which, ultrastructurally, is 
indistinguishable from a KdES. 
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Discussion 
A central issue of engineering human skin substitutes is the number and quality of 
epidermal keratinocyte stem cells present in the keratinocyte preparation. A distinct 
keratinocyte stem cell pool, referred to as the epidermal proliferative unit (EPU), is 
commonly thought to be located in the epidermal stratum basale (Ghazizadeh and 
Taichman, 2005; Kaur, 2006; Strachan and Ghadially, 2008). An additional source of 
self-renewing keratinocytes is the hair follicle (Alonso and Fuchs, 2003; Cotsarelis, 
2006; Blanpain and Fuchs, 2009). However, there is evidence that keratinocyte stem 
cells are only released from the hair follicle bulge if induced by epidermal wounding 
(Ito et al., 2005; Levy et al., 2005, 2007). The fact that there are regions of the human 
body that are devoid of hair follicles, such as palmo-plantar skin, indicate that hair 
follicles are not an exclusive source for keratinocyte stem cells.  
An additional appendage of human skin is the eccrine sweat gland. Almost the entire 
human body is covered with sweat glands. One may therefore ask whether, in 
analogy to hair follicles, sweat glands can give rise to interfollicular keratinocytes in 
wound situations, or even serve as a permanent source of interfollicular keratinocyte 
stem cells (see also Figure 7).  
Using a combined in vitro/in vivo bioassay, we demonstrated that ESs can be 
generated from sweat gland-derived epithelial cells. These substitutes can be further 
differentiated and maintained in homeostasis on experimental animals for at least 2 
months. They exhibit almost all the properties of an epidermis derived from a priori 
epidermal keratinocytes (with the exception of K2e expression, which appears to be 
retarded). This is substantiated by the following findings: (1) a stratified epidermis 
consisting of 10–12 cell layers is formed by sweat gland cells; (2) a distinct, anuclear 
stratum corneum develops and is maintained after transplantation of SdES in vivo; 
(3) proteins centrally involved in the process of cornification, such as filaggrin, 
loricrin, involucrin, envoplakin, periplakin, and the transglutaminases I and III, are 
expressed in a pattern that matches that of normal human skin; (4) junctional 
complexes and hemidesmosomes are readily and regularly established; (5) K15 and 
K19-expressing keratinocytes become expressed in a distinct stratum basale 3 
weeks after transplantation (K19-expressing cells disappear 7 weeks after 
transplantation.); (6) cell proliferation in the basal layer reaches homeostatic levels; 
(7) the sweat glandderived epidermis is anchored within a well-developed basal 
lamina; (8) palmo-plantar or mucosal markers are not expressed in the sweat gland-
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derived epidermis; (9) similar to KdESs, engineered SdESs undergo maturation after 
their transplantation onto a living organism.  
It was important to have the sweat gland preparations free of epidermal 
keratinocytes. This was achieved by using the micro-dissection technique, which was 
based on optical inspection of every single sweat gland, allowing the careful 
exclusion of the upper ‘‘epidermal’’ duct in all of the prepared sweat glands. The 
absence of epidermal tissue was confirmed by showing that K2e-positive 
keratinocytes, constituting 80–90% of the cells of the human epidermis, were absent 
in the sweat gland preparations. In addition, we provided indirect indication that no 
cells of the epidermal stratum basale were ‘‘contaminating’’ the sweat gland cell 
fraction. As there was no reliable antibody that allowed to discriminate between basal 
epidermal keratinocytes and sweat gland cells, this was done by demonstrating that 
epidermal melanocytes were absent in the sweat gland cell fraction. Taken together, 
these lines of evidence strongly suggest that a pure sweat gland cell population, 
consisting of secretory and ductal cells, has the potential to develop into a functional, 
stratified epidermis.  
Although SdESs exhibited almost the complete set of epidermal markers and all the 
features of epidermal differentiation (see also Table 2), we realized a developmental 
delay in the expression of these markers and the establishment of epidermal 
homeostasis when compared with KdESs. This is most likely due to sweat gland cells 
undergoing a timeconsuming transition from ductal or secretory glandular cells to 
interfollicular epidermal keratinocytes. Thus, the delayed expression of markers such 
as K1, K10, K5, K19, and occludin in SdES is not really surprising. In addition, 
myoepithelial cells that were co-isolated with secretory sweat gland cells may have a 
stabilizing effect on the sweat gland cell phenotype in the organism. In our 
experimental setting, myoepithelial cells relatively rapidly disappeared in the cell 
cultures. Thus, the loss of myoepithelial cells, which are closely associated with 
secretory sweat gland cells, in combination with the massive cell dissociation 
(representing an extreme wound situation) and the subsequent proliferation on cell 
culture plastic, may be the prerequisite for the transition of sweat gland cells into 
epidermal keratinocytes.  
Sweat gland cells are derived from ectodermal cells that differentiated into ductal and 
secretory glandular cells during embryogenesis (Fu et al., 2005). The cell transition 
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described in this paper may represent the reversion of this ontogenetic process. 
There are two conceivable mechanisms:  
1. A multipotent, sweat gland-derived stem cell population proliferates and the 
resulting new cells differentiate in response to their new epidermal environment.  
2. Sweat gland cells might de-differentiate into a more naive state, after which they 
differentiate into a new phenotype, i.e., epidermal keratinocytes. Based on the fact 
that the new sweat gland-derived epidermis reached a state of homeostasis, and was 
permanently maintained in vivo, it has to be postulated that self-renewing cells 
assured the integrity of the new epidermis. We consider it therefore likely that both 
re-programmed sweat gland derived cells and sweat gland-derived stem cells in 
concert formed and maintained the new epidermis.  
Interestingly, under no experimental circumstances did sweat gland-derived epithelial 
cells develop into sweat glandlike structures. This suggests that the observed cell 
transition follows a default pathway of differentiation, which invariably causes sweat 
gland cells to convert into epidermal keratinocytes. This pathway may well be of 
regulatory relevance. It is consistent with the concept that, in analogy to 
keratinocytes derived from human hair follicle bulge, a self-renewing subpopulation of 
sweat gland cells has the potential to reconstitute human epidermis upon wounding, 
or even to permanently participate in regenerating it (for an illustration, see Figure 7). 
As glabrous skin (such as the palms and soles) is rich in sweat glands (Frinkel and 
Woodley, 2001), the presence of a self-renewing, potentially epidermal cell 
population in sweat glands was repeatedly postulated (Brouard and Barrandon, 
2003; Barrandon, 2007). The data presented in this paper provide evidence that 
significantly supports this assumption. To our knowledge this is previously 
unreported.  
It remains to be investigated which subtype of sweat gland cells, secretory and/or 
ductal cells, is involved in epidermal regeneration and maintenance. Some recent 
evidence suggests the presence of a label-retaining, multi-potent stem cell population 
in the secretory domain of the human eccrine sweat gland (Nakamura and Tokura, 
2009). Apart from that, only few data can be found in the literature that support the 
ability of the human sweat gland cells to form an epithelium in culture and in vivo. 
Miller et al. (1998) reported that in pigs the ‘‘sweat apparatus’’ can re-epithelialize the 
skin ‘‘de novo’’ after wounding. These authors concluded that porcine sweat gland 
cells formed an epithelium that had the morphological and structural features of 
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palmo-plantar or buccal epithelia, rather than the features of trunk epidermis. 
However, in contrast to human skin, which contains eccrine sweat glands, porcine 
skin harbors apocrine glands, the function of which is different from that of human 
sweat glands (Montagna and Yun, 1964; Ferry et al., 1995).  
In conclusion, this is the first study generating comprehensive evidence that a near-
normal epidermis can be cultured from sweat gland cells in vitro. Furthermore, the 
SdES can be successfully transplanted onto immuno-incompetent rats on which they 
adhere, further differentiate, and survive as a mature graft, which is strikingly similar 
to the KdES. This study enlarges the understanding of skin biology in that it 
corroborates the thesis that sweat gland cells can switch their phenotype and 
become keratinocytes. From a tissue engineering point of view, sweat gland-derived 
epithelial cells obviously represent an additional source of keratinocytes to grow a 
near-normal autologous epidermis. This is particularly relevant for patients requiring 
large and urgent covering of skin defects, such as severe burn injuries (third degree; 
>50% BSA). In these cases, self-renewing keratinocytes are urgently required for the 
in vitro production of as many life-saving skin grafts as possible. 
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Materials and Methods 
Preparation of skin cells 
This study was conducted according to Declaration of Helsinki Principles. Human 
skin samples from scalp, abdomen, retroauricular skin or foreskins were obtained 
from patients ranging in age between 1 and 18 years, after permission by the ethic 
commission of the Canton Zurich and after informed consent given by parents or 
patients. The skin samples were used for the isolation of sweat gland cells, 
keratinocytes, and fibroblasts, or employed for histological analysis.  
Establishment of primary cell cultures 
Keratinocytes and fibroblasts were isolated as described (Pontiggia et al., 2009). For 
sweat gland cells, we used the following procedure:  
The day before isolation mitomycin-treated or irradiated swiss albino 3T3 mouse 
fibroblasts (ATCC CCL-92) were seeded at a density of 10'000 per cm2 in DMEM, 
10% calf serum and 5 µg/ml  gentamycin. Just before plating the fragments of sweat 
glands, the medium was changed to Rheinwald and Green medium (RGM) (Jones et 
al., 1988; Schon et al., 1999), i.e. 3 parts of DMEM and one part of Ham’s F12, 10% 
FCS, 5 µg/ml gentamycin, 1.4 mM CaCl2 (all Sigma, Buchs, Switzerland), 0.4 µg/ml 
hydrocortisone, 5 µg/ml insulin, 2 nM triiodothyronine, 180 µM adenine, 10 ng/ml 
EGF
 
(all from Invitrogen, Basel, Switzerland) and 0.1 nM choleratoxin 
(Calbiochem/VWR International AG, Dietikon, Switzerland). Skin samples were cut 
into small pieces (~6 mm2), digested in DMEM containing 12 U/ml dispase 
(Invitrogen, Basel, Switzerland), 2 mg/ml collagenase blend F (Sigma, Buchs, 
Switzerland) and 38 U/ml collagenase II (Worthington, Bioconcept, Allschwil, 
Switzerland) for 16 h at 4°C and 4 h at 37°C until the mesenchyme was almost 
completely digested. The tissue pieces were centrifuged and fat droplets were 
removed with the supernatant. The pellet was resuspended in 20 ml of DMEM 
containing 3-fold concentrated antibiotics (gentamycin 15 µg/ml, penicillin 3000 U/ml, 
streptomycin 3 mg/ml and fungizone 750 ng/ml), 1% FCS and transferred to a new 
culture dish. The dermal tissue was removed from the epidermis and fragments of 
sweat glands were collected employing a stereomicroscope and micropipettes. The 
fragments were washed with culture medium and finally transferred to the culture 
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dish. At days 4-5 the first outgrowing cells were visible. After two weeks the feeder 
cells were removed by digestion with 0.1% Trypsin, 1 mM EDTA (Invitrogen, Basel, 
Switzerland) for 2 min at 37°C. The remaining sweat  gland cells were washed twice 
in PBS and detached from the dish with 0.5% trypsin, 5 mM EDTA, for 5 min at 37°C. 
Trypsin activity was stopped by the addition of 3.75 mg/ml soy bean trypsin inhibitor 
(Invitrogen, Basel, Switzerland). An almost single cell suspension was reached by 
repeated pipetting through a fine pipette tip. 
Keratinocytes and sweat gland cells were further expanded during passage 1.  
Keratinocytes were grown in a serum-free medium (SFM, Invitrogen, containing 0.2 
ng/ml EGF and 25 µg/ml Bovine Pituitary Extract). sweat gland cells were maintained 
in RGM. 
Organotypic cultures 
Organotypic cultures were prepared using a previously established transwell system   
consisting of 6 well cell culture inserts with membranes of 3.0 µm pore-size (BD 
Falcon, Basel, Switzerland) (Pontiggia et al., 2009). The membranes were covered 
with collagen type I hydrogels containing human dermal fibroblasts (passage 1). 
The collagen matrix was prepared according to the protocol of Costea et al. (Costea 
et al., 2003). Briefly, 0.7 ml of rat tail collagen type I (3.2-3.4 mg/ml, BD Biosciences, 
Allschwil Switzerland), were added to 0.2 ml chilled neutralization buffer containing 
0.15 M NaOH and 1x105 fibroblasts. After polymerization (10 min at room 
temperature and 20 min at 37°C) these dermal equiva lents were grown in 
DMEM/10%FCS for 5 days. Subsequently, keratinocytes and sweat gland cells were 
seeded onto each dermal equivalent at a density of 125x103 cells per cm2 within 
siliconized polypropylene rings of 5 mm in diameter to avoid dispersion. After 7h the 
rings were removed, 1 ml RGM was added in the upper chamber, and 2 ml were 
added to the lower chamber. Triplicate wells were set up for each dermo-epidermal 
substitute. The constructs were cultured in RGM. After 4 days the dermo-epidermal 
substitutes were raised to the air/liquid interface and cultured for 3 additional weeks. 
The medium was changed every 2nd day. Cultures were finally processed for 
transplantation or for cryo- and paraffin sections.  
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Transplantation of cultured dermo-epidermal composites 
Dermo-epidermal grafts were transplanted onto full thickness skin defects created 
surgically and encased by polypropylene rings, 27 mm in diameter as previously 
described (Pontiggia et al., 2009). The rings were sutured on the back of 10 weeks 
old, female athymic Nu/Nu rats. The transplants were covered with a silicon foil. After 
14 days the grafts were excised and processed for cryo- and paraffin sections. 
Anesthesia for all procedures was performed using isoflurane (Abbott AG, Baar, 
Switzerland). 
Histology and Immuno-fluorescence 
The epidermal substitutes were embedded in OCT compound (Sakura 
Finetek/Digitana AG, Horgen, Switzerland) and frozen at -20°C.  
Melanin was visualized using the Masson-Fontana technique with nuclear fast red as 
counterstain (Stevens and Chalk, 1996).  
Cryosections were fixed and permeabilized in acetone for 5 min at -20°C, air dried, 
washed 3x in PBS and blocked in PBS, containing 2% BSA (Sigma, Buchs, 
Switzerland) for 30 minutes. Incubation with the diluted antibodies was performed in 
blocking buffer for 1 hour at room temperature. Slides were washed three times for 5 
min in PBS and blocked for additional 15 min before the second antibody was added. 
If necessary the same procedure was repeated for the third antibody incubation. 
Finally the slides were incubated for 5 min in PBS containing 1 µg/ml Hoechst 33342 
(Sigma, Buchs, Switzerland), washed twice for 5 min in PBS and mounted with Dako 
mounting solution (Dako, Baar, Switzerland) containing 25 mg/ml of DABCO anti-
quenching agent (Sigma, Buchs, Switzerland). 
To stain freshly isolated sweat glands cells the glands were dissociated for 3 min by 
means of concentrated (3x) trypsin/EDTA (Invitrogen, Basel, Switzerland). After 
inactivation of trypsin, the cells were fixed in 2% PFA for 10 min, permeabilized with 
0.5% saponin for 5 min and incubated with the primary antibodies for 15 minutes on 
ice. The cells were passed through a 0.2 ml-serum layer by centrifugation and 
resuspended in PBS containing 2% BSA and the fluorescent-dye- conjugated 
secondary antibody for 15 min on ice. After a second serum-washing step the cells 
were centrifuged onto glass slides and the cytospins were analyzed by fluorescence 
microscopy. 
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Antibodies 
For IF the following antibodies were used: From Dako (Baar, Switzerland): K10 
(clone DE-K10, 1:100), E-Cadherin (clone NCH-38, 1:30), laminin 10 (clone 4C7, 
1:25), K19 (clone RCK108, 1:100), Melanosome (clone HMB45, 1:50); from Progen 
(Heidelberg, Germany): K2e (clone Ks 2.342.7.4, 1:100), K9 (polyclonal, 1:200), K5 
(polyclonal, 1:100); from Chemicon (Millipore AG, Zug, Switzerland): K16 (clone 
LL025, 1:100), K1 (clone LHK1, 1:200), α6 integrin (clone 4F10, 1:100), K15 (clone 
LHK15, 1:100); from Zymed (Invitrogen, Basel, Switzerland): occludin (polyclonal, 
1:50), desmoglein 1 (clone 27B2, 1:50), desmoglein 3 (clone 5G11, 1:200); from 
LabVision (P.H.Stehelin&CIE AG, Basel, Switzerland): involucrin (clone SY5, 1:100), 
filaggrin (FLG01, 1:100); from Genetex (Biozol, Eching, Germany): K8 (clone B391, 
1:200); from Sigma (Buchs, Switzerland): K4 (clone 6B10, 1:600); from BD 
Pharmingen (Basel, Switzerland): Ki-67 (clone B56, 1:200); from Abcam (Cambridge, 
UK): loricrin (polyclonal, 1:500); from Santa Cruz (Labforce AG, Nunningen, 
Switzerland): laminin 5 (clone P3H9-2, 1:100). The periplakin and envoplakin 
antibodies were a kind gift of Dr. Fiona Watt (Cambridge Research Institute, UK). As 
a secondary antibody we used FITC-conjugated polyclonal goat F(ab’)2 fragments 
directed to mouse immunoglobulins (Dako, Baar, Switzerland). For double IF, some 
of the primary antibodies were pre-labeled with Alexa 555-conjugated polyclonal goat 
F(ab’)2 fragments, according to the instructions of the manufacturer (Zenon Mouse 
IgG Labeling Kit, Molecular Probes, Invitrogen, Basel, Switzerland). 
Fluorescence microscopy 
Fluorescence microscopy was performed using a Nikon Eclipse TE2000-U inverted 
microscope equipped with Hoechst, FITC, and TRITC filter sets. For confocal 
imaging we used a Leica SP1 confocal laser scanning microscope (Leica, 
Heerbrugg, Switzerland) equipped with Argon UV laser with 351 nm / 364 nm 
excitation, Argon/Krypton laser with 474 nm / 488 nm / 568 nm / 647 nm excitation, 
fluorescence filters for DAPI, FITC and TRITC. The line average was set to 4. 
Images were processed with Imaris 5.0.1 (Bitplane AG, Zurich, Switzerland). 
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Electron Microscopy 
For transmission electron microscopy (TEM) analysis, tissue blocs (approximately 1 
mm3) were prefixed in 0.1 M cacodylate buffer (Merck, Hohenbrunn, Germany), pH 
7.3 containing 2.5% glutaraldehyde for 2 hours, washed in cacodylate buffer, 
postfixed with an aqueous solution of 1% OsO4 and 1.5% K4Fe(CN)6 for 1 hours, 
dehydrated and finally embedded in EPON 812 (Catalys AG, Wallisellen, 
Switzerland). Ultrathin sections (approximately 50-70 nm) were collected on copper 
grids were contrasted with 4% uranyl acetate and 3% lead citrate, and examined with 
a CM 100 transmission electron microscope (Philips, Eindhoven, The Netherlands). 
All reagents were from Sigma (Buchs, Switzerland) unless mentioned otherwise. 
In situ Hybridisation with Alu-probes 
The epidermal substitutes (ES) were fixed in 4% neutral formalin and embedded in 
paraffin according to standard protocols. We used basically the method published by 
Just et al. (Just et al., 2003). Briefly: The genomic DNA (gDNA) was extracted with 
the QIAamp DNA Blood Mini Kit (Qiagen) from the whole blood of a volunteer which 
donated 2 ml blood after written informed consent. 50 ng of gDNA and 0.5 µM of the 
primers (Alu-sense: 5' ACG CCT GTA ATC CCA GCA CTT 3'; Alu-antisense: 5' TCG 
CCC AGG CTG GAG TGC A 3' produced by Microsynth, Balgach, Switzerland) were 
applied in a PCR with Hot Star Taq DNA polymerase (Qiagen, Hombrechtikon, 
Switzerland) under the following conditions: 95°C f or 15 min, 25x (94°C for 30 s, 
58°C for 45 s, 72°C for 45 s) and 72°C for 10 min. The 245 bp-product was purified 
by agarose gel electrophoresis and the QIAquick Gel Extraction Kit (Qiagen). 200 pg 
were used as template for the DIG-labeling PCR (PCR DIG probe synthesis kit, 
Roche, Rotkreuz, Switzerland) under the same conditions but with increased MgCl2 
concentration (5 mM). The DIG-labelled probe was purified by ethanol precipitation. 
Paraffin sections were mounted on superfrost slides, deparaffinized (xylol, 3x 10 
min), hydrated (ethanol 100-96-80-70-50%, 2 min each) and washed in PBS (3x 5 
min). Cryosections (16 µm thick) were mounted on superfrost slides, dried for 30 min 
at 37°C, washed in PBS (3x 5 min), fixed with 4% PF A for 20 min and washed again. 
Both section types were further permeabilized (0.3% Triton X-100 in PBS, 10 min), 
digested with proteinase K (2 µg/ml in 100 mM Tris/HCl pH 8, 50 mM EDTA, 15 min 
at 37°C, cryosections 5 min only), acetylated (0.1 M triethanolamine,  0.25% Acetic 
anhydride, 2x 5 min) and washed first in PBS (2x 5min) and finally in 2xSSC (0.3 M 
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NaCl, 0.03 M sodium citrate, pH 7.0, 5 min). The hybridisation was performed in a 
moist chamber with 50% formamide. The slides were incubated in hybridization 
buffer (50% formamide in 5x SSC, 0.15% N-lauroylsarcosine, 0.02% SDS, 2% 
blocking reagent) without probe for 30 min at 85°C and with 100 ng/ml DIG-labelled 
DNA-Probe for 30 min at 85°C. After chilling on ice  for 10 min the slides were 
incubated over night at 42°C and finally washed in 2x SSC (briefly) and 0.1x SSC (3x 
15 min at 42°C). For staining the sections were blo cked (30 min in 0.15 M NaCl, 0.1 
M maleic acid pH 7.5, 1% blocking reagent), incubated with an alkaline phosphatase-
conjugated anti-DIG antibody (1:2000 in blocking buffer and 0.1% Triton X-100, 60 
min), washed (4x 15 min in 0.15 M NaCl, 0.1 M maleic acid pH 7.5), equilibrated in 
TBS (0.1 M Tris pH 9.5, 0.1 M NaCl, 5 min), incubated with the substrate solution 
(200 µl of Nitroblue tetrazolium salt + bromo-chloro-indolyl phosphate in 10 ml TBS, 
120 min) and the stop solution (10 mM Tris pH 8.0, 1 mM EDTA, 2 min) and washed 
in PBS (3x 15 min, second wash containing 1 µg/ml Hoechst 33342). Finally the 
slides were mounted in Eukitt® quick-hardening mounting medium. All reagents were 
form Fluka (Buchs, Switzerland); the proteinase K and the DIG nucleic acid detection 
kit including blocking reagent and substrate solution were from Roche (Rotkreuz, 
Switzerland). 
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Figure 1. Macroscopic and histologic appearance of SdES and KdES in vitro 
and after transplantation onto immuno-incompetent rats. 
(a) Isolation of human sweat glands after dispase/collagenase digestion. Sweat gland 
fragments containing the glandular domain (white arrowheads) and parts of the 
intradermal ducts (black arrows). (b) A typical epithelial cell colony growing out from 
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a human sweat gland fragment. (c, d) Keratinocytes and sweat gland cells grown at 
the air/liquid phase on collagen type I hydrogels on permeable inserts. Keratinocytes 
were initially seeded within a ring area of 0.7 cm2. Three weeks after plating this area 
was increased by about 4 times. Sweat gland cells increased this area by approx. 2.5 
times. (e, f) KdES in e, and SdES in f, three weeks after transplantation onto full 
thickness skin wounds on the back of athymic rats. (g,h) Hematoxylin/eosin staining 
of KdES (g) and SdES (h) three weeks after transplantation reveals a stratified 
multilayer consisting of a basal layer, 10-12 suprabasal layers and a stratum 
corneum in both types of substitutes. Scale bars in a) 500 µm, in b) 200 µm, in g, h) 
100 µm. The rings in e) and f) are 2.7 cm in diameter. 
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Figure 2. Tissue specific markers in KdES and SdES. 
Double immuno-fluorescence using the antibody combinations K2e/K8 (a, b, c, d, e, 
f) and K9/K4: (g, h). (a) K2e is expressed in suprabasal layers (white arrowhead), as 
demonstrated in the area of the glandular acrosyringium. Note that the sweat gland 
duct (dotted circles), meandering through the acrosyringium, does not express K2e. 
K8 is not expressed in normal human epidermis. (b) In normal human skin the duct 
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(du) of an eccrine sweat gland is negative for K8 (and K2e), whereas the secretory 
domain (se) expresses K8. (c) Cytospin of a freshly isolated human sweat gland cell 
suspension. About 50% of the cells are positive for K8. All sweat gland cells are 
negative for K2e. (d) In contrast, freshly isolated human keratinocytes are positive for 
K2e and negative for K8. (e) Immuno-fluorescence staining for the expression of K2e 
and K8 of KdES three weeks after transplantation. (f) Only a few single cells are 
staining for K2e/K8 in SdES. (g, h) Almost no expression of the palmoplantar marker 
K9 and the mucosal marker K4 in KdES (g) and SdES (h) after transplantation. (i) In-
situ hybridization of SdES using a DNA-probe that hybridizes to human-specific Alu-
sequences. Positive (violet) staining proves the human origin of the dermo-epidermal 
graft. The boundary between human tissue and the underlying unstained rat tissue is 
obvious. White dotted line: Dermo-epidermal border. Scale bars for all panels: 50 µm. 
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Figure 3. Preparations of human eccrine sweat gland epithelial cells are not 
contaminated by basal epidermal cells. 
a) Histological section of a typical dermo-epidermal substitute (KdES) transplanted 
onto immuno-incompetent nu/nu rats 3 weeks after transplantation. Melanocytes 
(HMB45, green cells) located in the stratum basale are obvious. The basement 
membrane is stained by a laminin 332 antibody. b) No melanocytes are detectable in 
sections of SdES, indicating that no basal epidermal cells, hence no basal epidermal 
keratinocytes, were present in the initial sweat gland cell preparation. c) Fontana-
Masson staining reveals the melanin content both in basal melanocytes and 
epidermal keratinocytes. d) No melanosomes are detectable in SdES. e) Magnified 
detail of c). f) Magnified detail of d). (a-f) Bar = 50 µm. 
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Table 1. The expression patterns of epithelial markers 
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Figure 4. Epidermal stratification and homeostasis in KdES and SdES after 
transplantation onto immuno-incompetent rats. 
Double immuno-fluorescence using antibodies to Ki-67/Cytokeratin 16 (a,b,c), 
Loricrin/Involucrin (d,e,f), Cytokeratin 1/Cytokeratin 10 (g,h,i), Occludin/E-cadherin 
(k,l,m). (a, d, g, k) Indirect immuno-fluorescence reveals the usual epidermal 
differentiation of KdES three weeks after transplantation. (b, e, h, l) Epidermal 
differentiation of SdES three weeks after transplantation. A delayed differentiation is 
obvious with respect to the expression pattern of K1/K10 (h). (c, f, i, m) Epidermal 
differentiation of SdES seven weeks after transplantation. No difference to the control 
situation (compare to a, d, g, k) can be observed. White dotted line: Dermo-epidermal 
border. Scale bar for all panels: 50 µm. 
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Figure 5. Epidermal stratification and homeostasis in KdES and SdES after 
transplantation onto immuno-incompetent rats. 
Double immuno-fluorescence of cryosections using antibodies to: 
Desmoglein1/Desmoglein3 (a,b,c), Periplakin/Integrin-α6 (d,e,f), Cytokeratin 
5/Laminin 5 (Laminin-332) (g,h,i), Cytokeratin 15/Cytokeratin 19 (k,l,m). (a, d, g, k) 
Indirect immuno-fluorescence displays the typical epidermal differentiation of KdES 
three weeks after transplantation. (b, e, h, l) Epidermal differentiation of SdES three 
weeks after transplantation. A delayed differentiation is visible with respect to the 
expression pattern of Dsg1/3 (b), Integrin α6 (e) and K5 (g). Note that some K19-
positive keratinocytes are still distributed suprabasally (white arrows in l).  (c, f, i, m) 
Epidermal differentiation of SdES seven weeks after transplantation. No difference to 
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the control situation (compare to a, d, g, k) can be observed. K19-positive 
keratinocytes in the stratum basale have already disappeared indicating advanced 
tissue homeostasis and differentiation. White dotted line: Dermo-epidermal border. 
Scale bar for all panels: 50 µm. 
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Table 2. Expression of epidermal markers in KdES and SdES 
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Figure 6. Transmission electron microscopy of a SdES after transplantation 
reveals that sweat gland-derived cells develop into characteristic human 
epidermal structures. 
(a) The typical epidermal stratification and the characteristic adhesion of epidermal 
keratinocytes by numerous desmosomes are obvious. The lower pale cells are 
dermal fibroblasts (F). Dark cells are sweat gland-derived cells (S). (b) A mature 
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dermo-epidermal junction has developed. A basal lamina (group of small arrows) and 
hemidesmosomes (black filled arrows) as well as the keratin filament network (white 
single arrow) and an autophagosom (asterisk) in an epithelial cell are indicated. (dem 
= dermal extracellular matrix, F = fibroblast) (c) The complex structure of a 
hemidesmosome is shown (pm = plasma membrane, ip = inner plate, op = outer 
plate). A complete basal lamina is deposited consisting of the sublamina dense plate 
(white arrow), the lamina lucida (black arrow) and the lamina densa (ld). (d) Mature 
desmosomal connections (black arrows) between adjacent epithelial cells of the 
spinous layer. The inset depicts a typical desmosome at a higher magnification. (e) 
Magnification of the upper epidermal layers showing the stratum spinosum (ss), the 
stratum granulosum (sg) containing the dark keratohyalin granula (white arrows), the 
stratum corneum (sc) and skin squames (sq). (f) A lamellar body (lb) between two 
corneocytes in the stratum corneum (sc) is depicted. Scale bars: 10 µm (a, e), 5 µm 
(b), 1 µm (d) and 0.2 um (c, f). 
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Figure 7. Hypothetical scheme considering both, the human eccrine sweat 
gland and the human hair follicle as sources for epidermal keratinocyte (stem) 
cells. 
The human hair follicle bulge (bg) gives rise to epidermal keratinocytes that migrate 
towards the epidermis as it is locally injured upon wounding (ch = club hair). As 
eccrine sweat gland cells have the general potential to generate an epidermis (ep), 
sweat gland cells derived from the secretory domain (sd) or ductal domain (dd), may 
also migrate towards the epidermal stratum basale (sb) to participate in closing an 
epidermal wound. It may even be considered that sweat gland cells are involved in 
the homeostatic maintenance of the human epidermis. 
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Figure S1. Distinct markers in normal human skin. 
Indirect immuno-fluorescence of normal human skin using antibodies to (a) Ki-
67/Cytokeratin 16, (b) Periplakin/Integrin-α6, (c) Loricrin/Involucrin (d) Cytokeratin 
1/Cytokeratin 10, (e) Occludin/E-cadherin, (f) Desmoglein1/Desmoglein3, (g) 
Cytokeratin 5/Laminin 5 (Laminin-332) and (h) Cytokeratin 15/Cytokeratin 19. These 
antibodies were employed to create a normal reference for the analysis of our in vitro 
and vivo skin substitutes. Scale bar for all panels: 50 µm. 
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Abstract 
 
We screened a series of antibodies for their exclusive binding to the human hair 
follicle bulge. In a second step these antibodies were to be used to identify basal 
keratinocytes and potential epithelial stem cells in the human epidermis and in 
engineered skin substitutes. Of all the antibodies screened, we identified only one, 
designated C8/144B, that exclusively recognized the hair follicle bulge. However, 
C8/144B-binding cells were never detected in the human epidermal stratum basale. 
In the bulge C8/144B-binding cells gave rise to cytokeratin 19-positive cells, which 
were also tracked in the outer root sheath between bulge and the hair follicle matrix. 
Remarkably, cytokeratin 19-expressing cells were never detected in the hair follicle 
infundibulum. Yet, cytokeratin 19-expressing keratinocytes were found in the 
epidermal stratum basale of normal skin as a subpopulation of cytokeratin 15-positive 
(not C8/144B-positive) basal keratinocytes. Cytokeratin 19/cytokeratin 15-positive 
keratinocytes decreased significantly with age. We suggest that cytokeratin 19-
expressing cells represent a subpopulation of basal keratinocytes in neonates and 
young children (up to 1.5 years) that is particularly adapted to the lateral expansion of 
growing skin. Our data show that cytokeratin 19 in combination with cytokeratin 15 is 
an important marker to routinely monitor epidermal homeostasis and (at least 
indirectly) the self-renewing potential of engineered skin. 
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Introduction 
Epidermal self-renewal in native skin indispensably requires adult epidermal stem 
cells (SCs). This is equally true for all sorts of surgically harvested as well as 
laboratory grown skin grafts. Epidermal SCs are thought to reside in the basal layer 
of the interfollicular epidermis and are supposed to be unipotent SCs that give rise to 
only one cell lineage, namely keratinocytes (Brouard and Barrandon, 2003). 
Furthermore, there is convincing evidence that multipotent epithelial SCs are located 
in the bulge region of the hair follicle (HF; Blanpain et al., 2004; Morris et al., 2004). 
These cells have the potential of generating at least three different cell lineages 
including hair matrix cells, sebaceous gland cells, and epidermal keratinocytes 
(Alonso and Fuchs, 2003).  
Although significant advances were made in identifying and locating the epithelial 
stem cell compartment in rodent skin (Cotsarelis et al., 1990; Taylor et al., 2000; 
Oshima et al., 2001; Braun et al., 2003; Blanpain et al., 2004; Fuchs et al., 2004; 
Morris et al., 2004), stem cell data regarding human skin are still vague. A number of 
putative stem cell markers, such as β1-integrin (Jones and Watt, 1993; Jones et al., 
1995), α6-integrin in combination with CD71 (Li et al., 1998; Webb et al., 2004), 
CD34 (Trempus et al., 2003; Blanpain et al., 2004), AC133 (Belicchi et al., 2004), 
p63 (Pellegrini et al., 2001; Koster and Roop, 2004), keratin (K)15 (Lyle et al., 1998), 
ABCG2 (Terunuma et al., 2003; Triel et al., 2004), and BMI-1 (Park et al., 2003) have 
been suggested. However, convincing evidence that these markers exclusively 
identify cells that have the capacity to self-renew and to maintain long-term tissue 
integrity and function is mostly missing.  
Clinical follow-up studies demonstrate that epidermis generated from cultured 
epidermal autografts can self-renew for decades (Carsin et al., 2000), indicating that 
a sufficient number of viable stem cells was initially present and survived in the 
transplanted graft. On the other hand there is also evidence that freshly transplanted 
cultured epidermal autografts are lost, due to the melting graft phenomenon, when 
grafts contain an insufficient number of viable epidermal stem cells (Matsumura et 
al., 1998).  
According to the literature there are different views on how keratinocyte stem cells 
are organized in human skin. They may be arranged as epidermal proliferative units 
(Mackenzie, 1970; Potten and Morris, 1988), or be derived from skin appendages. 
Also, homeostatic regulation may cause suprabasal (K10 expressing) keratinocytes 
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to retrodifferentiate into unipotent self-renewing keratinocytes (Li et al., 2004), for 
instance in a wound with a shortage of selfrenewing keratinocytes.  
On the basis of the above considerations we aimed at searching for tools suited to 
evaluate the quality and selfrenewing potential of engineered human dermoepidermal 
skin grafts. We present data showing that the C8/144B antibody is the only one in our 
antibody screening that recognizes a distinct cell population in the HF bulge. This cell 
population gives rise to K19-positive cells which may produce matrix cells that 
contribute to hair growth. We also provide evidence that K19-expressing cells 
represent a subpopulation of keratinocytes in the human stratum basale during 
proliferative lateral skin expansion. We have developed a one-step dermoepidermal 
transplantation model which reveals that K19 is a valuable marker to monitor the 
quality, homeostasis, and self-renewing capacity of engineered skin substitutes. 
Notably, we found that the situation in human skin differs in many aspects from that 
in mouse. 
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Results 
Two types of epithelial cells can be distinguished in the hair follicle bulge of 
normal human skin 
We have analyzed skin biopsies from human individuals (aged 1 day to 49 years). 
We intended to identify antibodies specifically binding to the human HF bulge, a 
region known to contain multipotent skin epithelial stem cells (Cotsarelis et al., 1990; 
Taylor et al., 2000; Oshima et al., 2001; Braun et al., 2003; Fuchs et al., 2004). In a 
second step we employed selected bulge-specific antibodies to search for 
keratinocyte stem cells within the stratum basale. Antibodies directed to the following 
antigens were tested: β1-integrin, α6-integrin, CD71, ABCG2, p63, Ki67, K15, 
antigen detected by C8/144B, K19, CD34, melanoma chondroitin sulphate 
proteoglycan, PLZF, BMI-1, CD200, follistatin, Dkk3, and Wif-1 (Table 1).  
The only antibody, which exclusively bound to the HF bulge, was clone C8/144B from 
Dako (Baar, Switzerland; Figure 1a; Table 1). The C8/144B monoclonal antibody was 
originally generated against a short intracytoplasmic peptide of CD8. There are 
reports claiming that C8/144B recognizes K15 in the bulge region of human HFs 
(Lyle et al., 1998). Using confocal microscopy we confirmed that C8/144B indeed 
specifically binds to the HF bulge (Figure 1b and c; Table 1). Thus, we consider 
C8/144B the most reliable human HF bulge marker presently available.  
The human HF bulge was also recognized by an antibody to K19, however, K19-
positive cells were also detected along the variable region of the HF down to the HF 
matrix (Figure 1a). Importantly, K19-positive cells were never seen in the 
infundibulum above the bulge (Figure 1a), suggesting that HF-derived, K19-
expressing cells do usually not give rise to epidermal cells (under nontraumatic 
conditions). 
 
K19-positive cells originate from CD8/144B-expressing cells in the hair follicle 
bulge of normal human skin 
The data shown in Figure 1a raise the possibility that K19-positive cells originate in 
the HF bulge and migrate from there to the HF matrix. Therefore, we also performed 
double immunofluorescence using C8/144B and K19 antibodies and confocal 
microscopy on HF bulge sections (Figure 1c–e).  
We identified a region in the asymmetrically organized bulge, which consisted almost 
exclusively of cells recognized by the C8/144B antibody (Figure 1b). As the optical 
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sections approached the region underneath the C8/144B-positive cells (toward the 
centrally located hair shaft), a short zone of cells was detected by both the C8/144B 
(FITC conjugated) and the anti-K19 (PE conjugated) antibodies resulting in a yellow 
fluorescence (Figure 1c and d). Towards the inner cell layers of the bulge, cells 
recognized by C8/144B became rare, whereas K19-expressing cells were more 
abundant (Figure 1e). These data imply that C8/144B-binding and K19- expressing 
cells are organized in distinct layers in the human HF bulge. The existence of a small 
transitional zone in which both markers are expressed in the same cells suggests 
that K19-positive cells are directly derived from C8/144B-binding cells.  
A scheme summarizing these results is shown in Figure 1f. In accordance to other 
published data, our findings suggest that there are two distinct populations of 
epithelial cells in the human HF bulge (Blanpain et al., 2004). However, in contrast to 
Blanpain et al., who described a CD34-positive cell population restricted to the 
mouse HF bulge, we detected CD34-expressing cells all along the outer root sheath 
in the human HF.  
 
C8/144B does not recognize interfollicular keratinocytes 
Upon testing the C8/144B antibody no cells were recognized in human interfollicular 
epidermis. This was invariably the case in human skin derived from different sites, 
such as foreskin, scalp, abdomen, back, and retroauricular (Table 2). This finding 
suggests that (multipotent) stem cells in the HF bulge are distinct from (unipotent) 
stem cells located in the epidermis.  
To gain more insight into their K15 specificity, we compared C8/144B with two 
commercially available, K15-specific antibodies, designated LHK15 and SPM190. 
Proteins were extracted from HaCaT cells, which are known to express K15 on cell 
culture plastic (Werner and Munz, 2000) and analyzed in western blots. The LHK15 
antibody clearly recognized a band of 55 kDa (Figure 2). SPM190 also showed the 
same prominent band, however, also weakly detected some additional proteins. 
Interestingly, C8/144B also showed weak binding to the diagnostic protein (Figure 2). 
Differences in the affinity of the three antibodies to K15 may account for these 
variations in staining intensities.  
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K19-positive cells are a subpopulation of K15-expressing keratinocytes in the 
interfollicular epidermis of normal human skin 
In very young skin (from neonate to 1.5-year old) K15 was expressed in all 
keratinocytes of the stratum basale (Figure 3a), whereas in the skin of older patients 
it was expressed in cells of the lower parts of the rete ridges only (Figure 3b). 
Suprabasal keratinocytes did not show K15 expression. These data are in accord 
with previous studies (Waseem et al., 1999; Ghali et al., 2004; Porter et al, 2000; 
Webb et al., 2004) and imply that in human interfollicular epidermis K15 is not 
necessarily a stem cell marker but rather a marker for basal keratinocytes anchored 
to a functional basement membrane.  
K19-positive basal keratinocytes were found in all body sites investigated (Table 2). 
Importantly, K19 was expressed in an age-dependent manner. The number of K19-
positive basal cells accounted for 50–70% of basal keratinocytes in newborn skin 
(Figure 3c), 10–30% in infant skin (8 days to 2 years), and was hardly detectable in 
adult skin (18–49 years; data not shown).  
K19-positive cells represented a subpopulation of K15- expressing basal 
keratinocytes (Figure 3d). K19/K15-expressing basal keratinocytes were almost 
always arranged in clusters (Figure 3d). K20 staining demonstrated that about 0.1% 
of all K19-expressing cells were Merkel cells (data not shown). 
 
Basal keratinocytes-expressing K19 are indicators of an intact epidermal 
homeostasis in dermoepidermal substitutes engineered in vitro 
To evaluate the fate of K19-expressing cells on a plastic substrate in culture, 
epidermal keratinocytes derived from children and adults (Table 2) were 
immunostained with K19 antibodies. At 2 days after plating, keratinocytes were 
completely spread out on the substrate. Several K19-positive cells were arranged in 
pairs (Figure 4a) indicating that the first mitoses had occurred. After 4 days in culture, 
K19-positive cells were still arranged in colonies (Figure 4b). After 7–10 days, the 
keratinocytes had become confluent in culture and about 30–50% of the cells 
expressed K19 (Figure 4c). The significant increase of K19-expressing keratinocytes 
derived from young children (up to 5 years) is shown in Figure 4d. In contrast, adult 
keratinocytes never gave rise to this high numbers of K19-expressing cells. In 
keratinocyte cultures derived from 40 to 50 years old patients we found 3–5% of K19-
posive cells 7, 9, and 15 days after plating (Figure 4d). These data suggest that the 
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in vitro outgrowth of K19-positive keratinocytes decrease with increasing age. They 
also underscore the value of K19 expression as a marker to monitor the self-
renewing and regenerating potential of a given epidermal substitute.  
To determine the epidermal regenerative capacity of keratinocytes, primary cells 
were grown into multilayered epidermal constructs. Keratinocytes were plated onto 
collagen type-I hydrogels populated by dermal fibroblasts on which they developed 
into multilayered epidermal equivalents within 3 weeks (Figure 5a). These exhibited a 
basal layer of densely packed cells, followed by 10–15 layers of differentiating 
keratinocytes and some layers of terminally differentiated cells forming a stratum 
corneum (Figure 5a). Upon organotypic dermoepidermal culture on collagen type-I 
hydrogels, homeostatic regulation caused excess K19-positive keratinocytes 
(previously expanded on plastic) to be eliminated by their release into terminally 
differentiated strata. However, a substantial number of K19-expressing cells 
remained in the basal layer (Figure 5b). A basal lamina-like structure had been 
deposited, as demonstrated by antibodies to laminin 10 (Figure 5c). Furthermore, 
K15 was not expressed in the basal cells of these constructs (data not shown), 
indicating that the in vitro grown epidermis still lacks some significant organizational 
properties in vitro. However, as these substitutes perfectly survived after 
transplantation onto immunoincompetent nude rats, it is clear that (although K15 was 
not expressed in these basal keratinocytes) a selfrenewing keratinocyte compartment 
was existent. Ki67-expressing, that is proliferating keratinocytes, were present 4 
weeks after seeding and were located almost exclusively basally (Figure 5d). In 
contrast to the situation on cell culture plastic, only a small percentage (3–5%) of 
K19-expressing cells was positive for Ki67, indicating cell proliferation (see also 
Figure 6h).  
These findings are consistent with the view that K19- positive keratinocytes in the 
stratum basale reveal a ‘‘young’’ epidermis, and are indicators of intact tissue 
homeostasis in engineered skin substitutes. 
 
Basal K15/K19-expressing cells are indicators of epidermal homeostasis in 
skin resulting from grafted in vitro engineered dermoepidermal substitutes 
We sought to determine the regenerative potential and homeostasis of 
dermoepidermal composites after transplantation. Full thickness skin defects were 
created on immunoincompetent Nu/Nu rats and sheltered against the surrounding 
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skin by implanting a transplantation chamber, a modified Fusenig chamber (Fusenig 
et al., 1983), to prevent wound healing through rat-derived cells (Figure 6a).  
The only dermoepidermal skin grafts that were rapidly and sufficiently vascularized 
after transplantation, and hence readily integrated into the wound, were those based 
on collagen type-I hydrogels. Importantly, these grafts could be transplanted in only 
one single surgical intervention. Histological analyses 21 days after transplantation 
revealed an epidermis with a near to normal stratification and discernable rete ridges 
(Figure 6b). The human origin of the transplanted keratinocytes was confirmed using 
a mouse antihuman nuclei monoclonal antibody (Figure 6c). K19-positive cells were 
relatively abundant and formed monolayered clusters, firmly attached to a basement 
membrane-like structure, as demonstrated by K19/laminin 5 double staining (Figure 
6d). The number of K19-expressing cells, 3 weeks after transplantation was 
comparable to the number found in the skin of 0–2 years old children. Importantly, 
this was also true for grafts derived from keratinocytes of adult donors.  
In contrast to nontransplanted skin substitutes, transplanted grafts exhibited a 
continuous layer of basal cells expressing K15, with K19-positive cells representing a 
subpopulation of these (Figure 6e). This is identical to the situation in native skin 
(Figure 3d).  
Obviously, human dermal fibroblasts, initially submerged in polymerizing collagen 
type-I, remained viable and proliferated after transplantation, as a near normal 
dermal layer of human origin was clearly distinguishable from the underlying rat 
tissue using an antibody recognizing human fibroblasts, 3 weeks after transplantation 
(Figure 6f). Thus, dermoepidermal grafts after transplantation matured into tissues 
closely resembling normal human skin.  
Co-staining the stratum basale with Ki67 and K19-specific antibodies and the 
subsequent quantification of doublepositive cells revealed that in human skin, in 
engineered grafts (in vitro), and in transplanted engineered substitutes (Figure 6g), 
the number of double-positive cells was about 5% of all K19-positive keratinocytes 
(Figure 6h). These findings are in accord with the hypothesis that the vast majority of 
K19-expressing keratinocytes are slowly proliferating (or nonproliferating). In 
contrast, 90% of the K19- expressing keratinocytes derived from young children (up 
to 5 years), when grown on cell culture plastic, became Ki67-positive and hence 
proliferating (Figure 6h). As a consequence these ‘‘young’’ (and initially quiescent) 
K19-positive cells were finally dominating the culture. 
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Comparing K19 expression with other potential keratinocytes stem cell 
markers 
We were wondering whether K19-positive keratinocytes were also recognized by 
other described keratinocyte stem cell markers. In particular the combination of α6-
integrin and CD71 (transferrin receptor) antibodies appears to be relevant in this 
respect. α6-Integrin-bright (bri)/CD71-dim keratinocytes have been published to be 
enriched for keratinocytes stem cells (Li et al., 1998; Tani et al., 2000). Our 
Fluorescence activated cell sorting (FACS) analyses revealed that the α6-integrin-
bri/CD71-dim fraction shows indeed significantly more K19-positive keratinocytes (up 
to 3x more) than the initially prepared, total keratinocyte population (Figure 7). The 
α6-integrin-dim population contained almost no K19-positive cells (data not shown). 
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Discussion 
The goal of this study was to identify markers suited to evaluate epidermal 
homeostasis and the self-renewing potential of skin substitutes, both in vitro and after 
transplantation. As the C8/144B antibody binds exclusively to the HF bulge, the 
corresponding cells are most likely identical to multipotent epithelial stem cells 
(Cotsarelis, 2006). We provide evidence that these cells give rise to two distinct cell 
fractions. One C8/144B-binding fraction remains in place to maintain the multipotent 
stem cell pool. The second fraction develops into a transiently existing cell population 
which binds both C8/144B and K19-specific antibodies. These double-positive cells 
then give rise to K19- expressing cells which are no longer recognized by C8/144B. 
According to the stem cell migration hypothesis (Fuchs et al., 2001; Oshima et al., 
2001), K19-positive cells may represent unipotent, self-renewing keratinocytes 
exiting the bulge and migrating along the outer root sheet to the basis of the HF. 
Here they may maintain the pool of matrix cells that contribute to hair growth.  
K19-expressing keratinocytes are not found in the constant region of the HF above 
the bulge. Hence, bulge-derived K19-positive cells may not contribute to epidermal 
renewal (under normal, homeostatic conditions). This view is supported by 
convincing recent reports showing that bulge-derived stem cells are not responsible 
for maintaining the interfollicular epidermis in homeostatic conditions (Claudinot et 
al., 2005; Ito et al., 2005; Levy et al., 2005).  
Nevertheless, we found a distinct population of K19-positive keratinocytes in both the 
stratum basale of young individuals and the basal layer of engineered, stratified skin 
substitutes. The clustered pattern of these keratinocytes corresponds to the 
distribution one would expect for selfrenewing keratinocytes in the stratum basale. 
Concomitantly, there are several reports stating that K19-expressing keratinocytes 
represent self-renewing cells (Lane et al., 1991; Jones et al., 1995; Michel et al., 
1996; Cotsarelis et al., 1999; Akiyama et al., 2000). On the basis of our data the 
following questions arise: What are the properties of the distinct set of K19-positve 
keratinocytes in the human stratum basale? Why are K19-expressing cells so 
dramatically reduced with age?  
K19-positive keratinocytes are highly abundant in the epidermis of fetuses and 
neonates (Van Muijen et al., 1987; Kwaspen et al., 1997). We show here that K19-
positive keratinocytes are still detectable in the stratum basale of 1.5-year-old 
children. The epidermis of these individuals is characterized by rapid lateral growth. 
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We suggest that K19-positive cells represent a population that is adapted to this 
rapid lateral expansion of the epidermis and represents a keratinocyte population that 
is uncommitted to terminal squamous differentiation. As with progressing age this 
lateral growth ceases, this type of cell is no longer required. Stratification and 
permanent regeneration (vertical maintenance), however, are ongoing in adult skin. 
This of course also requires self-renewing keratinocytes, which in adult skin are 
extremely rare or K19-negative. It still remains to be determined where in the adult, 
interfollicular self-renewing keratinocytes are derived from. As in the adult, significant 
numbers of K19-expressing cells are located in the HF, it cannot be excluded that 
these cells contribute to the basal epidermal cell pool, should there be a shortage of 
selfrenewing cells. An additional interesting possibility is that in humans keratinocyte 
stem cells may derive from sweat glands (which are distributed almost throughout the 
entire human skin), an issue that still is only moderately investigated.  
How do K19-expressing human keratinocytes compare to K19-positive keratinocytes 
in mouse? The murine K19 gene shows high homology to its human counterpart, and 
the gene is located in the acidic keratin cluster on mouse chromosome 11 (Lussier et 
al., 1990). In both species precursor cells in different tissues display high K19 levels 
(Brembeck and Rustgi, 2000). However, in mouse K19 is expressed in the HF but is 
absent from the interfollicular epidermis at hairy sites (Michel et al., 1996). Once 
again this difference has to be taken into account when comparing biological 
phenomena in both species.  
Conventional cell culture conditions provide an environment in which dissociated 
(single) primary keratinocytes have to newly establish their epithelial phenotype. The 
regulatory mechanisms of stratification and tissue homeostasis are greatly disturbed 
under these culture conditions. These conditions may represent a situation of 
extreme wound healing under which initially quiescent K19-expressing cells enter a 
state of proliferation. In contrast, organotypic (dermoepidermal) culture of 
keratinocytes, using collagen hydrogels that contain fibroblasts, induces epidermal 
stratification and tissue homeostasis. As a consequence surplus K19-positive cells 
(having accumulated during cell expansion on a plastic substrate) are now eliminated 
by terminal differentiation. Yet, a physiologically reasonable number of basal K19-
expressing keratinocytes remains in the basal layer.  
As for the quality control of engineered skin substitutes, these basal, K19-positive 
cells are important indicators of a young, proliferating, and self-renewing graft.  
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It has been reported that the C8/144B antibody recognizes K15 and defines the 
location of human HF stem cells in the bulge (Lyle et al., 1998). However, further 
work demonstrated that K15 expression is not only restricted to the bulge but is also 
expressed in a significant stretch of the outer root sheath of the human HF and in the 
stratum basale of human epidermis (Porter et al., 2000). We show here that the 
C8/144B antibody indeed weakly recognizes K15 in immunoblots, whereas it does 
not detect keratinocytes in the human stratum basale. A possible explanation for this 
discrepancy is that in human HF bulge cells, a distinct epitope of K15 is exposed, 
which is masked in the keratinocytes of the stratum basale. Furthermore, it is likely 
that there are differences in the affinities of the three K15-specific antibodies used in 
our immunostainings. Additional experiments are required to shed some more light 
on this issue.  
Using collagen type-I hydrogels and a rat transplantation model we were able to 
achieve rapid vascularization and functional integration of complex dermoepidermal 
skin substitutes after one single surgical intervention. This was not possible using 
porous lyophilized collagen scaffolds (sponges) for epidermal reconstitution, because 
vascularization was too slow to keep the epidermal substitute alive.  
It was also evident that transplantation of engineered dermoepidermal composites 
was a crucial step in completing physiological differentiation and epidermal 
stratification. Employing K19 and K15 as markers, it became possible to show that 
the organism is an extremely efficient bioreactor and a perfect regulator of organ 
structure and function.  
In summary it can be said that K19/K15-double-positive keratinocytes represent a 
distinct basal-cell population in growing skin. For engineered skin substitutes, K19 
and K15 in combination are valuable tools to monitor tissue homeostasis and the 
potential to self-renew. 
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Materials and Methods 
Preparation of skin specimens 
Human skin samples were taken from the scalp, the abdomen, the retroauricular 
region, or from foreskins. Parents or patients gave their written informed consent. 
The medical ethical committee of the Kanton Zurich approved all described studies. 
Furthermore this study was conducted according to the Declaration of Helsinki 
Principles. Tissues were embedded in OCT compound (Sakura Finetek/Digitana AG, 
Horgen, Switzerland) and placed in dry ice. Cryosections of 6–30 mm were cut at -30 
°C. 
 
Isolation and culture of keratinocytes and fibroblasts 
Skin biopsies were digested for 15–18 hours at 4 °C  in 12 U ml-1 dispase in Hank’s 
buffered salt solution containing 5 µg ml-1 gentamycin. Thereafter the epidermis and 
the dermis were separated using forceps. The epidermis was further digested in 1% 
trypsin, 5mM EDTA for maximal 3 minutes at 37 °C. T he dermal tissue was digested 
in 2 mg ml-1 collagenase for approximately 60 minutes at 37 °C.  Epidermal cells were 
resuspended in serum-free keratinocytes medium containing 25 µg ml-1 bovine 
pituitary extract, 0.2 ng ml-1 EGF, and 5 µg ml-1 gentamycin. A total of 4x106 dermal 
cells per Ø10cm dish were grown in DMEM supplemented with 10% fetal calf serum, 
4mM L-alanyl-L-glutamine, 1mM sodium pyruvate, and 5 µg ml-1 gentamycin. 
Collagenase was from Sigma (Buchs, Switzerland), all other compounds were from 
Invitrogen (Basel, Switzerland).  
 
Organotypic cultures 
Organotypic cultures were prepared using a previously established transwell system 
(six-well cell culture inserts with membranes of 3.0 mm pore size; BD Falcon, Basel, 
Switzerland). The membranes were covered with collagen type-I hydrogels which 
contained 1x105 human dermal fibroblasts (passage 1). These dermal equivalents 
were grown in DMEM for 6 days to allow for gel contraction. Subsequently 5x105 
basal keratinocytes were seeded on each dermal equivalent. Triplicate wells were set 
up for each dermoepidermal substitute. Keratinocytes were cultured for 4 days in 
three parts of DMEM and one part of Ham’s F12, 0.3% fetal calf serum, 4mM L-
glutamine, 1mM sodium pyruvate, 5 µg ml-1 gentamycin (all; Invitrogen), 0.4 µg ml-1  
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hydrocortisone, 5 µg ml-1 insulin, 5 µg ml-1 transferrin, 2nM triiodothyronine, 180 µM 
adenine, 5.3 pM sodium selenite, 20 nM progesterone, and 1.8mM CaCl2 (all; 
Sigma). After 4 days the keratinocyte layer was raised to the air/liquid interface and 
cultured for 3 additional weeks. During the first week, the culture medium was a 1:1 
mix of DMEM and Ham’s F12 containing the supplements described above and 2% 
FCS (Invitrogen). The fetal calf serum was reduced to 1% during the second and 
third week. Cultures were finally processed for transplantation or for cryo- and 
paraffin sections. 
 
Transplantation of cultured dermoepidermal composites 
Dermoepidermal grafts were transplanted onto full thickness skin defects created 
surgically and encased by polypropylene rings, 27mm in diameter (modified Fusenig 
chamber; Fusenig et al., 1983). The rings were sutured on the back of 10-week-old, 
female athymic Nu/Nu rats. The transplants were covered with a silicon foil. After 14 
days the grafts were excised in toto and processed for cryo- and paraffin sections. 
Anesthesia for all procedures was performed using isoflurane (Abbott AG, Baar, 
Switzerland). 
 
Antibodies 
CD8 (clone C8/144B, 200 µg ml-1, 1:30) from Dako (Switzerland AG, Baar, 
Switzerland); CD71 (clone berT9, 1:10): K19 (clone RCK108, 1:100); K20 (clone 
Ks20.8, 1:100); K10 (clone DE-K10, 1:100) from Santa Cruz (Labforce AG, 
Nunningen, Switzerland); laminin 5 (clone P3H9-2, 1:100); p63 (clone 4A4, 1:100); 
Dkk3 (polyclonal, 1:100); Wif-1 (polyclonal, 1:100) from Chemicon (Millipore AG, Zug, 
Switzerland); K15 (clone LHK15, 100 µg ml-1, 1:100; clone SPM190, 100 µg ml-1, 
1:50); human nuclei (clone 235-1, 1:50); CD49f (clone 4F10, 1:200) from R&D 
Systems (Abingdon, UK); ABCG2 (clone 5DS, 1:20); follistatin (clone 85918, 1:40); 
melanoma chondroitin sulphate proteoglycan (clone LHM-2, 1:500) from BD 
Pharmingen (Basel, Switzerland); Ki67 (clone B56, 1:200); CD34, PE conjugated 
(clone 581, 1:50) from ABD Serotec (Dusseldorf, Germany); CD200 (clone MRC 
OX104, 1:20) from Dianova (Hamburg, Germany); human fibroblast (clone AS02, 
anti-CD90/Thy-1, 1:100) from Calbiochem (VWR, Dietikon, Switzerland); PLZF (clone 
2A9, 1:50) from Upstate (Millipore AG); BMI-1 (clone 22F6, 1:100) from Spring 
Bioscience (AMS Biotechnology, Bioggio, Switzerland). Goat anti-mouse coupled 
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with horseradish peroxidase (polyclonal). For double immunofluorescence, some of 
the primary antibodies were prelabeled with Alexa 555-conjugated polyclonal goat 
F(ab0)2 fragments, according to the instructions of the manufacturer (Zenon Mouse 
IgG Labeling Kit; Molecular Probes/Invitrogen, Basel, Switzerland). 
 
Immunohistochemical staining 
Sections and/or cells were fixed and permeabilized in acetone for 5 minutes at -20 
°C, air dried and washed 3x in phosphate-buffered s aline (PBS). Thereafter they 
were blocked in PBS containing 2% BSA (Sigma) for 30 minutes. Incubation with the 
diluted first antibody was performed in blocking buffer for 1 hour at room 
temperature. Slides were washed three times for 5 minutes in PBS and blocked for 
additional 15 minutes. The secondary antibody was added for 1 hour. Thereafter 
sections and/or cells were incubated for 5 minutes in PBS containing 1 µg ml-1 
Hoechst 33342 (Sigma) and then washed twice for 5 minutes in PBS. Finally, the 
probes were mounted with Dako mounting solution (Dako) containing 25 mg ml-1 of 
DABCO anti-quenching agent (Sigma). 
 
Western blotting 
HaCaT cells (3x106) were lysed on ice in 1ml high salt lysis buffer (1.5 M KCl, 0.5% 
Triton X-100, 5mM EDTA) containing a proteinase inhibitor cocktail (Roche 
Diagnostics AG, Rotkreuz, Switzerland). The lysate was centrifuged at 15,000g at 4 
°C for 10 minutes and the pellet was solubilized in  200 ml 9M urea, 50mM Tris-HCl 
pH 7.5 for 20 minutes at room temperature. Twenty ml of 6x Lämmli Loading buffer 
containing β-mercaptoethanol was added to 100 µl of the extract, and boiled for 5 
minutes. Aliquots (25 µl) of the sample were loaded per lane and SDS–PAGE was 
performed. Semi-dry western blotting was done according to standard protocols. 
After blocking (blocking reagent; Roche), the membranes were incubated overnight 
with primary antibodies, diluted 1:100 in blocking reagent. After three washes in Tris-
buffered saline Tween-20, the membranes were incubated for 1 hour with goat anti-
mouse antibodies coupled with horseradish peroxidase, diluted 1:1000 in blocking 
reagent, followed by three washes in Tris-buffered saline Tween-20. Detection was 
performed using the ECL Plus kit (GE Healthcare Europe GmBH, Otelfingen, 
Switzerland) and a ChemiDoc-It imaging station (UVP). 
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Fluorescence microscopy 
Fluorescence microscopy was performed using a Nikon Eclipse TE2000-U inverted 
microscope equipped with Hoechst, FITC, and TRITC filter sets (Nikon AG, Egg, 
Switzerland). For confocal imaging, the Eclipse TE2000-U was upgraded with a 
Nikon C1 Laser Scanning Microscope. A helium–neon laser with 543nm excitation 
was used for tetramethyl rhodamine iso-thiocyanate and an argon laser with 488nm 
excitation was used for FITC. With the Plan Apo x40 c/N.A. 0.95 objective 50 optical 
sections with an increment of 0.5 mm were captured. The line average was set to 4. 
Images were processed with Photoshop 7.0 (Adobe Systems Inc., Munich, 
Germany). 
 
 
 
CONFLICT OF INTEREST 
The authors state no conflict of interest. 
 
ACKNOWLEDGMENTS 
We thank the European Union (EuroSTEC : LSB-CT-2006-037409), the University of 
Zurich, the sponsors of Dona Tissue (Therese Meier and Robert Zingg), the Vontobel 
Foundation and the Werner Spross Foundation for financial support. 
 
 
 
 
 
 
 
 
 
 
 
Markers to Evaluate the Quality and Self-Renewing Potential of Engineered Human Skin 
Substitutes In Vitro and after Transplantation 
 90 
REFERENCES 
Akiyama M, Smith LT, Shimizu H (2000) Changing patterns of localization of putative stem cells in developing 
human hair follicles. J Invest Dermatol 114:321–7 
 
Alonso L, Fuchs E (2003) Stem cells of the skin epithelium. Proc Natl Acad Sci USA 100(Suppl 1):11830–5 
 
Belicchi M, Pisati F, Lopa R, Porretti L, Fortunato F, Sironi M et al. (2004) Human skin-derived stem cells migrate 
throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 
77:475–86 
 
Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E (2004) Self-renewal, multipotency, and the existence of 
two cell populations within an epithelial stem cell niche. Cell 118:635–48  
 
Braun KM, Niemann C, Jensen UB, Sundberg JP, Silva-Vargas V, Watt FM (2003) Manipulation of stem cell 
proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. 
Development 130:5241–55 
 
Brembeck FH, Rustgi AK (2000) The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 
and Sp1. J Biol Chem 275:28230–9 
 
Brouard M, Barrandon Y (2003) Controlling skin morphogenesis: hope and despair. Curr Opin Biotechnol 14:520–5 
 
Carsin H, Ainaud P, Le Bever H, Rives J, Lakhel A, Stephanazzi J et al. (2000) Cultured epithelial autografts in 
extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. 
Burns 26:379–87 
 
Claudinot S, Nicolas M, Oshima H, Rochat A, Barrandon Y (2005) Long-term renewal of hair follicles from 
clonogenic multipotent stem cells. Proc Natl Acad Sci USA 102:14677–82 
 
Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M et al. (2004) Essentials role of Plzf in 
maintenance of spermatogonial stem cells. Nat Genet 36:653–9 
Cotsarelis G (2006) Epithelial stem cells: a folliculocentric view. J Invest Dermatol 126:1459–68 
 
Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J (1999) Epithelial stem cells in the skin: definition, 
markers, localization and functions. Exp Dermatol 8:80–8 
 
Cotsarelis G, Sun TT, Lavker RM (1990) Label-retaining cells reside in the bulge area of pilosebaceous unit: 
implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61:1329–1337 
 
Fuchs E, Merrill BJ, Jamora C, DasGupta R (2001) At the roots of a neverending cycle. Dev Cell 1:13–25 
 
Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116:769–78 
 
Fusenig NE, Breitkreutz D, Dzarlieva RT, Boukamp P, Bohnert A, Tilgen W (1983) Growth and differentiation 
characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 
81:168s–75s 
 
Ghali L, Wong ST, Tidman N, Quinn A, Philpott MP, Leigh IM (2004) Epidermal and hair follicle progenitor cells 
express melanoma-associated chondroitin sulfate proteoglycan core protein. J Invest Dermatol 122:433–2 
 
Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ et al. (2005) Stem cells in the hair follicle bulge contribute to 
wound repair but not to homeostasis of the epidermis. Nat Med 11:1351–4 
 
Jones PH, Harper S, Watt FM (1995) Stem cell patterning and fate in human epidermis. Cell 80:83–93 
 
Jones PH, Watt FM (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of 
differences in integrin function and expression. Cell 73:713–24 
 
Koster MI, Roop DR (2004) The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 
34:3–9 
 
Kwaspen FH, Smedts FM, Broos A, Bulten H, Debie WM, Ramaekers FC (1997) Reproducible and highly 
sensitive detection of the broad spectrum epithelial marker keratin 19 in routine cancer diagnosis. Histopathology 
31:503–16 
 
Lane EB, Wilson CA, Hughes BR, Leigh IM (1991) Stem cells in hair follicles. Cytoskeletal studies. Ann N Y Acad 
Sci 642:197–213 
Markers to Evaluate the Quality and Self-Renewing Potential of Engineered Human Skin 
Substitutes In Vitro and after Transplantation 
 91 
 
Legg J, Jensen UB, Broad S, Leigh I, Watt FM (2003) Role of melanoma chondroitin sulphate proteoglycan in 
patterning stem cells in human interfollicular epidermis. Development 130:6049–63 
 
Levy V, Lindon C, Harfe BD, Morgan BA (2005) Distinct stem cell populations regenerate the follicle and 
interfollicular epidermis. Dev Cell 9:855–61 
 
Li A, Pouliot N, Redvers R, Kaur P (2004) Extensive tissue-regenerative capacity of neonatal human keratinocyte 
stem cells and their progeny. J Clin Invest 113:390–400 
 
Li A, Simmons PJ, Kaur P (1998) Identification and isolation of candidate human keratinocyte stem cells based on 
cell surface phenotype. Proc Natl Acad Sci USA 95:3902–7 
 
Lussier M, Filion M, Compton JG, Nadeau JH, Lapointe L, Royal A (1990) The mouse keratin 19-encoding gene: 
sequence, structure and chromosomal assignment. Gene 95:203–13 
 
Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, Cotsarelis G (1998) The C8/144B monoclonal 
antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 111(Part 
21):3179–88 
 
Mackenzie IC (1970) Relationship between mitosis and the ordered structure of the stratum corneum in mouse 
epidermis. Nature 226: 653–655 
Matsumura H, Meyer NA, Mann R, Heimbach DM (1998) Melting graftwound syndrome. J Burn Care Rehabil 
19:292–5 
 
Michel M, Torok N, Godbout MJ, Lussier M, Gaudreau P, Royal A et al. (1996) Keratin 19 as a biochemical 
marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of 
anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 109(Part 5):1017–28 
 
Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S et al. (2004) Capturing and profiling adult hair follicle stem 
cells. Nat Biotechnol 22:411–7 
 
Ohyama M, Terunama A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB et al. (2006) Characterization 
and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 116: 249–60 
 
Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y (2001) Morphogenesis and renewal of hair follicles 
from adult multipotent stem cells. Cell 104:233–45 
 
Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. (2003) Bmi-1 is required for maintenance of 
adult self-renewing haematopoietic stem cells. Nature 423:302–5 
 
Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S et al. (2001) p63 identifies 
keratinocyte stem cells. Proc Natl Acad Sci USA 98:3156–61 
 
Porter RM, Lunny DP, Ogden PH, Morley SM, McLean WH, Evans A et al. (2000) K15 expression implies lateral 
differentiation within stratified epithelial basal cells. Lab Invest 80:1701–10 
 
Potten CS, Morris RJ (1988) Epithelial stem cells in vivo. J Cell Sci Suppl 10:45–62 
 
Tani H, Morris RJ, Kaur P (2000) Enrichment for murine keratinocyte stem cells based on cell surface phenotype. 
Proc Natl Acad Sci USA 97:10960–5 
 
Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM (2000) Involvement of follicular stem cells in forming not 
only the follicle but also the epidermis. Cell 102:451–61 
 
Terunuma A, Jackson KL, Kapoor V, Telford WG, Vogel JC (2003) Side population keratinocytes resembling 
bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells. J Invest Dermatol 
121:1095–103 
 
Trempus CS, Morris RJ, Bortner CD, Cotsarelis G, Faircloth RS, Reece JM et al. (2003) Enrichment for living 
murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 120:501–11 
 
Triel C, Vestergaard ME, Bolund L, Jensen TG, Jensen UB (2004) Side population cells in human and mouse 
epidermis lack stem cell characteristics. Exp Cell Res 295:79–90 
 
Van Muijen GN, Warnaar SO, Ponec M (1987) Differentiation-related changes of cytokeratin expression in 
cultured keratinocytes and in fetal, newborn, and adult epidermis. Exp Cell Res 171:331–45 
 
Markers to Evaluate the Quality and Self-Renewing Potential of Engineered Human Skin 
Substitutes In Vitro and after Transplantation 
 92 
Waseem A, Dogan B, Tidman N, Alam Y, Purkis P, Jackson S et al. (1999) Keratin 15 expression in stratified 
epithelia: downregulation in activated keratinocytes. J Invest Dermatol 112:362–9 
 
Webb A, Li A, Kaur P (2004) Location and phenotype of human adult keratinocyte stem cells of the skin. 
Differentiation 72:387–95 
 
Werner S, Munz B (2000) Suppression of keratin 15 expression by transforming growth factor beta in vitro and by 
cutaneous injury in vivo. Exp Cell Res 254:80–90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Markers to Evaluate the Quality and Self-Renewing Potential of Engineered Human Skin 
Substitutes In Vitro and after Transplantation 
 93 
 
Table 1. Presumptive keratinocyte stem cell-specific antibodies 
 
 
 
 
Markers to Evaluate the Quality and Self-Renewing Potential of Engineered Human Skin 
Substitutes In Vitro and after Transplantation 
 94 
 
Figure 1. Two different cell types can be distinguished in the human hair 
follicle bulge. (a) Double immunofluorescence employing C8/144B (green) and anti-
K19 (red) antibodies on scalp skin of a 3-year-old child. The positions of the three 
cross-sections through the hair follicle are indicated by 1, 2, and 3. C8/144B 
exclusively binds to cells of the HF bulge (Bu and 1). K19-specific antibodies 
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recognize cells in the bulge and all along the outer root sheath (2) down to the HF 
matrix (Mx and 3). Nuclei are counterstained with the Hoechst dye 33342 (blue). 
None of the two antibodies binds to the constant region (CR) above the HF bulge. 
(b–e) Serial confocal sections show the asymmetric organization of the HF bulge and 
reveal C8/144B-binding multipotent stem cells (green). Boxes (white frames) indicate 
the magnified region depicted underneath. (c, d) A thin layer of C8/144B and K19-
doublepositive cells (arrows in d, and yellow cells in the magnified field in d) becomes 
obvious underneath the layer of C8/144B-positive cells. (e) Bulge-derived, K19-
expressing cells at the lower end of the bulge region. (f) Scheme, summarizing the 
immunofluorescence patterns (Bu, bulge; CR, constant region; Mx, hair follicle 
matrix). All scale bars: 50 mm. 
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Table 2. K19 and K15 expression in basal keratinocytes in correlation with 
donor sites and donor age 
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Figure 2. Testing different K15-specific antibodies by immunoblotting. Three 
different antibodies, LHK15, SPM190, and C8/144B were used. LHK15 and SPM190 
clearly recognized a band of 55 kDa. C8/144B also showed some weak binding to 
the 55 kDa band. Equal volumes (25 ml) of the identical lysate were loaded. 
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Figure 3. K19-expressing cells are a subpopulation of K15-positive 
keratinocytes. (a) All basal keratinocytes of the abdominal epidermis of a 10-month-
old child express K15 (green). (b) Basal keratinocytes derived from the back of an 8-
year-old child express K15 in the tips of the rete ridges. (c) About 50% of all basal 
keratinocytes isolated from the back of a 1-day-old neonate express K19 (red). (d) 
Double immunofluorescence using K15 (green) and K19 (red) antibodies on the 
epidermis derived from the retroauricular skin of a 3-week-old child. Note that K19-
positive cells are a subpopulation of K15-expressing cells. Nuclei are counterstained 
with the Hoechst 33342 dye (blue). All scale bars: 50 mm. 
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Figure 4. K19-positive keratinocytes proliferate under non-homeostatic 
conditions on cell culture plastic. (a) Doublets of K19-expressing keratinocytes. 
(b) K19-positive and K19-negative colonies of human keratinocytes can be observed 
4 days after plating. (c) A confluent layer of keratinocytes 8 days after plating. A total 
of 30–50% of the cells express K19. (d) Quantification of K19-expressing cells 
isolated from children (from neonate to 5 years) at four different time points, reveals a 
steadily increasing number of K19-positive keratinocytes on cell culture plastic. 
Notably, adult (40 to 50-year old) keratinocytes show 10 times less K19-positive cells 
after 7 days in culture. Dark columns represent results with infant keratinocytes 
(infant KC). Bright columns represent results with adult keratinocytes (adult KC). 
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Figure 5. Evaluation of engineered epidermis equivalents. (a) Histological section 
and H/E staining of an in vitro engineered human epidermis equivalent grown on a 
collagen type-I gel which contains human dermal fibroblasts, 4 weeks after plating. 
The epidermis equivalent consists of a stratum basale, 10–15 keratinocyte layers, 
and a stratum corneum. (b) K19-expressing keratinocytes are apparently not yet 
polarized and are somewhat scattered in the basal layer. Homeostatic regulation in 
an organotypic graft causes excess K19-positive keratinocytes (created during their 
propagation on cell culture plastic) to be terminally differentiated, and hence 
eliminated, during stratification. (c) Laminin 10 staining shows that a basement 
membrane is about to be deposited. (d) Ki67/K19 double staining. Proliferating, Ki67- 
expressing, keratinocytes are located basally. The arrow indicates a rare Ki67/K19-
double-positive keratinocyte. All scale bars: 50 mm. 
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Figure 6. K19-positive human keratinocytes are indicative of an intact 
epidermal homeostasis in a grafted dermoepidermal skin substitute.  
(a) Dermoepidermal skin substitutes consisting of an epidermal equivalent and a 
collagen type-I hydrogel containing dermal fibroblasts was transplanted on the back 
of immunoincompetent Nu/Nu rats. At 3 weeks after transplantation, an intact human 
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epidermis covered the former full thickness wound. (b) H/E staining of cryosections 
through the grafted area 3 weeks after transplantation shows a near normal skin 
histology apart from missing skin appendages. The epidermis reveals an almost 
normal stratification with already developing rete ridges. It is tightly connected to the 
underlying dermis. (c) The antibody specific to human nuclei confirms the human 
origin of the epidermis (green fluorescence). (d) K19-positive cells (red) are 
organized in clusters. Note that K19-positive cells are restricted to the well-defined 
stratum basale. These cells are strictly adhering to the continuous basement 
membrane (green) which here is visualized by a laminin-5 antibody. (e) In contrast to 
the nontransplanted engineered graft, K15 (green) is now expressed in all 
keratinocytes of the basal-cell layer. K19-expressing cells (red) are a subpopulation 
of K15-positive keratinocytes. (f) Human dermal fibroblasts (green) are recognized by 
the human CD90 (Thy-1)-specific antibody, whereas the rat tissue underneath stains 
negatively. (g) Within the clusters of K19-expressing cells only few, if any, cells were 
proliferating as shown by antibodies to the cell-cycle marker Ki67. (h) The vast 
majority of K19-expressing keratinocytes are slowly proliferating (or nonproliferating) 
as seen in human skin, in engineered constructs in vitro, and after their 
transplantation in vivo. In contrast, when dissociated and grown on cell culture 
plastic, almost every K19-expressing cell becomes Ki67-positive, thus indicating 
intensive cell proliferation. All scale bars: 50 mm. 
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Figure 7. Comparing K19-positive keratinocytes and α6-integrin-bright/CD71-
diminished cells. Staining primary keratinocytes for α6-integrin, results in two major 
cell populations, one of which shows low a6 expression (α6-dim), whereas the other 
exhibits high α6 expression (α6-bri). A subpopulation of α6-bri cells expresses low 
levels of CD71 (α6-bri/CD71-dim). α6-bri/CD71-dim cells are thought to contain 
keratinocyte stem cells. FACS analyses reveals that these α6-bri/CD71-dim fraction 
contains 49% K19-positive keratinocytes, whereas only 1% of the total keratinocytes 
preparation are K19 positive. 
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Abstract 
Aim: To compare engraftment rates and vascularisation in a rat model using either 
Integra Artificial Skin® or Matriderm®. 
Methods: Matriderm® and the dermal part of Integra® were compared in a two-step 
procedure including matrix implantation and subsequent epidermal grafting. Neonatal 
rat epidermis was used as coverage to test for rapid and complete take. 
Results: Efficiency and quality of vascularisation expressed by take rate of epidermis, 
and thickness of resulting neodermis, were identical for both matrices. 
Conclusion: This first comparison of Matriderm® with Integra® in a rat model revealed 
no major differences in engraftment rates or vascularisation. 
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Introduction 
Since its introduction in the late 1980s [1], Integra® dermal regeneration template, an 
irreversibly cross-linked collagen/glycosaminoglycan matrix, has been widely used 
for dermal replacement in reconstructive surgery [2–6]. It has offered for the first time 
the possibility of building up two-layered skin after excision of full-thickness burns, 
scars, or giant naevi [7–9]. As it has some drawbacks, alternative matrices have 
been developed consisting of less densely packed collagen fibres. Matriderm®, a 
collagen/elastin matrix that is not chemically cross-linked, is one of the few 
alternatives that are licensed for reconstructive surgery [10–13]. Both Integra® and, to 
a lesser extent, Matriderm® have been studied in various settings [3,13], but a direct 
comparison of the two has never been performed. Thus, there is no information as to 
whether more or less densely packed collagen has superior clinical performance. 
The goal of this study was to compare Matriderm® and the dermal part of Integra® in 
an animal model, with particular focus on the time period needed for sufficient matrix 
vascularisation to allow epidermal graft take, and on the thickness and architecture of 
the neodermis. 
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Materials and Methods 
Study design 
Either Matriderm® or the dermal part of Integra® was implanted onto full-thickness 
skin defects of immunoincompetent rats. Either immediately or after a waiting period 
of 1 (group 1) or 2 (group 2) weeks, the matrices were covered with neonatal 
epidermis (Fig. 1 and Table 1) and then assessed after 7, 14 and 21 days. After 21 
days, the matrices were excised for histological analysis. 
 
Matrices 
The two matrices, Matriderm® (Dr. Suwelack Skin & Health Care AG, Billerbeck, 
Germany) and Integra® (Integra Life Science, Plainsboro, NJ, USA), both 2 mm thick, 
were cut into pieces 2.5 cm in diameter to fit into the transplantation devices. After 
removal of the silicone foil of Integra®, both matrices were soaked for 30 min in 
Dulbecco modified Eagle medium (Invitrogen, Carlsbad, CA, USA) containing 10% 
fetal calf serum (Invitrogen). Immuno-incompetent female nu/nu rats, 6–8 weeks old 
(Elevage Janvier, Le Genet St Isle, France) were anaesthetised by inhalation of 5% 
Isofluran® (Baxter, Volketswil, Switzerland), and maintained by inhalation of 2.5% 
Isofluran® via mask. Before the operation, 0.5 mg/kg buprenorphine (Temgesic®, 
Essex, Luzern, Switzerland) for analgesia and retinol cream (Vitamin A ‘‘Blache’’®, 
Bausch & Lomb, Steinhausen, Switzerland) for eye protection were applied. To 
prevent wound closure from the surrounding skin, polypropylene rings, 2.6 cm in 
diameter, were designed in our laboratory. The rings were sutured into full-thickness 
skin defects created on the backs of the rats, using non-absorbable polyester sutures 
(Ethibond®, Ethicon, Piscataway, NJ, USA). The matrices were implanted within the 
polypropylene rings and covered with silicone foil (Silon-SES, BMS, Allentown, PA, 
USA). Finally, the rings were covered with 5 cm x 5 cm polyurethane sponges 
(Ligasano®, Ligamed, Innsbruck, Austria). No dressing changes were performed until 
epidermal grafting. 
 
Neonatal rat epidermis 
To obtain an epidermis free of dermal components, fullthickness skin samples of 
appropriate size from newborn Wistar rats (University of Zurich animal breeding 
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programme) were treated overnight in dispase (BD Biosciences, San Jose, CA, USA) 
diluted 1:1 in Hank’s balanced salt solution (Invitrogen) containing 5 mg/ml 
gentamicin (Invitrogen) at 4 8C. The epidermis was peeled off the dermis 
immediately before transplantation. Neonatal epidermal grafts were transplanted onto 
both matrices either immediately or after a waiting period of 1 or 2 weeks. As a 
control, neonatal epidermis was also transplanted directly onto subcutaneous tissue. 
Subsequently, silicone foils and dressings were applied as described above. All 
experiments were repeated three to four times for both matrices and each waiting-
period group (Table 1). 
 
Photographic monitoring of take rates 
Transplantation sites were photographically documented in a standardised way at 7, 
14, and 21 days after transplantation of the neonatal epidermis. Images were 
exported to a graphic program (ImageJ1, http://rsb.info.nih.gov). Three independent 
observers delineated the area with intact epidermis (take). The enclosed area was 
calculated from the number of pixels in the delineated area compared with the 
number of pixels corresponding to the known diameter of the polypropylene ring [11]. 
The maximal area was 4 cm2, which was therefore defined as 100% take rate. 
 
Histology and measurement of neodermis 
Wound sites were excised 21 days after epidermal grafting, embedded in O.C.T. 
compound (Tissue-Tek®, Sakura Finetek, Japan), and stored at -80 °C. Cry osections 
(12 mm thick) from the central portion of the excised area were prepared and stained 
with haematoxylin and eosin (Sigma, St. Louis, MO, USA) and thereafter mounted 
within Eukitt® (Fluka, Buchs, Switzerland). The thickness of the neodermis (defined 
as the vertical distance between the basal layer of the epidermis and the 
subcutaneous adipose tissue) was measured four times in each of five representative 
sections cut from each sample. 
 
Immunohistochemistry 
For immunostaining vascular endothelial cells, frozen sections were fixed and 
permeabilised for 5 min in acetone/ methanol (1:1) at -20 °C. After blocking with 3% 
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bovine serum albumin (Sigma) in phosphate-buffered saline (Invitrogen), sections 
were incubated with an anti-rat CD31 antibody (BD Pharmingen, San Jose, CA, 
USA) conjugated previously with the Zenon Alexa Fluor 555 labelling kit (Molecular 
Probes, 
Eugene, OR, USA). Hoechst 33342 (Sigma) was used for nuclear counterstaining. 
Sections were mounted with fluorescent mounting medium (DakoCytomation, 
Glostrup, Denmark). 
 
Statistical analysis 
The results were analysed using VassarStats® online software 
(http://faculty.vassar.edu/lowry/VassarStats.html) performing unpaired Student’s t-
test or one-way analysis of variance where appropriate; p < 0.05 was considered 
significant. 
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Results 
Take rates of epidermal grafts  
The mean take rate of neonatal rat epidermis 7 days after transplantation on a group 
1 wound bed was 20% (±13.2%) for Matriderm® using 3 rats and 13% (±3.8%) for 
Integra® using 3 rats (Figs. 2 and 3). The mean take rate of neonatal rat epidermis 7 
days after transplantation on a group 2 wound bed was 49% (±8.5%) for Matriderm® 
using 4 rats and 52% (±16.0%) for Integra® using 4 rats (Figs. 2 and 3). There was 
no statistically significant difference between the take rates of Matriderm® and 
Integra® within the same waiting period after matrix implantation (group 1: p = 0.45; 
group 2: p = 0.66). There was, however, a clear difference in take rates, which 
depended on how long the matrices were implanted before epidermal transplantation 
(Fig. 3) (p < 0.05). A second series of macroscopic inspections was undertaken 14 
days after epidermal transplantation onto group 1 and group 2 wound beds. Again, 
the take rates on group 1 matrices were significantly lower, namely 20% (±10.5%) for 
Matriderm® and 14% (±1.4%) for Integra® (Figs. 4 and 5; p = 0.82), compared with 
group 2 rates which were 33% (±7.6%) for Matriderm® and 48% (±19.0%) for 
Integra® (Figs. 4 and 5; p = 0.23). The situation in terms of take rates remained 
basically unchanged 21 days after transplantation of the epidermis. Therefore, it can 
be assumed that a stable incorporation was achieved. At any observed time point 
after transplantation of the epidermis, the take rates of the matrices with a waiting 
period of 2 weeks were significantly superior to the take rates of the matrices with a 
waiting period of 1 week (p < 0.05). 
 
Neodermis measurement 
According to the experimental scheme shown in Fig. 1, the dermo-epidermal grafts 
were excised 21 days after epidermal transplantation. The mean thickness of the 
neodermis was 1.7mmfor both Integra® (±0.2 mm) and Matriderm® (±0.1 mm) (Figs. 
6 and 7); after transplantation without any matrix was it significantly lower at 0.7 mm 
(±0.3 mm), using 4 rats in each case (Fig. 7). 
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Vascularisation 
The qualitative immunohistochemical analysis of vascularisation 3 weeks after 
epidermal grafting revealed no obvious difference between epidermis derived from 
Matriderm® or from Integra® (Fig. 8). 
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Discussion 
To our knowledge, this is the first study comparing Matriderm® and the dermal part of 
Integra® (i.e. Integra® without silicone foil) in an animal model. We did not find 
significant differences between the two matrices regarding graft take, neodermis 
formation or vascularisation. Importantly, there was also no difference in the take 
rates when the epidermis of neonatal rats was transplanted onto the neodermal 
tissue derived from the tested matrices. The following aspects deserve a more 
detailed comment. For proper comparison, we used a 2-mm thick Matriderm® that 
equalled the thickness of the dermal part of Integra®. With respect to physiological 
skin dimensions and eventual scarring, it appeared reasonable to use dermal 
templates approximating to the physiological thickness of human dermis. In all 
previous reports, Matriderm® was used in a thickness of 1 mm [12,14,15]; the thinner 
product allows simultaneous matrix implantation and split-thickness skin grafting. 
However, this one-step approach is debatable since it does not appear to yield better 
long-term results than split thickness skin grafting alone [13]. Another methodological 
novelty was the application of pure neonatal epidermis for grafting. This approach 
enabled us to monitor the quality and function of the developing neodermis without 
the influence of variable amounts of vascularised native dermis present in split-
thickness skin grafts. 
The core finding of our study is that in this animal model Matriderm® and Integra® 
demonstrated similar performance with regard to incorporation into the wound, 
neodermal regeneration, vascularisation and, finally, acceptance of epidermal grafts. 
Matriderm® is composed of bovine dermal collagen I, III, V and elastin with no cross-
linking [12,14,15], whereas Integra® consists of bovine tendon collagen type I and 
shark glycosaminoglycan, cross-linked with glutaraldehyde [1,3,16]. However, these 
structural and biochemical differences probably do not play an instrumental role 
regarding biological behaviour in a rat model. Alternatively, the higher resistance to 
degradation of Integra® due to cross-linking of collagen might be counterbalanced by 
other mechanisms, such as foreign body reaction [17,18]. Importantly, both matrices 
produced significantly more and better structured neodermis than occurred after 
epidermal grafting onto subcutaneous tissue. This is consistent with the hypothesis 
and some preliminary data in the literature, namely that using dermal templates 
results in better functional and cosmetic long-term outcomes than grafting only of 
split skin or cultured epidermis [3,4]. 
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Furthermore, we generated compelling evidence that the time interval between 
matrix implantation and epidermal transplantation was important, in that take rates 
were significantly better ( p < 0.05) when grafting was performed 2 weeks rather than 
1 week after matrix implantation. This finding is no surprise, since we know from 
published clinical data [18], as well as from our own observations not yet published 
(of >50 paediatric cases), that a minimum of 3 weeks is required for Integra® to 
produce a neodermis suitable for epidermal coverage. As mentioned above, clinical 
or other experimental data using 2-mm thick Matriderm® are not available for 
comparison. Matrix vascularisation was addressed immunohistochemically by 
selectively staining vascular endothelial cells. Although analyses were done 
qualitatively and not quantitatively, histological comparison demonstrated 
approximately the same vascularisation pattern in both matrices. The fact that matrix 
and graft takes were identical for both templates strongly corroborates the thesis that 
a very similar, if not identical, blood supply is present. 
A point deliberately not addressed was the problem of scarring and contraction. 
Notoriously, all dermal replacement materials lead to some scar formation and thus 
they contract, usually more than full-thickness skin contracts [6]. Although we did 
observe such shrinking in this study, we opted against studying the issue. Rat 
models in general and, in particular, the use of polypropylene rings create a non-
natural situation and thus a hardly controllable bias. On the other hand, the great 
advantage of the ring was to prevent wound closure from the surrounding tissue, i.e. 
host cell migration from the wound margins. 
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Conclusion 
Standardised comparison in a rat model of Matriderm® and the dermal part of 
Integra® revealed no statistically significant differences in their biological properties or 
behaviour. In contrast, the time span between matrix implantation and final coverage 
was crucial with respect to matrix incorporation and subsequent epidermal grafting. 
Randomised controlled human studies are needed to ultimately define the roles of 
these matrices in skin replacement strategies. 
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Fig. 1 – Schematic overview of experiments. 
 
 
 
 
Table 1. 
 
 
 
 
 
Matriderm vs. Integra: A Comparative Experimental Study                                                                                    
 116 
      
Fig. 2 – Photodocumentation 7 days after transplantation of neonatal epidermis: (A) 
Matriderm® implanted for 1 week (group 1), (B) Integra® implanted for 1 week (group 
1), (C) Matriderm® implanted for 2 weeks (group 2) and (D) Integra® implanted for 2 
weeks (group 2). 
 
 
 
Fig. 3 – Mean take rates of epidermis 7 days after transplantation onto matrices. 
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Fig. 4 – Photodocumentation 14 days after transplantation of neonatal epidermis: (A) 
Matriderm® implanted for 1 week (group 1), (B) Integra® implanted for 1 week (group 
1), (C) Matriderm® implanted for 2 weeks (group 2) and (D) Integra® implanted for 2 
weeks (group 2). 
 
 
 
Fig. 5 – Mean take rates of epidermis 14 days after transplantation onto matrices. 
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Fig. 6 – Haematoxylin and eosin staining of neodermis 21 days after transplantation 
of epidermis, group 2: (A) Integra®, (B) Matriderm® and (C) control, direct 
transplantation of the epidermis onto subcutaneous tissue (scale bar: 100 mm). 
 
 
Fig. 7 – Mean thickness of the neodermis 21 days after transplantation of the 
epidermis onto Integra®, Matriderm® and directly onto the subcutaneous tissue 
(control). 
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Fig. 8 – Histology of neovascularisation: Left, Matriderm®. Right, Integra®. Red, CD 
31 antibody staining. Blue, Hoechst staining. Green, autofluorescence of collagen in 
Integra®. No autofluorescence is observed with Matriderm® (scale bar: 50 mm).  
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Abstract 
The engineering of skin substitutes and their application on human patients has 
become a reality. However, cell biologists, biochemists, technical engineers, and 
surgeons are still struggling with the generation of complex skin substitutes that can 
readily be transplanted in large quantities, possibly in only one surgical intervention 
and without significant scarring. Constructing a dermo-epidermal substitute that 
rapidly vascularizes, optimally supports a stratifying epidermal graft on a 
biodegradable matrix, and that can be conveniently handled by the surgeon, is now 
the ambitious goal. After all, this goal has to be reached coping with strict safety 
requirements and the harsh rules of the economic market. 
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Introduction 
 
 
Large full-thickness skin defects resulting from burns, soft tissue trauma, congenital 
giant nevi, and disease leading to skin necrosis [1], [2], [3], [4], [5], [6], [7] and [8], 
represent a significant clinical problem that is far from being solved. The main 
challenges encountered are the following two. 
First, there is donor site shortage for autologous skin transplantation when the defect 
exceeds 50–60% of the total body surface area (TBSA) [9]. The typical clinical 
example is a massive deep burn. 
Second, most conventional skin grafting techniques to provide autologous defect 
coverage are based on transplanting split-thickness skin (the today's gold standard). 
Split-thickness skin contains all of the epidermis but only part of the dermis, and that 
frequently leads to scarring. Rarely, scarring is mild and irrelevant. Often, particularly 
in children, there is hypertrophic scarring or keloid formation that is frequently 
disabling and disfiguring [10] and [11]. Interestingly, full-thickness skin transplantation 
is not usually associated with scarring, however autologous full-thickness skin 
transfer can only be performed for injured areas <2% TBSA. 
Theoretically, both main problems, donor site shortage and scarring, could be 
reduced if not eliminated if it were possible to grow an autologous full-thickness skin 
analogue with near normal anatomical and functional properties: a cultured dermo-
epidermal skin substitute. 
There are still some major challenges concerning the development of such a skin 
substitute: 
1) A dermo-epidermal substitute should exhibit a barrier function immediately or 
rapidly after transplantation. A central question that remains is what minimum level of 
differentiation (and barrier function) has to be achieved in a skin substitute during its 
growth in vitro to result in an optimal structure and function after its transplantation 
onto the patient. 
2) On its way to an optimized and long lasting structure and function, a dermo-
epidermal substitute should be efficiently and appropriately vascularized. Attempts to 
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reach this goal have entered a period of significant progress; however, a final 
breakthrough is still missing. 
3) Much is still unknown about the mechanisms by which tissues form and heal, yet 
insights from developmental biology and other biological disciplines are already 
guiding the development of “intelligent materials” that work with nature's own 
mechanisms of organogenesis and repair. Biologically active and appropriate 
matrices and factors in combination with automated (tissue printing) techniques [12], 
designed to produce a new generation of complex skin substitutes both, in a desired 
number and with a constant quality, are now the guidelines of modern 
“skingineering”. 
This article summarizes the progress in the field, reviews some critical aspects of the 
underlying cell and skin biology, and points out some remaining challenges, key 
clinical landmarks, commercial considerations and future directions that may foster 
the progress in the engineering of skin. 
Principles of skin reconstitution and scarring 
Skin is an efficient barrier against external influences such as mechanical 
disturbances, UV radiation, pathogenic microbial agents; it prevents the substantial 
loss of body fluid and plays a significant role in thermoregulation and immune 
defence. Different cell types, such as keratinocytes, melanocytes, fibroblasts and 
endothelial cells, constituting the epidermis, the dermis and the subcutis, are 
necessary to guarantee its full function (Fig. 1). If this barrier is destroyed, different 
measures need to be taken, depending on the depth of the skin defect. Injuries 
involving the epidermis alone, and injuries extending into the superficial layer of the 
dermis, will re-develop an epidermis without surgical intervention, provided there is a 
sufficient number of keratinocyte stem cells present in the remaining epidermis or in 
the residual dermis. If epidermal keratinocytes are missing, regeneration may be 
achieved by epithelial stem cells derived from hair follicles and/or sweat glands. 
Patients with defects extending into the deeper dermis or even the hypodermis need 
a more complex treatment, as the injured surface is depleted of its keratinocyte stem 
cells. In this case the “gold standard” approach is to apply split-thickness skin grafts 
that contain all the epidermis and marginal parts of the dermis, thereby transferring 
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self-renewing keratinocyte stem cells to the affected area. With full-thickness skin 
lesions, involvement of surgical excision with closure of the wound is almost always 
mandatory and scarring a fact [13]. Hence, next to the availability of stem cells, 
scarring is another crucial hallmark of skin reconstitution. Because scar formation is 
unique to humans in most aspects, animal model research is only of limited value 
and has not contributed much to our understanding and the treatment of scars. To 
mend the damage, the body has to produce new collagen fibers. However, because 
the body cannot re-build the tissue exactly as it was, the new (scar) tissue will have a 
distinct collagen pattern and a different skin texture (and quality) than the 
surrounding normal skin. 
The main feature of the phenomenon “scarring” is called “wound contraction”. Wound 
contraction is caused, at least in part, by the presence of myofibroblasts which 
develop characteristics of smooth muscle cells under the influence of TGFβs [14]. In 
contrast to embryonic wound healing [15] and [16], which still occurs without scarring, 
wound contraction is the general mode of wound healing in humans after birth [17] 
and [16]. Taken together it can be said that successful reconstitution of skin with skin 
substitutes depends crucially on two factors: the presence of self-renewing 
keratinocyte stem cells for re-epithelialization, and a functional dermal substitute 
consisting of the appropriate cellular and acellular components, that allow no or only 
limited scarring of the developing skin. 
 
Key events in the development of skin substitutes 
The first milestones in skin research and skin tissue engineering were the enzymatic 
separation of the epidermis and dermis [18] and the in vitro culture of keratinocytes 
[19]. A major breakthrough was made in 1975, when Rheinwald and Green managed 
to grow human primary epidermal cells in serial culture on a layer of lethally 
irradiated 3T3 murine fibroblasts (Fig. 2). These researchers showed that limitations 
observed previously in the cultivation of epidermal cells in surface cultures were not 
intrinsic, but due to the complex relationship between keratinocytes and fibroblasts 
[20]. Taking advantage of the 3T3 cell-feeder layer technique, an epidermal graft 
could be expanded to more than 500 times its size within 3–4 weeks [21]. After the 
first clinical application [22], cultured epidermal autografts (CEAs) were tested in 
almost all leading burn centers world wide [23], [24], [25], [26], [27], [28], [29] and 
Tissue Engineering of Skin                                                                                     
 124 
[30]. However, there were disadvantages that included a widely variable CEA take, 
depending on the wound site and status, age of the patient, and knowledge and 
experience of the operator [26] and [31]. In 1981 Bell et al. [32] generated a dermo-
epidermal substitute which was tested in an animal model. Subsequently this 
technique was transformed into the product Apligraf®, which was prepared using 
human allogeneic fibroblasts and keratinocytes (see also Table 1). On the basis of 
this development also dermo-epidermal skin substitutes consisting of human 
autologous keratinocytes and fibroblasts in bovine collagen were applied in severe 
burn patients [33]. Interestingly, because of the effort to establish dermo-epidermal 
skin grafts, researchers revealed the importance of epithelial–mesenchymal 
interactions. They observed that the cross-talk between fibroblasts and keratinocytes 
was essential for the establishment of a functional basement membrane [34] and 
[35]. A further significant progress was the development of a bilayered “artificial skin” 
[36]. This acellular collagen-glycosaminoglycan-based skin substitute is now 
commercially available as Integra Artificial Skin® (commonly referred to as Integra). 
Integra® was developed in the 1980s and commercially launched in the United States 
in 1996. The appealing idea of combining cultured keratinocytes with Integra® has 
generated a fascinating new field of research and much optimism to finally provide 
patients with a dermis off the shelf and a laboratory grown epidermis, thus eliminating 
the need for donor sites. However, reality has shown that simple cultured epidermal 
autografts do not take well on the neodermis produced by Integra® [37] and [38]. 
The invention of Integra Artificial Skin was certainly a major step in tissue 
engineering of skin. However, the time has come to explore new avenues for the 
development of a single step clinical application of novel dermo-epidermal skin 
substitutes. This not only because of increasing hospitalization costs (increasing 
health insurance costs, budget restrictions) but also, and predominantly, to optimize 
clinical skin substitution with superior functional and cosmetic results. 
Improved engineered skin substitutes for clinical applications 
Two main groups of patients would profit most from a tissue-engineered skin 
substitute. The first group includes burn patients, suffering from an acute life-
threatening situation (Fig. 3A). Large and deep burn wounds leave little remaining 
healthy skin to be used for split-thickness skin grafts. The challenge here is to rapidly 
produce large quantities of autologous, dermo-epidermal substitutes. The second 
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group denotes the elective or chronic situation. Disabling scars, giant nevi (Fig. 3B) 
or chronic ulcers are ideally replaced by a skin graft of matching size, texture, and 
colour. Full- and split-thickness skin grafts may not always be available in a sufficient 
quantity. The challenge in this respect is the engineering of functionally and 
cosmetically adjusted skin substitutes, ready for transplantation at a previously 
scheduled point in time. 
There exist several “commercial” treatment modalities next to skin grafting. These 
may or may not help to improve the structure and function of the grafted skin, such 
as some dermal substitutes or keratinocyte sprays. In any case, various basic 
problems are still encountered. 
For a given skin substitute to attach promptly after transplantation, a well prepared 
and vascularized wound bed is required. This is not always easy to achieve in deep 
burn wounds or with chronic wounds. If a dermal substitute reaches a threshold 
thickness [39], vascularization is too slow to assure nutrition of the overlying 
epidermis resulting in epidermal necrosis or graft loss. Therefore, most dermal 
substitutes thicker than 1 mm (Integra®, Matriderm®) are applied using a two-step 
approach. This avoids epidermal necrosis, as the dermal substitute is given sufficient 
time to vascularize. However, an additional operation is needed for transplantation of 
an epidermal component. This procedure is lengthy, gives no guarantee of success 
and is an additional stress factor for the patient. The transplanted epidermal 
component produces skin of varying quality and exhibits properties that are distinct 
from the original. Features of the transplant may be missing elasticity, contraction of 
the graft, lack of pigmentation, and thereby lack of protection against UV radiation. All 
these factors let us conclude that there is still a high potential for the development of 
novel, significantly improved skin substitutes. 
Tissue homeostasis, keratinocyte stem cells, and rapid 
vascularization as indicators of skin quality 
To reconstruct skin in the laboratory, a skin biopsy from the patient is required to 
isolate the different cell types (Fig. 4). Mainly, keratinocytes, melanocytes, dermal 
fibroblasts and vascular endothelial cells can be obtained. Each cell type is expanded 
in its appropriate culture medium, in close contact with appropriate extracellular 
matrix components, and if required in the presence of supportive (mesenchymal) 
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cells. As a result a complex skin substitute may develop. However, the quality of 
such a skin graft is frequently not determined prior to transplantation. How can the 
quality of a given engineered skin substitute be monitored? To date only a very 
limited number of indicators or markers has proven useful in this respect. Cytokeratin 
19 (K19) expressed in basal keratinocytes (Fig. 5A) has recently been described as a 
marker for epidermal homeostasis, and as an indicator of young, possibly laterally 
expanding skin [40]. Furthermore, K19 is expressed in the stratum basale of 
engineered skin substitutes, indicating a potentially thriving and functional epidermis 
that is very likely to be taken after its transplantation. However, as K19-positive 
keratinocytes are frequently described as keratinocyte stem cells [41] and [40] and as 
they are no longer detectable in human individuals older than 2 years, it remains to 
be determined whether K19-positive basal keratinocytes are a subtype of 
keratinocyte stem cells, exclusively expressed in very young skin. Other keratinocyte 
stem cell markers may be the integrin α6 chain (highly expressed) in combination 
with the transferrin receptor, CD71 (low expression) [42] and [43]. The problem with 
any of these markers is that their usefulness has to be confirmed by a reliable 
bioassay. The only reliable bioassay, however, appears to us is the formation of a 
stratified epidermis that remains fully functional for at least 12 weeks after 
transplantation. An additional criterion significantly influencing the quality of a given 
skin substitute is its rapid and appropriate vascularization after transplantation. The 
thickness of a (non-pre-vascularized) skin graft that can easily become vascularized 
is about 0.7–1.0 mm. In grafts thicker than 1.0 mm, new blood vessels cannot grow 
quickly enough to nourish the overlaying epidermal layer [44]. Vascularization is 
particularly problematic if the respective skin substitute is based on a dense or highly 
cross-linked extracellular matrix, or if it is placed over fatty tissue or poorly 
vascularized wound beds. One promising line of research investigates the pre-
vascularization of engineered tissues in vitro [44], [45], [46], [47], [48] and [49]. 
In this context adult human dermal microvascular endothelial cells (HuMECs) are 
submerged within fibrin or collagen hydrogels in which they develop into true 3D 
capillaries (Fig. 5B) displaying a real lumen (Fig. 5C) [50]. Subsequently these pre-
vascularized substitutes are transplanted to have the engineered capillaries 
stabilized by mural cells (pericytes, smooth muscle cells) derived from the wound 
bed. Finally the engineered capillaries are thought to connect to the microvessels of 
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the wound ground (inosculation). So far only very few laboratories managed to 
convincingly show the proof of this principle. 
What has been achieved so far: currently available skin 
replacements 
Several commercial products were developed during the last 30 years. Most of them 
were designed for permanent use, some of them as temporary substitutes. They 
contain cells of differing origin (autologous, allogenic or xenogeneic) and 
biodegradable materials (naturally occurring or synthetic polymers) as scaffolds for 
cell attachment and facilitated handling. To give an overview, we have classified 
them into epidermal, dermal and dermo-epidermal substitutes (Table 1). 
Epidermal substitutes contain autologous keratinocytes, often grown in the presence 
of murine fibroblasts. Most products belong to the category of “cultured epidermal 
autografts”, also called CEAs (Epicel®, Epidex™, Myskin™), for which keratinocytes 
are grown to stratified cell sheets. Starting off from a skin biopsy, the production of 
the final substitute takes about 3 weeks [51] and [52]. This is why burn wounds 
initially need to be treated with temporary wound dressings. Once applied to the pre-
treated dermal wound bed, CEAs can be applied directly or in combination with other 
methods (e.g. the sandwich technique). Several studies and multi-centre trials over 
the past years [52] and [53] show a wide range of take rates with an average value of 
50% or less [54] and statements about qualitative outcomes are inconclusive due to 
the diversity of application methods. Disadvantages are mainly their slow preparation 
time, variable engraftment rates, difficult handling due to the thin, fragile cellular 
layers and their high production costs [30]. 
Another approach for epidermal cellular replacement is the use of cultured 
autologous keratinocytes in suspension (ReCell®) [55], [56] and [57]. With this 
method, keratinocytes can be sprayed onto the wound bed directly after having been 
prepared from a biopsy in the operation room. Although this method has shown a 
somewhat faster epithelialization and epidermal maturation in wound models [58], 
this method is not suited to treat 3rd degree burn wounds. The quality and patient's 
benefit of this method in clinical settings is still debated. 
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As with these methods a dermal component is missing, the degree of epidermal 
attachment and scarring is highly dependant on the quality and condition of the 
underlying dermal wound bed [39]. The additional unsatisfying results in regard to 
mechanical stability and scarring led to another approach in skin substitute 
development. 
Engineered dermal substitutes restore dermal tissue by promoting new tissue growth 
and optimising healing conditions [59]. They need to be covered by a permanent 
epidermal surface or substitute. Some of them consist of acellular matrices and are 
permanently incorporated into the patient's wound bed (AlloDerm®, Integra®, 
Matriderm®) [60], [61], [62], [63], [64] and [65]. After application to a prepared dermis, 
these substitutes are colonized and vascularized by the underlying cells [66]. Finally 
an autologous neodermis is formed. As soon as vascularization has advanced 
sufficiently (usually 3–4 weeks after application), a split-thickness skin graft can be 
placed on the neodermis [67]. Others include human allogeneic cells and are applied 
as transient wound dressings that stimulate wound healing (Dermagraft®). 
Dermagraft® consists of allogeneic fibroblasts seeded in a polyglactin mesh [68]. 
They secrete growth factors and deposit dermal matrix proteins and are thought to 
facilitate the healing process [59], [67] and [69]. Histologic evaluation of biopsies did 
not show any evidence of immunologic response [70], however, the product is mostly 
used for chronic venous or diabetic foot ulcers [69]. 
The application of dermal substitutes using the two-step surgical procedure has 
shown improved scarring [62], but more recent approaches are utilizing thinner 
dermal layers, with the aim of transplanting the dermal substitute together with the 
epidermal graft in a single step [56], [63], [64], [71] and [72]. Clinical studies have so 
far shown promising results with a thin (1 mm) dermal matrix (Matriderm®) limited to 
the hand and wrist region. Further clinical applications and studies will show if this 
method can be applied more broadly. 
Few engineered, “off-the-shelf” dermo-epidermal substitutes have been produced. 
Human allogeneic neonatal keratinocytes and fibroblasts are combined with a 
scaffold to form a temporary covering (Apligraf®, Orcel®) and are used mostly for 
chronic wounds [39], [59], [66] and [69]. Studies have mostly reported about its use 
for chronic wounds and ulcers and have shown a higher incidence of wound closure 
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[74] and [75]. One study reports improved clinical outcome [76] for burn patients. For 
autologous cultured dermo-epidermal substitutes [59], keratinocytes and fibroblasts 
are collected from a burned patient's biopsy and added to a collagen-
glycosaminoglycan substrate [77]. Cultivation time after biopsy needs about 4 weeks 
before the substitute can be transplanted. Few clinical trials have been conducted so 
far. In terms of graft take and scar appearance, results appear superior to 
conventional techniques [59], but further clinical studies need to confirm these 
results. 
Commercial considerations 
Tissue engineering of skin was thought to have such obvious clinical benefits that it 
led to unrealistic clinical and commercial expectations. The initial objective with the 
aim to rapidly come up with perfect skin grafts for patient treatment soon turned out 
to be unrealistic. Delivering a customized product shows a high complexity from its 
fabrication with autologous cells until delivery at its destination. In addition to slow 
progress for graft development, even slower progress for administrative demands like 
quality and safety controls and regulations (GMP production, FDA approval, 
microbiologic and immunologic safety required) might lead to a delayed market 
launch. Needless to say that a relatively small number of customized products, with 
already high production costs, raises costs even more and reduces the chance for 
health care institutions to approve of upcoming costs. All in all, development and 
production of tissue-engineered skin substitutes seems unattractive so that 
companies deviate towards more broadly applicable products, such as acellular 
materials or temporary dressings, which can be sold as “off-the-shelf” products [78] 
and [79]. 
It should, however, be taken into consideration that the application of an engineered 
substitute made of autologous cells in a fitting size and of matching colour and 
texture, would also simplify medical treatment. Multiple operations could be avoided 
by applying the substitute in a one-step procedure. Some corrective operations would 
become unnecessary, and therapy for chronic diseases could find an easier solution. 
With fewer operations and interventions, medical risks for patients could be reduced, 
recovery time decreased and costs thereby be diminished. In addition to making 
treatment methods easier and optimizing the biology and function of skin substitutes, 
hopes for a satisfactory cosmetic outcome are high. 
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Concluding remarks and perspectives 
Tissue engineering of skin is based on 25 years of research and rests on a strong 
background of material technologies and cell and molecular biology. The challenge 
that still remains is the generation of a complex dermo-epidermal substitute that can 
be securely and conveniently transplanted with minimal scarring in one single 
surgical intervention. Means to significantly speed up vascularization in these 
complex skin grafts, such as controlled release of angiogenic and/or vasculogenic 
factors from matrices [80], [81], [82], [83], [84] and [85], seeding endothelial cells 
directly into the matrix, and engineering the vasculature directly into the tissue [86], 
[87] and [88] will largely contribute to reach this goal. 
Furthermore the development of novel ECM matrices and scaffolds will still be central 
in engineering optimized skin grafts. Numerous attempts to develop novel skin 
substitutes are still (and will be in the future) based on purified ECM components 
such as collagens, fibrin and hyaluronic acid (see also Table 1). These represent a 
relative basic ECM environment, which is conductive to the activities of determined, 
non-stem keratinocytes. Imposing a tissue-specific identity on the epidermal 
keratinocyte stem cell fraction is likely to require more specific influences during their 
3D organotypic culture and after transplantation on the organism, if not already 
during their expansion in 2D cultures. It is promising that the outcome of growth 
factor administration can be improved enormously with the employment of technically 
relatively simple slow release schemes [89]. However, it also needs to be taken into 
account that an epithelium and its mesenchyme support each other in an equilibrated 
and complete manner. Thus, the growth factors and matrix components released by 
different, but interacting cell types may be even more “instructive” than slowly 
released “instructive” factors and matrices. It remains to be investigated whether 
purified factors alone or distinct cell types in concert, or combinations thereof, will 
provide the “skingineering” concept of the future [39], [89] and [90]. 
The field of stem cell biology also has to be integrated in this future concept. There is 
a huge potential for using human originated adult stem cells as a source of in vitro 
generation of skin [91], [92] and [93]. Human keratinocytes derived from the 
epidermal stratum basale [20], [21], [22], [42] and [43], from hair follicles [94], [95], 
[96] and [97] and as recently suggested, also from eccrine sweat glands [98] and 
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[99], are sources that allow scaling up the self-renewing keratinocyte fraction in 
engineered human skin grafts. 
The experience of the past 25 years has identified that in the production of tissue-
engineered materials the focus must move more quickly from laboratory to clinical 
use. Yet safety precautions have to be met. Production costs must be carefully 
considered, so that reimbursement gives a sufficient income. New products have to 
be more rapidly adapted to a rapidly changing regulatory environment. Despite initial 
unrealistic commercial and clinical expectations, tissue-engineered skin has already 
now delivered considerable benefits to patients with burns, accidents, infections and 
chronic wounds. “Skingineering” has enormous potential that has just begun to be 
realized. 
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Fig. 1. The structure of human skin. Human skin consists of three layers. The 
outermost layer, the epidermis, measures about 0.1–0.2 mm. Keratinocytes and 
melanocytes are prominent cell types of the epidermis. The basement membrane 
physically separates the epidermis from the underlying dermis, however, functionally 
it connects both tissues. The major cellular components of the dermis are fibroblasts 
producing extracellular matrix. The rich dermal vascular system provides all cell 
types with nutrients. Skin appendages like hair follicles, sebaceous and sweat glands 
are situated throughout the dermis and epidermis. The subcutis (hypodermis) 
consists mainly of fat tissue, which functions as insulation and as an energy source 
[16].  
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Fig. 2. Timeline of key developments [100], [101] and [102]. 
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Table 1.  Examples of commercially available skin substitutes. 
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Fig. 3. The need of tissue-engineered skin. (A) The acute situation. Patient, suffering 
from large and deep burn injury after escharatomy, necessitating necrectomy and 
skin coverage. Due to the large total body surface area affected, little healthy skin 
remains as donor site for a split-thickness skin graft. (B) The elective situation. 
Patient with a giant congenital melanocytic nevus, expanding over the elbow. After 
resection, the patient would benefit of the application of a tissue-engineered skin 
substitute of matching colour and texture to the adjacent skin.  
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Fig. 4. Tissue engineering of the skin. Reconstruction of tissue-engineered skin. A 
patient's skin biopsy is treated enzymatically to digest the basement membrane. 
Epidermis and dermis are separated, followed by isolation of epidermal keratinocytes 
and melanocytes, dermal fibroblasts and vascular endothelial cells. The cells are 
cultured in culture dishes in the appropriate medium for each cell type. Dermo-
epidermal substitutes, consisting of fibroblasts in a collagen hydrogel and 
keratinocytes/melanocytes seeded on top of the hydrogel. Cultured vascular 
endothelial cells are seeded in hydrogels to form a network of lumenized capillaries 
[50], [54], [123] and [124].  
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Fig. 5. Epidermal homeostasis in transplanted dermo-epidermal substitutes and pre-
vascularized hydrogels. (A) Cytokeratin 19-positive (K-19) human keratinocytes are 
indicative of an intact epidermal homeostasis in a grafted dermo-epidermal skin 
substitute. The dermo-epidermal skin substitute consisting of human keratinocytes as 
epidermal equivalent and a collagen type-I hydrogel containing human dermal 
fibroblasts was transplanted onto the back of immuno-incompetent rats. Cytokeratin 
19-positive cells (red) are organized in clusters. Note that Cytokeratin 19-positive 
cells are restricted to the well-defined stratum basale. Human dermal fibroblasts 
(green) are recognized by the human CD90 (Thy-1)-specific antibody, whereas the 
rat tissue underneath stains negatively (cell nuclei: blue) [40]. (B and C) Phase 
contrast micrograph of capillary formation in vitro. Human microvascular endothelial 
cells (HuMECs) were isolated from a skin biopsy, cultured and seeded in a hydrogel. 
(B) HuMECs develop into dense networks of branching solid cords after 1 week. 
Anastomoses are indicated by black arrows. (C) Branching, completely lumenized 
capillaries developing in hydrogels (white arrow). Regularly alternating nuclei (black 
arrows) and the cytoplasm are retracted towards the plasma membrane. The two 
branches of a capillary are indicated by asterisks [50]. Scale bars: (A) 100 µm; (B 
and C) 50 µm. (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of the article.) 
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3   Conclusion 
 
The idea that human eccrine sweat glands contain epidermal keratinocyte stem cells 
was discussed in several previous reports, however, data and a final proof were not 
reported (Brouard, 2003, Barrandon, 2007, Nakamura, 2009). 
In this work I could show, to my knowledge for the first time, that isolated primary 
human eccrine sweat gland cells are capable to develop into a stratified epidermis 
both, in vitro and in vivo. Notably, there was no major difference between sweat 
gland cells and epidermal keratinocytes regarding the formation of an epidermis. 
The following aspects deserve a detailed comment. In all our analyses, sweat gland 
cells forming the epidermis, expressed well-known interfollicular epidermal markers 
such as integrin α6β4, involucrin, loricrin, envoplakin and transglutaminases 
(Biedermann, 2010, Pontiggia, 2009, Tharakan, 2010). Although we observed a 
somewhat delayed expression of several of these markers in sweat gland cell 
derived epidermises (such as K2e expression), these finally developed into a 
complete and functional epidermis. The delay mentioned above is most likely due to 
sweat gland cells undergoing a phenotypic transition from ductal or secretory 
glandular cells into interfollicular epidermal keratinocytes.  
The sweat gland cell transition may represent the reversion of the ontogenetic 
process in embryogenesis, when ectodermal cells differentiate into ductal and 
secretory cells (Fu, 2005). Two conceivable mechanisms for this cell transition may 
exist: 
1. Sweat gland cells might de-differentiate (or retrodifferentiate) into a more naive 
state, after which they differentiate into a new phenotype, i.e., epidermal 
keratinocytes. 
2. A multipotent, sweat gland-derived stem cell population may differentiate into 
epidermal keratinocytes in response to their new epidermal environment.  
Based on the fact that the new sweat gland derived epidermis was permanently 
maintained in vivo, it has to be postulated that self-renewing keratinocytes assured 
the integrity of the new epidermis. It may well be possible that even both, sweat 
gland derived epithelial stem cells and re-programmed sweat gland derived cells in 
concert formed the new epidermis. 
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Published data show that epithelial stem cells, located in hair follicles can re-
establish the epidermis in a wound situation (Ito, 2005, Levy, 2005). However, there 
is also glabrous skin (palms and soles) of humans in which not a single hair follicle 
can be found, but a relatively great number of sweat glands is present (Frinkel, 
2001). Therefore, our findings support the idea that sweat glands, in analogy to the 
hair follicle bulge, contain potential keratinocyte stem cells (Brouard, 2003, 
Barrandon, 2007, Nakamura, 2009), which have the potential to reconstitute human 
epidermis upon wounding or even to permanently participate in regenerating human 
interfollicular epidermis. 
This concept is supported by our observation that the epidermis formed by sweat 
gland cells had no morphological and structural features of palmo-plantar or buccal 
epithelia, but features of normal interfollicular epidermis. This is in contrast to a report 
by Miller et al., 1998, who showed that porcine sweat gland cells developed an 
epidermis displaying palmo-plantar features. This different finding is most likely due 
to the fact that porcine skin harbors apocrine glands (which most likely do not even 
function as sweat glands), whereas human skin harbors functionally different eccrine 
sweat glands (Montagna, 1964, Ferry, 1995). 
 
A point which should be addressed in subsequent studies is the question where the 
epithelial stem cell niche is located in the sweat gland. The knowledge in this respect 
is very limited (Barrandon, 2007, Nakamura, 2009). One report suggests that 
keratinocyte stem cells are located in the proximal intraglandular duct immediately 
adjacent to the secretory domain or in the upper ductal portion (Langbein, 2005). Our 
data suggest that stem cells are situated in the secretory portion (Pontiggia, 
manuscript in preparation).  
The finding that sweat gland-derived epithelial cells obviously represent an additional 
source of keratinocytes which can grow to a near-normal autologous epidermis is 
important from a tissue engineering point of view. It is particularly relevant for 
patients requiring large and urgent covering of skin defects, such as severe burn 
injuries (third degree; >50% body surface area). In these cases, self-renewing 
keratinocytes are urgently required for the in vitro production of as many life-saving 
skin grafts as possible. 
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I was also involved in a second work in which we tested for potential keratinocyte 
stem cell markers and for markers of epidermal homeostasis as signs for the quality 
of produced human dermo-epidermal skin substitutes (Pontiggia, 2009). 
The novelty we observed in these experiments is the expression pattern of the cyto-
keratins K15/K19. Interfollicular keratinocytes neither express K15 after isolation from 
skin samples and growth on cell culture plastic, nor is K15 detectable in dermo-
epidermal substitutes in vitro. Obviously, keratinocytes on cell culture plastic and 
within engineered skin substitutes display a wound situation in which tissue 
homeostasis is not at all, or only imperfectly established. In contrast, after 
transplantation of engineered skin constructs onto immunoincompetent rats, we were 
able to identify K15-positive keratinocytes in the basal layer of the epidermis. 
Furthermore, we observed that K19 is expressed in single cells or in clusters of cells 
in the basal layer of the epidermis after transplantation of skin substitutes. We 
suggest therefore that K19-positive cells represent a population of keratinocytes that 
is adapted to lateral expansion of the epidermis.   
Taken together, we propose that basal K15/19-positive keratinocytes in the basal 
layer are indicators of epidermal homeostasis, thus a marker for the quality of 
(grafted) engineered dermo-epidermal substitutes.      
 
Dermo-epidermal skin substitutes can also be used to study certain skin diseases. 
Although several methods to study melanoma biology are known, a reliable model to 
study the genesis of melanoma in human skin in vivo is missing (Satyamoorthy, 
1999, Bissell, 2010, Verbridge, 2010).  
With our dermo-epidermal skin substitutes we can also employ human melanoma 
cells in the epidermal portion. The engineered skin constructs are then transplanted 
onto athymic rats. Using this in vivo assay we can show the process of basement 
membrane penetration, migration of melanoma cells into the dermis and formation of 
metastasis. As a methodological novelty our humanized 3-dimensional in vivo model 
can open new prospects in basic melanoma research (Biedermann, manuscript in 
preparation).  
 
 
An issue often underestimated is the generation of a proper dermal substitute. In the 
1970’s and 1980’s the focus in skin tissue engineering was the epidermis. It was a 
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challenging task to isolate and culture human epidermal keratinocytes (Rheinwald, 
1975), even more to transplant the first keratinocyte sheets to patients (O’Connor, 
1981, see also for review Böttcher, 2010). But soon it was recognized that not only 
the epidermis is important. Wound contraction and scarring are dependent on the 
dermis (Grinnell, 1994, Gurtner, 2008, for review Böttcher, 2010). This is supported 
by the observation that functional dermal substitutes, used in combination with 
epidermal tissue in surgical skin reconstruction, resulted in a significantly better 
functional and cosmetical outcome, as compared to grafting of only cultured 
epidermal sheets or split-thickness skin (Moiemen, 2001, Moiemen, 2006).  
This prompted us to employ commercially available matrices to engineer dermo-
epidermal skin grafts (Schneider, 2009). We found that dermal templates based on 
lyophilized collagen “sponges” are not suitable to produce an autologous skin 
substitute. Of course, these matrices may serve as a basis for the development of a 
vascularized neodermis in clinical use. In a second surgical intervention then this 
neodermis may be covered by split-thickness skin grafts (for review, van der Veen, 
2010, Böttcher, 2010). We also realized this quality in our studies, showing that the 
formation of an epidermis is possible after vascularization of collageneous templates, 
such as Integra® or Matriderm® (Schneider, 2009).  
However, we showed that our dermo-epidermal skin grafts, based on collagen 
hydrogels, are perfectly suited to bring about a high quality, novel skin in a one step 
operation. The biological properties of these skin grafts do greatly support the 
formation of an epidermis and a well-vascularized dermis after transplantation 
(Biedermann, 2010, Pontiggia, 2009). Importantly, the biological advantages of these 
hydrogels can now be combined with plastic compression of hydrogels (Braziulis, 
manuscript in preparation) and the use of a biodegradable supporting mesh 
(Hartmann, manuscript in preparation) to yield a more stable construct. This prevents 
the skin substitutes from contraction and leads to a significant improvement in 
handling properties, especially concerning a future surgical application. Thus, our 
challenging aim to produce a large-scale autologous dermo-epidermal skin substitute 
for clinical application is in reach.  
 
Of course, skin constructs have to be tested in preclinical studies before there is an 
implementation for humans.  
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The typical in vivo model for preclinical studies for new skin products is to apply them 
onto pigs (Sullivan, 2001, Middelkoop, 2004). At the moment we conduct such a 
preclinical study. We have already established a pig model for our large (7 x 7cm) 
skin grafts, which has not been described before (Schiestl, manuscript in 
preparation).   
 
Taken together it can be said that the tissue engineering of skin is the point of 
intersection of applied and basic research. This is also underscored in my work. On 
the one hand, I was able to show that eccrine sweat gland cells are capable to form a 
stratified, functional epidermis. On the other hand I was involved in improving our 
dermo-epidermal skin substitutes and in conducting a preclinical study. All this is 
done to apply autologous skin equivalents onto patients in the near future.  
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